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ABSTRACT 
 
Psittacid Herpesviruses Associated with Internal Papillomatous Disease and Other  
Tumors in Psittacine Birds.  (August 2005) 
Darrel Keith Styles, B.S., Appalachian State University; 
D.V.M., North Carolina State University; 
M.S., The University of Texas at Austin 
Chair of Advisory Committee:  Dr. David N. Phalen 
 
 
     Internal papillomatous disease (IPD) is characterized by mucosal papillomas 
occurring primarily in the oral cavity and cloaca of Neotropical parrots.  These lesions 
can cause considerable morbidity, and in some cases result in mortality.  Efforts to 
demonstrate papillomavirus DNA or proteins in the lesions have been largely 
unsuccessful.  However, increasing evidence suggests that mucosal papillomas may 
contain psittacid herpesviruses (PsHVs).  In this study, PsHV 1 genotype 1, 2, and 3 
DNA was found in 100% of mucosal papillomas from 30 Neotropical parrots by PCR 
using PsHV specific primers.  However, Psittacus erithacus papillomavirus and finch 
papillomavirus DNA were not detected.  Additionally, a novel PsHV sequence related 
to, but phylogenetically distinct from PsHV 1, was identified in 4 African grey parrots 
(Psittacus erithacus), two of which exhibited papillomas. These findings suggest that 
mucosal papillomas may develop in parrots latently infected with PsHV.   Tumors of the 
bile and pancreatic ducts have also been observed in parrots with IPD.  Other mucosal 
tumors including carcinomas of the proventriculus and ventriculus may be coincident 
 iv
with bile duct tumors, but cloacal carcinomas usually develop as solitary lesions.  To test 
whether PsHV was associated with these tumors, the fresh tissues from 11 parrots and 
the formalin-fixed paraffin-embedded (FFPE) tissues of 5 parrots exhibiting mucosal 
tumors were examined by PCR.  All tumors were found to contain PsHV 1 genotype 3 
DNA except one bird with a cloacal carcinoma that contained genotype 4.  
Histologically normal tissues available from six parrots did not contain PsHV DNA.  
Experiments were performed using the FFPE tissues of 5 parrots with IPD related 
tumors known to contain PsHV by PCR, to show that the virus was in significantly 
higher concentration in the neoplastic tissue compared to adjacent histologically normal 
tissue.  Neoplastic and adjacent unaffected cells were dissected from the tissues using 
laser capture microdissection and the DNA was examined by PCR.  In situ hybridization 
using PsHV specific probes and direct in situ PCR were also performed on the tissues.  
A strong association was shown between infection by PsHV 1 genotype 3 and birds 
manifesting IPD related tumors and other neoplasms of the digestive tract.  
 
 
 
 
 
 
 
 
 
 v
DEDICATION 
 
 
 
 
 
 
 
 
This dissertation is dedicated to the work of the veterinarians and researchers  
whose efforts have advanced the knowledge of avian medicine and biology. 
And to my family and friends who have supported me through this effort. 
 vi
ACKNOWLEDGMENTS 
 
     I would like to thank my committee chair, Dr. David Phalen and my committee 
members, Dr. Judith Ball, Dr. Ian Tizard, and Dr. Van Wilson, for their guidance and 
support throughout the course of this research. 
     I would also like to thank the Schubot Exotic Bird Health Center and many 
aviculturists and bird clubs for funding this research.  I would also like to express my 
gratitude to Dr. Elizabeth Tomaszewski for her direction and assistance in the technical 
aspects of this work.  Thanks to Dr. Laurie Jaeger for her support and assistance with 
this project.  Thank you to Ms. Rosemary Vollmar and the histology group for their help 
and training.  And, thanks to Dr. Yawei Ni and laboratory group for their patience and 
assistance.   
 vii
TABLE OF CONTENTS 
 
  Page 
ABSTRACT.  iii 
DEDICATION..     v 
ACKNOWLEDGMENTS   vi 
TABLE OF CONTENTS.  vii 
LIST OF FIGURES..    xi 
LIST OF TABLES.   xiii 
CHAPTER 
 I INTRODUCTION..    1 
    
   Overview..   1 
   Herpesviridae       3 
 Model alphaherpesvirus-human herpesvirus 1..  5 
 Oncogenic herpesviruses 17   
 Papillomavirinae... 20 
 Model papillomavirus-bovine papillomavirus 1. 21 
 Psittacid herpesvirus. 33 
 Pachecos disease 35 
 Mucosal papillomatosis.. 38 
 A novel psittacid herpesvirus found in African   
  grey parrots.. 41 
 Internal papillomatous disease and other 
   associated tumors. 42 
 
 II PSITTACID HERPESVIRUSES ASSOCIATED WITH 
 MUCOSAL PAPILLOMAS IN NEOTROPICAL PARROTS.         45 
 Introduction 45 
 Results 49 
   
 
 
 
 viii
 
 CHAPTER   Page 
 
 
  Immunohistochemistry of mucosal papillomas  
   using anti-HPV6b L1 serum.. 49 
  Electron microscopy 51 
  PCR with PePV- and FPV-specific primers. 51 
  Amplification of DNA from known PsHVs using 
   primers from the DNA polymerase gene 52 
  PCR with PsHV specific primers.. 54 
  Phylogenetic analysis 57 
  Estimation of the distribution of genotypes in the 
   population of birds with mucosal papillomas. 57 
  Significance of the observed PsHV prevalence in 
   papillomas as compared to the estimated  
   prevalence rates in the general psittacine 
   population 59 
 Discussion 59 
 Materials and Methods... 65 
  Source of specimens.. 65 
  Histological evaluation of the mucosal  
   papillomas and unaffected tissue.. 67 
  Immunohistochemistry of mucosal papillomas  
   using papillomavirus anti-L1 major capsid 
   protein antibody 67 
  Electron microscopy.. 68 
  DNA purification 69 
  PCR of papilloma tissues with PePV- and  
   FPV-specific primers 69 
  Amplification of DNA of known PsHVs using 
   primers from the DNA polymerase gene. 70 
  PCR of DNA from papilloma tissues with  
   PsHV-specific primers. 71 
  DNA sequencing of PsHV amplicons.... 72 
  Phylogenetic analysis. 72 
  Statistical analysis.. 73 
    III A NOVEL PSITTACID HERPESVIRUS FOUND IN  
AFRICAN GREY PARROTS (PSITTACUS ERITHACUS 
ERITHACUS) 74 
 Introduction.. 74 
 Results.. 75 
  Histological examination of tissues 75 
 ix
 CHAPTER   Page 
 
 
 PCR with PsHV specific primers amplifying  
   regions of UL9, UL16/17, and UL30.. 76 
 Sequencing of PsHV amplicons from UL16/17  
    and UL30 78 
 Phylogenetic analysis.. 79 
 Discussion 79 
 Materials and Methods. 85 
  Sample history and collection. 85 
  Histological evaluation of the tissue .. 86 
  DNA extraction and polymerase chain reaction 86 
  PCR product purification and sequencing. 87 
  Phylogenetic analysis 88 
 IV INTERNAL PAPILLOMATOUS DISEASE AND OTHER 
TUMORS ASSOCIATED WITH PSITTACID 
HERPESVIRUS INFECTIONS IN PARROTS. 89 
 
 Introduction. 89 
 Results. 95 
  Histological evaluation of tissues. 95 
  PCR of fresh IPD tissues with PsHV-specific  
   primers. 98 
  Phylogenetic analysis of PsHV DNA  
   sequences from the fresh IPD tissues..  101 
  PCR of formalin-fixed paraffin-embedded IPD  
   tissues with PsHV specific primers.  101 
  Phylogenetic analysis of PsHV DNA sequences  
   from the FFPE-IPD tissues.  104 
  PCR of tissue collected by laser capture  
   microdissection  104 
  In situ hybridization..  107 
  Direct in situ PCR.  110 
 Discussion...  113 
 Materials and Methods..  119 
  Samples:  sources, history, and processing..  119 
  Histological evaluation of the tissues  122 
  Extraction of DNA from fresh IPD tissues..  122 
  Extraction of DNA from formalin-fixed  
   paraffin-embedded tissues..  122 
  PCR of IPD tissues with PsHV 1-specific  
   primers  123 
   
 x
 CHAPTER   Page 
 
 
  DNA sequencing of PsHV amplicons from  
   IPD tissues..  125 
  Phylogenetic analysis of sequences from  
   IPD tissues..  125 
  Preparation and sectioning of tissues for LCM  126 
  Laser capture microdissection (LCM)..  126 
  Tissue processing for in situ hybridization and 
    in situ PCR.  127 
  In situ hybridization:  synthesis of biotinylated  
   probes.  129 
  In situ hybridization.  131 
  In situ hybridization and direct in situ PCR:   
   detection of biotin and chromagenic  
   staining.  132 
  Direct in situ PCR:  blocking of non-specific  
   amplification using S1 nuclease or 2, 3  
   dideoxythymidine 5-triphophate (ddTTP) .  133 
   Direct in situ PCR  134 
 V DISCUSSION AND CONCLUSIONS..  136 
 Discussion  136 
 Future studies..  141 
REFERENCES  145 
VITA  171 
 xi
LIST OF FIGURES 
 
  
  Figure    Page 
1.1 Map of HSV-1 genome.    6 
1.2 Map of BPV-1 genome..   22 
 2.1  Immunohistochemical results of staining with the anti-L1 fusion  
 protein antiserum   50 
 
2.2 Comparison of the amplification efficiency of primer sets PsHV- 
 Johne and 23F-amplifying using paired DNA samples  
 representative of each of the four PsHV genotypes ....   53 
 
2.3 Evaluation of the sensitivity of the 23F primer set to detect PsHV 
 in serial dilutions of a PsHV clone of known concentration, and 
 from 100 ng of genomic DNA extracted from mucosal papillomas    55 
 
2.4 Consensus phylogenetic tree of a set of 419 bp PsHV sequences 
generated by bootstrap re-sampling, distance optimality, and 
neighbor-joining search using PAUP 4.0.   56 
 
 2.5 Phylogram displaying branch lengths and bootstrap values for one 
   representative of each genotype of the 419 bp PsHV sequence    58  
 
3.1 Unrooted consensus phylogram of an 88 amino acid fragment from  
 the DNA polymerase gene (UL30) generated by bootstrap re- 
 sampling, distance optimality, and neighbor-joining search  
 using PAUP 4.0.   80  
 
3.2 Unrooted consensus phylogram of a 139 amino acid fragment from  
 the host range protein gene (UL16) of African grey parrots and four  
 PsHV-1 reference sequences from Neotropical parrots generated by 
 bootstrap re-sampling, distance optimality, and neighbor-joining 
 search using PAUP 4.0 .   81  
 
4.1 Gross and microscopic views of the spectrum of change in two  
 parrots with bile duct carcinoma .   94 
 
 4.2  Microscopic views of an endoventricular and cloacal carcinoma ..   95 
 xii
 
 Figure    Page 
4.3 Consensus phylogenetic tree of a set of 419 bp PsHV sequences  
 generated by bootstrap re-sampling, distance optimality, and  
 neighbor-joining search using PAUP 4.0. 100 
 
4.4 A 1% agarose gel showing PCR results using primer set  
 23Ff5a/23Fr+114D with tissues of three different samples.    103 
 
4.5       In situ hybridization results of three control tissues and a  
 liver with bile duct carcinoma..    109
  
 4.6  In situ PCR results from two sections of crop     111  
 
4.7 In situ PCR results using a combination of PsHV primers  
 23Ff-131D/23Fr+63 (UL16/17 genes) and 39RADf/39Fr2  
 (UL30 gene) with S1 nuclease treatment.    112 
 
4.8 Chemiluminescent film of relative intensities of signal of  
 random probes to concentrations of known standards.    130 
 xiii
LIST OF TABLES 
 
 
 Table  Page 
 
 
 2.1  Primer sequences for PePV, FPV, and PsHV..  52 
 
 2.2  Tissues and sources.. . 66 
 
 3.1  Tissues and sequences... 76
  
 3.2  Primer sequences for PsHV and PePV.. 77 
 
3.3 PsHV amplification results for primer sets 11R, 23F, 39F,  
 ILK/IYG 78 
 
 4.1  Fresh IPD tissues, samples and sequence results. 96 
 
 4.2  PCR results of formalin-fixed paraffin-embedded tissues 97 
 
 4.3  Primer sequences for PsHV and cytochrome oxidase I. 99 
 
 4.4  Tissues examined using LCM.. .  106 
 
 4.5 Tissues examined by in situ hybridization and in situ PCR...  108 
 1
CHAPTER I 
 
INTRODUCTION 
 
Overview 
     Internal papillomatous disease (IPD) affects predominately captive psittacine birds of 
new world distribution, with the greatest prevalence reported in macaws (Ara spp.), 
Amazon parrots (Amazona spp.), conures (Aratinga spp.), and hawk-headed parrots 
(Deroptyus accipitrinus) (Graham, 1991; Gibbons et al., 2002; Hillyer et al., 1991; 
Phalen et al., 1997; Van der Heyden, 1988).  IPD is characterized by mucosal papillomas 
affecting primarily the epithelium of the oral cavity and cloaca, but are also observed in 
the esophagus, crop, proventriculus, ventriculus, conjunctiva, nasolacrimal duct, and 
bursa (Graham, 1991; Phalen et al., 1997).  Grossly, mucosal papillomas are pink to 
grey-tan verrucous lesions that may cause increased morbidity, interfere with 
reproduction, and potentially result in death (Graham, 1991; McDonald, 1988; Phalen et 
al., 1997).  Other tumors have also been associated with IPD including adenomas and 
carcinomas of the bile and pancreatic ducts (Graham, 1991; Elangbam and Panciera, 
1988; Gibbons et al., 2002; Hillyer et al., 1991; Phalen et al., 1997; Potter et al., 1983), 
and perhaps carcinomas of the proventricular, ventricular, and cloacal mucosa.  Because 
IPD and associated neoplasms posed a threat to the health of captive parrot populations, 
investigations into the cause of IPD and associated tumors were initiated.  
     Cutaneous and mucosal papillomas in mammals and cutaneous papillomas in two 
species of birds were known to be caused by species-specific papillomaviruses  
__________________ 
This dissertation follows the style of Virology. 
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(Brentjens et al., 2002; Moreno-Lopez et al., 1984; OBanion et al., 1992).    However, 
 there was little evidence supporting papillomaviruses as the cause of mucosal 
papillomas in parrots (Johne et al., 2002; Latimer et al., 1997; Sundberg et al., 1986).  
Due to the paucity of evidence associating papillomaviruses with mucosal papillomas, 
Graham (1991) introduced the term IPD to differentiate this disease from those 
papillomas known to be caused by papillomaviruses.  IPD and associated tumors 
appeared to have a common but undetermined etiology (Graham, 1991; Phalen et al., 
1997).   
     Clinical observations suggested that mucosal papillomas developed in parrots that 
survived outbreaks of Pachecos disease (PD) (Gaskin, 1989; Van der Heyden, 1988).  
PD is a generally fatal disease found predominately in Neotropical parrots, but also 
affects parrots from other geographical distributions (Tomaszewski et al., 2003).   PD is 
caused by one of four genotypes of psittacid herpesvirus (PsHV) and its lethality 
depends on the species of parrot infected as well as undetermined viral factors 
(Tomaszewski et al., 2003).  The possibility that a herpesvirus could be the cause of 
mucosal papillomas in parrots was supported by studies showing that in some cases, 
papillomas in other vertebrates were associated with herpesviruses rather than 
papillomaviruses (Calle et al., 1999; Goodwin and McGee, 1993; Herman et al., 1997; 
Lowenstine et al., 1983; Quackenbush et al., 2001).  There were also specific reports 
associating PsHV infection with the presence of mucosal papillomas (Johne et al., 2002; 
Phalen et al., 1998). 
     The hypothesis of our investigation was that survivors of PsHV infection may 
develop IPD.  We offer compelling evidence of a causal relationship between PsHV 
 3
infection and the lesions associated with IPD.  In the first report, we present data 
demonstrating a strong correlation between PsHV infection and the presence of mucosal 
papillomas.  In additional studies, we also show the association between PsHV infection 
and the other tumors associated with IPD.  Finally, our investigation of mucosal 
papillomas coincidentally yielded the discovery of a new species of PsHV found in 
African grey parrots that is related to, but phylogenetically distinct from, those PsHVs 
known to cause PD.  
     This introduction will review the biology of both herpesviruses and papillomaviruses 
and their potential to induce tumors.  The molecular biology of both PsHV and avian 
papillomaviruses is still under investigation, so much of the information on the 
biological properties of these viruses is lacking.  Therefore, these two viral families will 
be broadly discussed and model viruses will be selected to describe more specific 
biological properties.  
 
Herpesviriridae 
     Herpesviruses are double-stranded DNA viruses with linear genomes ranging from 
124-235 kbp in length.  Herpesvirus genomes can be divided into six groups designated 
A-F based the number and location of internal and terminal repeat sequences separating 
the unique and quasi-unique sequences.  The genome is packaged as a toroid in most 
herpesviruses, enclosed within an icosadeltahedral capsid surrounded by an amorphous 
material called the tegument.  The tegument contains viral proteins essential for the 
efficient replication of the virus.  Herpesviruses are enveloped viruses and the envelope 
appears to be derived from the cellular plasma membrane incorporating viral 
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glycoprotein spikes that project from the surface (Boehmer and Nimonkar, 2003; 
Herausgeber, 1992; Roizman and Pellet, 2001). 
     Herpesviruses are divided into three subfamilies, Alphaherpesvirinae, 
Betaherpesvirinae, and Gammherpesvirinae that are differentiated according to their 
biological properties, but the subfamilies do share some common characteristics.  All 
herpesviruses produce their own enzymes and other factors involved in viral nucleic acid 
synthesis.  Viral DNA synthesis and assembly of capsids occurs in the nucleus of the 
cell, and capsids are enveloped as they transit through the nuclear membrane.  
Productive infection always results in the death of the cell.  Importantly, all known 
herpesviruses can exist in a latent state within their natural hosts while expressing a 
small subset of viral genes.  Latent infection appears to be favored by particular subsets 
of the trigeminal ganglion sensory neurons while productive infection is preferred by 
other types of sensory neurons. (Herausgeber, 1992; Roizman and Knipe, 2001).      
     Alphaherpesviruses exhibit a variable host range and engage in a relatively short 
reproductive cycle.  They spread rapidly in culture and destroy infected cells efficiently.  
Alphaherpesviruses have the ability to penetrate both the apical and basilar aspects of 
epithelial cells as well as the dendrites of neurons.  They also have the potential to 
establish latent infections in sensory ganglia (Roizman and Pellet, 2001).  
     Betaherpesviruses express a restricted host range and display a long reproductive 
cycle that results in slow spread in culture.  These viruses often induce cytomegaly in 
infected cells.  Betaherpesviruses establish latent infections in lymphoreticular cells and 
possibly secretory glands as well as other tissues (Roizman and Pellet, 2001).   
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    Gammaherpesviruses are usually limited to members of the same order as their natural 
hosts.  They replicate in lymphoblastoid cells and cause lysis in some types of epitheliod 
and fibroblastic cells in vitro.   Gammaherpesviruses tend to be specific for T or B 
lymphocytes where they typically reside in a latent state in vivo (Roizman and Pellet, 
2001).  
 
Model alphaherpesvirus-human herpesvirus 1  
     Herpes simplex virus (HSV 1) was chosen as the model virus to describe the 
molecular properties of PsHVs because information regarding the molecular biology of 
the PsHVs and their nearest known avian alphaherpesvirus relatives is incomplete or 
lacking.  PaHV 1 (passerid herpesvirus 1) appears to be phylogenetically the closest 
PsHV relative, but only 177 bps of UL30 is available for study and little is known about 
the molecular biology of this virus (Wellehan et al., 2003).  This lack of information 
makes the placement of PsHV 1 questionable, but the complete sequence for the next 
nearest PsHV relative, GaHV 1 (gallid herpesvirus 1 or infectious laryngotracheitis 
virus), is available in the GenBank accession no. NC_006623), but again little is 
understood about the molecular biology of the virus and it has also diverged significantly 
from PsHV (Tomaszewski et al., 2001).  The biological properties of another close 
PsHV relative, GaHV 2 (gallid herpesvirus 2 or Mareks disease, GenBank accession no. 
NC_002229) are better understood, but this virus is too dissimilar for direct comparison 
 6
 
 
 
 
Fig. 1.1. Map of HSV-1 genome (from Roizman and Sears, 1996).   A more complete 
gene map may be found at http://www.stdgen.lanl.gov/ (Roizman and Knipe, 2001).  
The outermost radial shows the protein names, the next radial shows the UL or US 
designation along with the gene type (α, β, or γ).  The arrow radial designates the 
direction of transcription.  The next radial inward shows the ICP protein designations.  
The next inward radial is a schematic showing the three origins of replication and the 
flanking LTR regions.  The innermost radial shows the map units and kilobase pair 
measurement.    
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to PsHV.  However, much is known about herpes simplex viruses that share structurally 
similar genomes to PsHV with some comparable biological activities.   
     HSV 1 is a 152 kbp alphaherpesvirus that causes productive lesions of oral 
mucocutaneous tissues of humans where the virus resides latently in the ganglia 
associated with the site of active replication.  The linear double-stranded DNA genome 
arrangement of HSV-1 belongs to group type E, which is divided into unique long (UL) 
and unique short (US) coding sequences each flanked by their own individual inverted 
terminal repeat sequences (Fig. 1.1).  The UL and US sequences can invert relative to 
each other creating 4 linear isomers based on restriction endonuclease analysis. There 
are currently 84 known open reading frames (excluding the two latency associated 
transcripts) within the viral genome (Rajčáni et al., 2004).  Compared to other DNA 
viruses, there is relatively little overlap of the viral genes and only a few known 
instances of transcript splicing.  There are three classes of ORFs in HSV; those with 
common initiation signals but different termination points; those with different initiation 
sites but common termination points; and those that are nested differing at both initiation 
and termination points (Rajčáni et al., 2004).  The HSV genes are divided into five 
groups designated α, β1, β2, γ1, and γ2.  These genes are transcribed in a relatively 
sequential fashion according to the needs of the replicating virus.  Transcription of HSV 
genes will be described later in detail (Boehmer and Nimonkar, 2003; Roizman and 
Knipe, 2001). 
     Viral infection is initiated by attachment to cell surface receptors followed by fusion 
with the plasma membrane.  HSV can utilize more than one attachment pathway so a 
number of viral glycoproteins may be involved in this attachment.  This observation is 
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supported by the fact that in vivo HSVs attach not only to different cell types, both 
epithelial cells and neurons, but also to different polarized surfaces including the apical 
and basilar aspects of the epithelial cells and the axonal and dendritic portions of the 
neurons.  Glycoprotein gB and/or gC binds with cellular heparin sulfate attached to cell-
surface proteoglycans as the major binding factor for HSV (Shukla and Spear, 2001).  
Glycoprotein gC has also been shown to be required for attachment to the CD35 (CR-1) 
receptor on the apical portions of polarized cells but not for attachment of the virus to 
the basilar surface of the same cell (Roizman and Knipe, 2001).  Glycoproteins gB, gD, 
gH, and gL are believed to be essential for entry (Spear and Longnecker, 2003).  
Glycoprotein gD is the primary ligand for three recognized cell surface receptors that 
mediate fusion with the plasma membrane.  These receptors are HVEM (herpesvirus 
entry mediator, a member of the tumor necrosis family receptors), and nectins-1 & 2 
(members of the immunoglobulin receptor group) (Spear et al., 2000).  Any single 
receptor can bind gD and mediate fusion, and the receptor preference appears to vary 
with viral serotype.  The exact mechanism by which gD mediates fusion is not well 
understood, but glycoproteins gB, gH, and gL are required for successful entry.  HVEM 
is expressed on the exposed surface of a variety of cell types including epithelial cells.  
The nectins are located at the gap junctions of cells including epithelial cells and neurons 
and are not exposed unless there is cell disruption.  It is speculated that initial attachment 
in polarized cells is accomplished via HVEM and that cell-to-cell transmission is 
mediated via the nectins, particularly in the case of neurons (Haarr et al., 2001).   
     After this fusion event, the proteins of the tegument are released.  There are at least 
15 recognized tegument proteins and some estimates are as high as 21 proteins that 
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perform a variety of functions to prepare the cell for viral replication (Bearer and 
Satpute-Krishnan, 2002; Mettenleiter, 2002).  Two of the most notable tegument 
proteins are VHS and α-TIF.  VHS (UL41 or viral host shut-off protein) is active in the 
cytoplasm where it terminates cellular and viral protein synthesis by destabilizing and 
degrading mRNA in a sequence specific fashion (Esclatine et al., 2004).  Reasons for the 
destruction of host mRNA are obvious, but degradation of the viral mRNA seems less 
intuitive.  However, it is believed that degradation of viral mRNA permits the rapid 
switching of one regulatory class of HSV genes to another.  It is speculated that VHS 
degrades only select host cellular proteins, thus disabling specific functions of cellular 
metabolism while permitting activities conducive to viral replication (Smiley, 2004). 
The α-TIF protein (UL48 or alpha trans-initiating factor) is transported into the nucleus 
where it acts as a transcriptional activator of the early viral α-genes (Roizman and 
Knipe, 2001).   
     The de-enveloped virions are transported to the nuclear pores via the cellular 
cytoskeleton.  Retrograde transport of the virions to the nucleus of neurons is 
accomplished by attachment of the tegument protein VP16 (US11) to the minus-end 
dynein-type microtubule motor that carries the virion to the nucleus (Bearer and Satpute-
Krisnan, 2002; Tomishima et al., 2001).  It is speculated that the protein coded by US9 
may serve as the signal that directs transport to the nucleus (Tomishima et al., 2001). 
The virion then attaches to nuclear pore complexes by action of the cell protein β 
importin (Ojala et al., 2000). The viral DNA is then released into the nucleus through a 
virally mediated process where it immediately circularizes (Roizman and Knipe, 2001).  
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     HSV-1 blocks the cell cycle at G1 to prevent cellular DNA synthesis by inhibiting 
cyclin-dependent kinase leading to redistribution of transcription factor E2F4 into the 
nucleus resulting in the complex formation of retinoblastoma tumor suppressor protein 
(pRb) and p107 thus arresting the cell cycle (Flemington, 2001; Ehmann et al., 2000).  
Additionally, the ubiquitin-ligase activity of ICP0 degrades centromeric proteins 
(LaMonte et al., 2001). 
     Viral gene transcription proceeds as a cascade in an orderly manner and is performed 
by cellular RNA polymerase II.  The α-genes are the first to be transcribed and map near 
the UL and US termini and within the terminal repeat flanking these regions (Fig. 1.1).  
Transcription of the α-genes is activated by the γ-gene protein α-TIF (VP16) (alpha 
trans-inducing factor that is packaged in the tegument) in concert with the cellular 
transcription factor Oct-1 (LaBoissiere, S. and Ohare, P., 2000).  The promoter for the 
α-genes is ICP4 (gene α4) and ICP0 (gene α0), which is required for efficient 
reactivation of latent virus (Halford and Schaffer, 2001; Rajčáni et al., 2004).  ICP0 also 
functions as an ubiquitin-ligase targeting specific cellular proteins (Everett, 2000).  The 
α0 product is a cosmopolitan trans-activator of other gene groups.  The α4 product 
(ICP4) positively regulates β and γ-genes and down-regulates both itself and α0 
(Grondin and Deluca, 2000).  Hence, these alpha gene products peak early in infection 
although they continue to be produced throughout the replication cycle.  The β-gene 
products are primarily involved in viral nucleic acid metabolism and DNA synthesis and 
their.  The β1 genes prepare the cell for viral DNA synthesis (typified by UL29, the 
major ssDNA binding protein that facilitates renaturation, complementarity, and strand 
transfer), and the β2 genes are involved with nucleic acid metabolism and DNA synthesis 
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(typified by UL23, thymidine kinase, and UL30, DNA polymerase). The γ gene products 
are primarily the structural proteins of the virus and the proteins associated with DNA 
packaging and viral assembly.  Without viral DNA synthesis, expression of γ gene 
products is poor.  The transcripts are transported to the cytoplasm where they are 
translated on both free and bound polyribosomes.  Most of the viral proteins are 
extensively processed after synthesis and are transported back into the nucleus (Roizman 
and Knipe, 2001).   
     HSV DNA replication is best understood during the lytic state of HSV.  Replication 
proceeds bi-directionally from one or more origins of replication.  There are 3 origins of 
DNA replication, 2 are found in the unique short region (OriS) and one in the unique 
long region (OriL) (Boehmer and Nimonkar, 2003).  These multiple origins suggest that 
initiation of DNA synthesis may be trans-activated or the sites are individually 
responsive to factors in the cellular environment.  The UL9 origin of binding protein 
recognizes each origin of replication and forms a complex with the DNA binding protein 
UL29 that anchors the DNA polymerase UL30 to the DNA template.  UL9 and ICP9 
then act to unwind the origin (He and Lehman, 2000).  DNA replication then proceeds 
by rolling circle replication producing head-to-tail concatemers of viruses joined at their 
terminal repeat sections employing both viral and cellular enzymes and factors 
(Boehmer and Nimonkar, 2003). 
     One important viral enzyme that prepares purine nucleosides for incorporation into 
the DNA is UL23 thymidine kinase (TK).  TK phosphorylates purine pentosides and 
other nucleoside analogs not recognized by analogous cellular kinases.  This recognition 
of various nucleoside analogs by TK permits use of anti-viral drugs blocking its action.  
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Acyclovir, a common anti-herpesviral drug, is phosphorylated by TK but not cellular 
kinases and is incorporated into the nascent viral DNA chain.  Acyclovir then acts as a 
chain terminator that halts viral DNA synthesis (Morfin and Thouvenot, 2003).   
     HSV DNA can isomerize by homologous recombination.  This isomerization is not a 
property of all herpesvirus genomes.  As previously described the UL and US sequences 
can invert relative to their terminal repeat sections creating four isomers.  The purpose of 
this isomerization is unknown, yet it is not a requirement for replication in vitro.  
However, when single plaques infected with wild-type virus are sampled, each isomer is 
present in equimolar concentration.  It has been speculated that isomerization may 
prevent stalling of DNA synthesis are collapsed replication forks (Boehmer and 
Nimonkar, 2003; Roizman and Knipe, 2001). 
     The γ genes are now transcribed and proteins necessary for construction and 
processing of the virion are produced during this part of the DNA replication cycle.  The 
capsids are assembled in the nucleus although the specifics of their assembly are not 
well understood.  The viral DNA concatemers are then cleaved and packaged into 
assembled capsids and data suggests this proceeds from the L terminus toward the S 
terminus (Houma and Brown, 1997).  Models for the packaging process suggest that a 
receptor placed at an opening of the capsid complexes with a concatemer and viral 
DNA-cleaving/packaging proteins that are as yet not well understood. The capsid 
receptor then scans the DNA concatemer until a terminal repeat sequence is detected.  
This terminal repeat is secured to the capsid receptor continues to scan the DNA to 
locate the corresponding second terminal repeat sequence that encompasses a single 
genome complement.  During this scanning process, the DNA appears to be spooled 
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into the icosodeltahedral capsid until the corresponding terminal repeat is located.  The 
DNA is threaded into the capsid contacting the inner surface of the capsid shell, 
wrapping in an organized fashion around the inside of the shell concentrically one layer 
at a time (Zhou et al., 1999).  The DNA appears to be organized along a definite axis but 
the ordering of the strand becomes more chaotic the further it is from the capsid wall.  
This spooling pattern gives the appearance of a toroid in cross-section.   The densely 
packed DNA may be stabilized by the polyamines spermidine and spermine.  When the 
second terminal repeat is encountered, the two terminal repeat sequences are then 
aligned by the capsid receptor, the DNA cleaving/packaging protein cuts the viral DNA 
concatemer at a specific recognition site within the terminal repeats and leaves the 
terminal repeat ends packaged within the capsid unjoined.  The unjoined ends will be 
eventually repaired when the viral DNA circularizes after release into the host nucleus.  
Then the cleaving/packaging protein repairs the gap in the DNA concatemer so that the 
process can be repeated with another empty capsid (Houma and Brown, 1997; Roizman 
and Knipe, 2001).   
     The capsid is then surrounded by a visually amorphous structure called the tegument 
that contains up to 21 known proteins critical for viral transport and replication (Bearer 
and Satpute-Krishnan, 2002; Mettenleiter, 2002).  Models for envelopment and release 
suggest that the capsid undergoes an envelopment/de-envelopment/re-envelopment 
process.  The capsid appears to first bud through the inner lamella of the nuclear 
membrane acquiring an initial lipid envelope.  This activity appears to be directed by the 
products of UL31 and UL34, which target the nuclear membrane and facilitate egress 
(Ye and Roizmann, 2000).  There is some debate whether the capsid is fully tegumented 
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at this point or tegumentation is completed after nuclear budding.  However, data 
supports the idea that the capsid is de-enveloped at the outer lamella of the nucleus and 
re-enveloped by the endoplasmic reticulum because the UL31 and UL34 proteins are 
absent from intracytoplasmic and extracellular enveloped virions and the major 
tegument proteins UL46 and UL49 are present in intracytoplasmic and extracellular 
virion envelops but not perinuclear envelopes (Mettenleiter, 2002).   Therefore, most of 
the tegumentation process appears to occur in the cytoplasm.  Studies of the budding of 
the avian alphaherpesvirus GaHV-1 support this pathway where tegumentation has been 
observed to occur primarily in cytoplasmic vesicles (Granzow et al., 2001).  One 
important HSV protein mediating tegumentation is the product of UL48.  The UL48 
protein act not only as a transcription factor but also is a major component of the HSV 
tegument and is essential for viral assembly (Mettenleiter, 2002).  UL48 also appears to 
anchor UL41 (VHS protein), which is vital for successful cell infection.  The tegumented 
capsid is then targeted to the trans-Golgi network which is enriched with viral 
glycoproteins (Johnson and Huber, 2002).   
     Glycoproteins gD, gE/gI heterodimer, and gM have been proposed as mediators of 
final envelopment.  The tegument proteins are believed to interact in a protein-protein 
specific action with the cytoplasmic tails of the viral glycoproteins to facilitate the final 
budding process (Chi et al., 2005; Mettenleiter, 2002).  The gE/gI complex has been 
proposed to act as a signal directing the virion to the plasma membrane and both gD and 
gE/gI anchor the envelop to the tegument coated capsid (Farnsworth et al., 2003; 
Mettenleiter, 2002).  Transport of the enveloped virion to the plasma membrane has been 
speculated to occur in a cytoplasmic vesicle.  The anterograde motor kinesin has been 
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shown to bind tegument proteins VP16, VP22, and US11, with US11 being critical 
(Bearer and Satpute-Krishnan, 2002; Tomishima et al., 2001).  The capsid is believed to 
be released into the extracellular environment by fusion of vesicles carrying enveloped 
virus at the plasma membrane.   
     Superinfection of cells infected with HSV is prevented by the action of glycoprotein 
gD.  HSVs attempting to superinfect a cell will attach to the cell membrane, but are then 
endocytosed and destroyed (Roizman and Knipe, 2001).  The mechanism by which gD 
conveys this protection is thought to be by blocking of the shared alphaherpesvirus 
receptor HveC (Geraghty et al., 2000).  The gD glycoprotein competes with exogenous 
virus for HveC and blocks ligand binding sites.  
     A characteristic common to all herpesviruses is the ability to establish latency.  After 
a cycle of active replication (not always necessary) in the epithelial cells at the site of 
entry, intact HSV virions enter a sensory neuron presumably via similar mechanisms 
used to enter epithelial cells.  The capsid is then transported to the neuronal nucleus by 
retrograde axonal transport to the nucleus involving microtubules as previously 
described.  A brief period of replication may occur in the sensory neurons, which is then 
followed by latency although replication is not a prerequisite for the establishment of 
latency in the ganglion cell body (Jones, 2003; Khanna et al., 2004).  The genome of 
HSV persists as an episome associated with chromatin (Jones, 2003).  A report by Cai et 
al. (2002) places the estimate of copies of HSV/neuron to be between 2-20 copies.  What 
viral/cellular factors maintain the latent state are still being investigated.  However, there 
is little evidence for viral DNA transcription occurring in the neuron except latency-
associated transcript (LAT).  LAT is a stable intron approximately 2 kb in length derived 
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by splicing of an 8.3 kb transcript (Roizman and Knipe, 2001).  The promoters for LAT 
are neuron-specific and several candidate proteins have been studied but none confirmed 
to date (Jones, 2003).  LAT run in part anti-sense to the 3 terminus of the critical 
transcriptional HSV pan-activator protein ICP0 (gene α0) and thus may act as an 
inhibitor of reactivation (Jones, 2003).  No detectable protein is produced by LAT, yet 
LAT is abundant in the neuronal nucleus.  The functions of LAT are still being 
investigated, and it appears to be important but not absolutely essential for establishing 
latency or re-activation of the virus.  LAT has been shown to block the caspase-8 (death 
receptor pathway) in vitro, which may prevent apoptosis (Peng et al., 2004).  This 
apoptotic blocking function may be essential during the reactivation phase.   
     Reactivation begins with viral replication in the neuronal nucleus in response to local 
or systemic host stimuli.  Corticosteroids produced during stress can stimulate 
replication at (OriL) and may be one mechanism leading to reactivation (Hardwicke and 
Schaffer, 1997).  Corticosteroids may also induce apoptotic pathways in neurons, which 
underscore the importance of potential LAT protection.  HSV pan-transactivator ICP0 
has been shown to be essential for reactivation, however the mechanisms up-regulating 
its expression or de-repression are not well understood (Halford and Schaffer, 2001).  
While host immunity may play a role in controlling latency, it does not appear that cells 
of the immune system directly inhibit reactivation (Sawtell, 2003).  The nascent virions 
are then re-conveyed to the site of active replication (epithelial cells) by axonal transport 
(Roizman and Knipe, 2001). 
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Oncogenic herpesviruses 
     Oncogenesis is an important aspect of several animal herpesviruses.  Representatives 
include members from alphaherpesviruses such as Marekss disease herpesvirus (MDHV 
or GaHV-2) affecting gallinaceous birds and gammaherpesviruses such as Epstein-Barr 
virus (EBV or HHV-4) and Kaposis sarcoma-associated herpesvirus (KSHV or HHV-8) 
affecting humans (Epstein, 2001).  The relevance of discussing herpesvirus oncogenesis 
pertains to tumorgenic activity reported in this paper caused by PsHV.  This section will 
briefly review the oncogenic mechanisms of MDHV, EBV, and KSHV. 
     MDHV is an alphaherpesvirus based on the genomic organization, but its biological 
behavior is more consistent with gammaherpesviruses (Biggs, 2001).  Similar to EBV, 
MDHV is lymphotrophic and oncogenic.  However, MDHV infects T lymphocytes 
rather than B lymphocytes and causes paralysis due to lymphocyte accumulation in the 
peripheral nerves and lymphomas found in a variety of organ systems in gallinaceous 
birds.  Several proteins and gene regions have been proposed as cause of neoplasia in 
MDHV, but the Meq protein appears to be the most likely candidate to date (Lupiani et 
al., 2004; Liu and Kung, 2000; Venugopal, 2000).  Meq is present in two copies in the 
MDHV genome located in the repeat regions flanking the UL sequence (Tulman et al., 
2000).  The leucine-zipper regions at the N-terminal region of Meq are closely related to 
the Jun/Fos oncoproteins, and the C-terminal region is similar to the WT-1 tumor 
suppressor gene (Lupiani et al., 2004).  Meq can be found as a homodimer and a 
Meq/Jun heterodimer (Levy et al., 2003).  The Meq homodimer represses the MDV 
origin of replication suggesting that is may be involved in latency and replication and the 
Meq/Jun heterodimer transactivates the Meq promoter (Levy et al., 2003; Lupiani et al., 
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2004).  It has been proposed that Meq transforms cells through several pathways 
affecting the cell cycle.  Meqs transcriptional activation capacity up-regulates the anti-
apoptotic protein Bcl-2 and suppresses the apoptosis inducing Bax protein (Levy et al., 
2003).  Meq also appears to sequester p53 either through direct binding or other 
interactions.  Meq binds to and is also phosphorylated by CDK2.  The phosphorylation 
state of Meq is thought to alter its function in different situations such as acting as a 
transactivator or suppressor.  Meq also may translocate CDK2 into the nucleolar 
periphery where it activates cyclins that phosphorylates pRb (Liu and Kung, 2000).   
Meqs interaction with the Jun/Fos system promotes cell growth and enhances cell-
transforming capacity. 
     Epstein-Barr virus has been associated with the development of the B lymphocyte 
origin tumors Burkitts lymphoma and Hodgkins disease, and also implicated in 
nasopharyngeal carcinomas and gastric carcinomas in humans (Epstein, 2001; Niller et 
al., 2004).  Two viral proteins have been suggested as having transforming capacity, 
Epstein-Barr nuclear antigen 2 (EBNA2) and latent membrane protein 1 (LMP1) 
(Hammerschmidt and Sugden, 2004).  EBNA2 enables the transcription of promoters of 
the Notch signaling pathway (Hammerschmidt and Sugden, 2004).  The contributions of 
the proteins induced by the action of EBNA2 are not currently known, however it does 
activate LMP1.  LMP1 interacts with and activates a variety of cellular adaptor proteins 
from the tumor necrosis family (Damania, 2004; Pagano et al., 2004).  These include 
anti-apoptotic proteins such as Bcl-2, epidermal growth factor, and cell-adhesion 
molecules.  Importantly, LMP1 activates the transcription factor NF-κB in both 
lymphocytes and epithelial cells (Pagano et al., 2004).  Cofactors are speculated to be 
 19
involved with the development of EBV associated Burkitts lymphoma and 
nasopharyngeal carcinoma.  Chronic malaria has been associated with the development 
of Burkitts lymphoma (Hammerschmidt and Sudgen, 2004).  It is possible that 
immunosuppression coupled with the development of germinal centers of lymphocytes 
from the malarial infection increases the likelihood of EBV oncogenesis (Pagano et al., 
2004).  The specific cofactors for nasopharyngeal carcinoma have not been identified, 
but may be related to tumor-promoting compounds found in certain ethnic foodstuffs or 
perhaps development of these tumors may be more of a function of population genetics 
since they show population predilections (Pagano et al., 2004). 
     Kaposis sarcoma-associated herpesvirus (KSHV or HHV8) causes vascular 
endotheliosarcomas primarily in HIV-infected individuals and classically on the skin of 
men of Mediterranean descent (Damania, 2004).  In HIV patients, the tumors are not 
restricted to the skin but disseminate to the viscera.  KSHV establishes life-long 
infection in the B-lymphocytes of the host.  KSHV infection is pervasive in the 
population, but KS lesions result only when the host is immunocompromised or 
individual host factors or permissive to tumorogenesis.  Several viral proteins have been 
shown to transform cells, K1, vGPCR, Kaposin, and homologs of cellular cytokines and 
chemokines (Pagano et al., 2004).  K1 can activate the transcription factor NF-κB, block 
Fas-induced apoptotic pathways, and stimulates B cell proliferation via a tyrosine-based 
activation motif (Damania, 2004; Pagano et al., 2004).  KSHV protein vGPCR can 
activate phospholipase C and phosphatidylinositol 3 pathways.  Kaposin interacts with 
GTPases that regulate integrin-mediated cell adhesion (Damania, 2004).  KSHV also 
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encodes gene analogs for anti-apoptotic activity such as viral Bcl-2 and viral Inhibitor of 
Apoptosis (Pagano et al, 2004). 
 
Papillomavirinae 
     The lesions of IPD, particularly mucosal papillomas, are both grossly and 
histologically similar to those lesions known to be caused by papillomaviruses in other 
animals.  Species-specific papillomaviruses cause cutaneous papillomas in finches and 
African grey parrots (Jacobson et al., 1983; Lina et al., 1973).  Therefore, the first 
investigations into the cause of mucosal papillomas focused on finding papillomaviruses 
in the lesions.  Hence, a brief discussion of the molecular biology of papillomaviruses 
and their ability to transform cells is warranted.      
     Papillomavirinae is a subfamily of the larger family Papovaviridae.  Over 70 
different members of this subfamily have been described.  All members of the subfamily 
tend to be host specific and possess the ability to transform cells and result in the 
formation of proliferative papillary lesions or papillomas of the squamous or mucosal 
epithelium depending on the particular virus.  Papillomas are usually benign space-
occupying lesions where cell proliferation is under viral rather than host control.  
Papillomaviruses work to establish a regulated disorder that permits greater viral 
amplification and dissemination of the virus (Doorbar, 2005; Lowy and Howley, 2001).  
However, when the transforming capacity of the virus becomes unrestricted then more 
serious neoplastic lesions (carcinomas) can result.  The ability to cause serious disease 
depends upon the species of papillomavirus since some have greater transforming 
capacity than others.  While many papillomaviruses can transform cells in culture, they 
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do not undergo productive replication to produce intact virions.  This obstacle has 
impeded more complete understanding of papillomavirus biology.  Advances have been 
made using organotype (raft) culture systems that establish polarized cell layers and 
permit some papillomaviruses to complete their life cycle, but more work needs to be 
done in this area (McLaughlin-Drubin et al., 2003).   
     Papillomaviruses have a circular double-stranded DNA genome packaged into a non-
enveloped icosahedral capsid.  The virions range from 52-55 nm in diameter and the 
icosahedral capsid is a 72 capsomere shell composed of 2 structural proteins, major 
capsid proteins L1 and L2 (Modis et al., 2002).  The genome for all papillomaviruses is 
approximately 8 kbp in size and the open reading frames (ORF) are all located on one 
strand of the DNA indicating that all of the viral genes are confined to one strand.   The 
genome is structured into early (E) and late (L) gene regions separated by a segment that 
contains no ORFs, the long control region (LCR), the upstream regulatory region (URR), 
and the non-coding region.  There are eight early genes designated E1-E8 and two late 
genes, L1 and L2 (Fig. 1.2).  Because of the small size of the genome, there is 
considerable overlap of the ORFs of the E genes but the L genes are virtually 
sequentially ordered with minimal overlap.  There is great variability in the 
organizational order and even the number of the E genes varies with the individual 
papillomaviruses (Doorbar, 2005; Howley and Lowy, 2001).  
 
Model papillomavirus-bovine papillomavirus 1 
 
     While the molecular biology of FPV and PePV is described to some detail, much 
more is known about bovine papillomavirus 1 (BPV 1) as a model virus for describing
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Fig. 1.2.  Map of BPV-1 genome.  The schematic shows the ORFs of the early and late 
genes.  Pn designates individual early promoters where n is the approximate nucleotide 
position of the transcription initiation site.  PL is the promoter for the late genes.  AE and 
AL are the polyadenylation sites for the early and late genes.  CE is the constitutive 
transcriptional enhancer region. (from Lowy and Howley, 2001). 
 
 
 
the biological behavior of all papillomaviruses.  Where relevant, comparisons of FPV 
and PePV homologs of BPV structure and products will be made.  Also, much is 
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understood about the molecular biology of HPVs, especially in regard to their oncogenic 
potential.  Mechanisms involving HPVs will also be addressed when appropriate. 
     BPV is the cause of fibropapillomas in cattle and also demonstrates the ability to 
transform cells in culture making it a good model for understanding papillomavirus 
biology.  BPV is approximately 8 kbp in size and the genome is organized into 8 early 
genes (E1-E8), two late genes (L1 and L2), co-joined by a non-coding regulatory region 
(LCR) (Fig. 1.2) (Howley and Lowy, 2001).   
     Like all papillomaviruses, BPV attains access to the cell by a break in the epithelial 
defense.  The target of infection is the basal epithelium since it is the only cell capable of 
dividing (Egawa, 2003).  The process of viral attachment and entry is poorly understood, 
however it has been shown that heparin sulfate mediates the initial attachment of some 
HPVs via the L1 protein (Joyce et al, 1999).  It appears that BPV is cosmopolitan in its 
selection of cell types since it has been shown to infect a wide variety of cells in vitro.  
Therefore, the cell-tropism of BPV or HPV is not cell-receptor specific, but 
papillomaviruses overall do appear to bind as yet unidentified conserved cell-surface 
receptor and heparin sulfate is a likely candidate (Giroglou et al., 2001).  The assumed 
sequence of events is that BPV binds to some widely expressed receptor on basal cells, 
is endocytosed, and then transported to the nucleus.  Recent evidence suggests that this 
is mediated by endocytosis of clathrin-coated vesicles (Culp and Christensen, 2004).  At 
the nucleus, the virion is uncoated with the assistance of the reducing environment found 
in the cell cytoplasm and the viral DNA is released into the nucleus (Li et al., 1998).     
     Papillomavirus transcription is tightly regulated because different products are 
required as the virus is carried with evolving cell types from basal cell to differentiated 
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cell.  Transcriptional regulation must be carefully synchronized with cell differentiation 
for productive infection to occur.  Because of the overlap in the ORFs, particularly in the 
E region, a variety of polycistronic mRNA species are produced and splicing of these 
species results in the production of the various viral proteins (Longworth and Laimins, 
2004).   
     The LCR contains constitutive enhancer elements that are responsive to both cellular 
factors and viral regulatory elements (Howley and Lowy, 2001).  These enhancers 
express some cell or tissue specific behavior and are thought to be essential for initial 
transcription of viral genes.   There are 7 recognized promoters in BPV, six are 
associated with transcription in transformed cells and the seventh with transcription of 
late genes in productive cells.  Likewise there are two poly-adenylation sites, one for the 
E genes and another for L genes.  Several different cellular transcription factors have 
been identified as initiators of early transcription.  Common binding sites to all 
papillomaviruses are those for TFIID binding to TATA boxes upstream from the early 
start sites (Longworth and Laimins, 2004).  Upstream of these TATA sequences are 
found binding sites for factors AP1and Sp-1 found in all HPV types and there are 
additional transcription factor binding sites including Oct-1 and glucocorticoid 
responsive elements (Chang and Laimins, 2000; del Mar Pena and Laimins, 2001).  As 
the name early would imply, the E genes are the first to be transcribed.  The E genes are 
responsible for initiation of viral DNA replication and the transforming capacity of the 
virus.  Control of E gene transcription is mediated by the various proteins produced by 
E2 via E2-repsonsive elements found in the LCR.  There are 3 species of E2 protein, full 
length E2TA, and two shorted splice products E2TR and E8/E2 (Howley and Lowy, 
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2001; Ozbun and Meyers, 1998).  The E2TA is a transcriptional activator for the E genes 
while E2TR and E8/E2 are transcriptional repressors that inhibit the transactivation 
function of E2TA.  E2TA can activate almost all of the E promoters, although sensitivity 
to E2TA activation varies.  The E2TR and E8/E2 repressors bind at sites in close 
proximity to the TATA box near the individual promoters.  It is thought that these E2 
repressors displace the transcriptional activator SP1 and also inhibit the formation of the 
transcriptional pre-initiation complex.  It is important to note that mutations leading to 
the loss of function of the E2 repressors or loss of sensitivity at the E2 repressor binding 
site can permit the deregulation of cell transforming proteins such as E6 and E7 and lead 
to unrestricted cell growth and more serious neoplasia (Jeon et al., 1995).  
     One study reports that both FPV and PePV lack classical ORFs for E6 and E7 (Terai 
et al., 2002).  However, these investigators did designate a region within the genome as 
E7 and X-ORF (E6-like region).  While there is little overall homology between this new 
E7 region and E7s of other papillomaviruses, it does share classical binding motifs for 
pRB.    
     Transcription of the E genes is followed by either steady-state viral DNA replication 
or transition to productive infection.  Steady-state replication occurs after initial 
infection and is divided into two phases, establishment and maintenance.  During the 
establishment phase, the low viral copy number is amplified to 50-400 copies per basal 
cell.  This amplified copy number remains relatively constant during the following 
maintenance phase of infection.  Papillomavirus DNA can either exist as an 
extrachromosomal plasmid or integrate into the host genome.  In basal cells, 
papillomavirus DNA is maintained as multi-copy episomes that replicate in concert with 
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the cell cycle (You et al., 2004; Wilson et al., 2002).  The origin of DNA replication is in 
the LCR region and efficient replication requires the activity of both E1 and E2 proteins.  
E1 is a multi-functional protein that binds to the origin with E2 to form a stable complex.  
E1 forms a hexameric structure at the origin and acts as an ATP-dependent helicase to 
unwind the DNA and also recruits DNA polymerase α to induce replication (Wilson et 
al., 2002).  Other cellular factors such as thymidine kinase and proliferating cell nuclear 
antigen are also required to complete papillomavirus DNA replication.  The 
papillomavirus DNA is maintained then at a relatively constant copy number in a 
plasmid state.  These newly replicated genomes then serve as templates for increased 
expression of E1 and E2, which facilitates additional expression of viral genome 
(Middleton et al., 2003).  What mechanisms induce the change from steady state to 
vegetative replication with production of infectious virions is unknown.  Presumably, 
these factors are related to the state of cell differentiation because only terminally 
differentiated cells produce infectious virions (Doorbar, 2005).   
    Cell transformation is part of the strategy papillomaviruses use to replicate.  
Transformation is dependent up expression of viral DNA and whether the 
papillomavirus DNA exists in an integrated state or as a plasmid is immaterial.  Early 
proteins E5, E6, and E7 are primarily responsible for cell-transforming activities.  The 
E5 protein is highly conserved among papillomaviruses that induce fibropapillomas and 
exists as a homodimer localized primarily to the Golgi and smooth ER.  E5 has the 
ability to transform E5 does not exert any enzymatic activity but its primary target is the 
β receptor for platelet-derived growth factor (PDGF) in BPV (Howley and Lowy, 2001).  
However, the target in HPV appears to epidermal growth factor receptor (EGF) because 
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E5 increases phosphorylation of the receptor and decreases its degradation and its 
primary activity appears to be in differentiated cells (Fehrmann et al., 2003; Rodriguez et 
al., 2000). Each subunit of the E5 homodimer binds to a PDGF β receptor resulting in 
dimerization and activation of the receptors.  The activated receptors then precipitate a 
cascade that leads to mitogenic stimulation.  Importantly, E5 is not expressed in most 
human papillomavirus (HPV) positive cancers.  This suggests that E5 primarily 
functions to perpetuate the benign papillomatous state rather than participate in more 
severe oncogenesis (Howley and Lowy, 2001).   
     The E7 protein exerts its transforming effect primarily through deregulation of the 
cell cycle (Munger et al., 2001; Munger et al., 2004).  The E7 and E6 proteins are 
expressed in a bicistronic mRNA from the early viral promoter p97 (Stacey et al., 2000).  
The product of the retinoblastoma tumor suppressor gene (pRB) is a primary regulator of 
the cell cycle.  The hypophosphorylated form of pRB, present in the G0/G1 phase of the 
cell cycle, is bound to the cellular transcription factor E2F-1.  The complexed E2F-1 
cannot activate transcription and thus the cell is prevented from entering the S phase of 
the cycle.  A cyclin-dependent kinase phosphorylates pRB at multiple serine residues 
causing the dissolution of the pRB/E2F-1 complex.  E2F-1 is then free to initiate 
transcription and the cell enters the S phase of the cycle.  At the M/G0 boundary, pRB is 
returned to a hypophosphorylated state by a specific phosphatase where it once again 
binds E2F-1 and arrests the cell cycle at G0.  To induce transformation, the E7 protein 
preferentially binds the hypophosphorylated form of pRB and disrupts the pRB/E2F-1 
complex thus releasing the E2F-1 transcriptional activation factor.  This action also leads 
to the ubiquitinization and proteasome degradation of E7 (Wang et al., 2001).   The cell 
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cycle then proceeds to the synthesis phase unimpeded.  Importantly, E7 proteins from 
low risk (mildly oncogenic) HPVs such as HPV 6 and 11, bind pRB at a much lower 
affinity than those of high risk HPVs such as type 16 and 18 (Howley and Lowy, 2001).  
High-risk HPV E7 proteins also bind cyclin-dependent kinase inhibitors p21 and p27 
presumably to block their action thus enhancing cycling-dependent kinase 
phosphorylation of pRB and also associates with cyclins A and E acting to increase their 
concentration (Longworth and Laimins, 2004).  However, it appears that the ability of 
E7 to facilitate the progression of the cell to S-phase is limited to a subset of 
differentiated cells that either contain low levers of the cyclin-dependent kinase 
inhibitors p21 and p27 or high levels of E7 production because these inhibitors can form 
inactive complexes with E7 and the cell cycle is unaffected (Noya et al., 2001).  E7 can 
also bind histone deacetylases (HDACs) whose relevant action here is to deacetylate 
E2F resulting in a loss of function (Marks et al, 2001).  This binding also appears to be 
essential for maintaining the viral episome and facilitating immortalization in some cells 
lines (Longworth and Laimins, 2004).  The mechanism by which this particular E7-
HDAC interaction exerts its affect is unknown.  Some high-risk E7 proteins can also 
induce host genomic instability by interfering with centrosome function resulting in 
aneuploidy (Duensing et al., 2000). 
     The E6 protein works in conjunction with the E7 product to efficiently transform 
cells.  E6 protein from low risk HPVs has little to no transforming capacity.  However, 
E6 proteins from high risk HPVs have been shown to efficiently bind the tumor 
suppressor gene product, p53, but low risk E6 proteins bind no detectable amount.  
Production of increased concentrations of p53 occurs in response to cell stress or 
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damage.  The p53 protein can transcriptionally activate the p21 gene which inhibits the 
activity of the cyclin-dependent kinases that regulate the advance of the cell cycle.  
Therefore, the activity of p53 results in either the arrest of the cell cycle or propels the 
cell down the apoptotic pathway.  High-risk E6 proteins bind p53 in conjunction with a 
cellular protein E6-associated protein (E6AP).  E6AP does not bind p53 without the 
presence of E6, and the normal substrate of E6AP is unknown (Munger et al, 2004).  
This complex then functions as an ubiquitin ligase.  Ubiquitin tags signal the cell that 
this product has been designated for destruction by the proteasome.  Hence in 
papillomavirus transformed cells, the p53 levels are decreased.  Loss of p53 activity 
results in deregulation of the cell cycle and no arrest or apoptosis can halt the rapidly 
proliferating cells (Howley and Lowy, 2001).  HPV E6AP also targets some proteins of 
the src kinases that interact with signaling networks and can associate with other pro-
apoptotic proteins including Bak and Bax (Frame, 2002; Li and Dou, 2000).  While the 
significance of this activity are not understood at this time, it may have implications 
regarding trafficking of cellular proteins and inhibition of the apoptotic pathways.  
Additionally, degradation of p53 alone is not sufficient to ensure immortalization.  E6 
also appears to reduce PDZ protein binding domains (Liu et al., 1999).  PDZ binding 
domains are found at areas of cell-cell contact and the PDZ family of proteins function at 
these domains acts as molecular scaffolding and aid in signal transduction.  The binding 
of E6 to the PDZ domain is sufficient to induce cell proliferation in the superficial 
basilar layers and may contribute to metastasis by disrupting normal cell adhesion 
(Nguyen et al., 2003).  HPV E6 can also activate the hTERT subunit of telomerase by 
binding both Myc and its cofactor Max, leading to transcription activation of the hTERT 
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promoter (Veldman et al., 2003).  Telomerase activation shortens the telomeres leading 
to cellular senescence.  Quantitative experiments have shown that hTERT activity is 
more important that p53 degradation in regard to immortalization (Longworth and 
Laimins, 2004, Munger et al., 2004).  However, this observation tends to be dependent 
on the cell type and system and certainly other factors such as E7 activity are involved. 
     The activities of E6 and E7 in the normal life cycle of papillomaviruses are probably 
necessary to create a suitable environment for efficient viral replication.  E1 and E2 
proteins are necessary for the initiation of viral DNA replication, but also other cellular 
factors such as DNA polymerase, PCNA, and TK.  Papillomaviruses only undergo 
productive replication in terminally differentiated cells that have normally deactivated 
transcription of genes necessary for DNA replication.  E6 and E7 normally function to 
establish a perpetually cycling cell that is actively producing the necessary products for 
completion of viral replication.  However, in high-risk papillomavirus strains, the virus 
can no longer exert controlled disorder, because there is more efficient binding of E6 
for p53 and E7 for pRB as compared to low risk strains.  So, without either cellular or 
viral restraints on the cell cycle, malignancies result (Howley and Lowy, 2001). 
     Late gene functions associated with capsid protein synthesis, productive DNA 
synthesis, and virion assembly occur only in the terminally differentiated cells.  Genes 
included in the late gene category are L1, L2, and interestingly E4.  The E4 gene is 
designated as an early gene because its locus lies within the early gene region, but is 
considered a late gene because its expression is from the late promoter and its proteins 
function late in papillomavirus infection.  L1 and L2 expression occurs only in the 
terminally differentiated cells where they form the structural basis of the capsid with L1 
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being expressed after L2 facilitating assembly of infectious particles in the upper layers 
of the epithelium (Florin et al., 2002).  The L2 protein accumulates near nuclear 
structures known as PML bodies and recruits L1 to these domains (Doorbar, 2005).  It 
has been suggested that these PML bodies are the sites of papillomavirus DNA 
replication and that the capsid proteins are drawn to these sites where capsid assembly 
occurs (Swindle et al., 1999).  The papillomavirus is then shed from the epithelial 
surface in an enveloped form (Bryan and Brown, 2001).  It is thought that delaying 
release of the virions until cells have reached the uppermost epithelial layers may assist 
in avoiding host immune detection, particularly because the virus limits presentation of 
viral epitopes to the immune system in the lower epithelial layers (Marchetti et al., 2002; 
Matthews et al., 2003). 
     The E4 protein has several splice forms and is found in the suprabasilar layer through 
the differentiated layer.  It is believed that these different E4 proteins serve different 
functions in the various cell types.  Studies have suggested that the E4 protein found in 
the terminally differentiated cells induces the collapse of the cytokeratin network and 
this action may assist the virus in its egress from the cell and assembly of the envelope 
(Lehr et al., 2004; Wang et al., 2004).  Late gene expression is regulated from elements 
within the late region.  The transcripts from the late gene are initiated from a single late 
promoter and polyadenylated from a different site than those of the early genes.  What 
induces the switch from early to late expression is not well understood, but it is 
presumably cell factors that are found in the different cell types as the virus transits the 
epithelial layers acting on the late promoter.  Control also appears to be exerted at the 
transcription/post-transcriptional level. Rearrangement of the chromatin as the late 
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promoter site has been observed to occur prior to late gene transcription in some HPVs 
(del Mar Pena and Laimins, 2001).  While the mechanisms governing the switch from 
early to later expression are not clear, there are some significant findings that suggest 
possible pathways.  A negative regulatory control element in the 3 untranslated late 
region acts to decrease steady state levels of late mRNAs during the steady-state phase 
of infection.  It is thought that this element may alter the definition of the 3 exon region 
of the late genes, and terminates or pauses transcription.  This termination prevents the 
use of the late poly (A) site.  Therefore, transcripts encoding only early proteins using 
the early poly (A) site are preferred.  One model suggests that cellular factors produced 
only in undifferentiated cells, may contribute to transcriptional pausing perhaps in 
association with the negative control element.  These undifferentiated cell factors would 
be titrated out as the cell evolves to a terminally differentiated state and thus permit use 
of the late poly (A) site and complete transcription of late genes proceeds (Howley and 
Lowy, 2001). 
     The process of capsid assembly and virion release is not well understood.  In the 
terminally differentiated cell, host DNA transcription must be reactivated so that cellular 
factors essential for papillomavirus replication are available.  This reactivation is 
presumably the normal function of the E6 and E7 proteins.  The late genes are 
transcribed and capsid assembly and packaging of the genome follow.  E4 appears to 
disrupt the cellular cytoskeleton leading to the release of infectious virions. 
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  Psittacid herpesvirus 
     Psittacid herpesviruses (PsHV) are enveloped linear double-stranded DNA viruses of 
the subfamily Alphaherpesvirinae and are in the genus Iltovirus (α4) (Davison, 2002; 
McGeoch et al., 2000; McGeoch et al., 2005; VanDevanter et al., 1996; Tomaszewski et 
al., 2003).  The genome has been sequenced, GenBank accession no. AY372243, and is 
163 kbp in length and is organized into unique long (UL) and unique short (US) regions 
with corresponding genes mapping to homologs of other alphaherpesvirues (Thureen 
and Keeler, 2003).   
     The phylogenetically closest alphaherpesvirus relatives to PsHV are PaHV 1 and 
GaHV 1 based on sequence from the UL30 gene. However, the lack of sequence data for 
PaHV 1 makes this placement questionable.   However, GaHV 1 has been completely 
sequenced and is closely related based on partial sequence data from the UL30 gene of 
PsHV 1 (Davison, 2002, Tomaszewski et al., 2003).   
     Previous investigations suggested that PsHV demonstrated a significant degree of 
genetic polymorphism by restriction endonuclease analysis (Aini et al., 1993; 
Gravendyck et al, 1996; Günther et al., 1997).  Further investigation showed PsHVs be 
classified into four genotypes; number 1, 2, 3, and 4 based on the partial sequence data 
from the UL16 gene (host range protein) (Tomaszewski et al., 2003).  These four 
genotypes generally correspond to known PsHV serotypes where genotype 1 and 4 
viruses mapped to serotype 1, genotype 2 viruses mapped to serotype 2, genotype 3 
viruses mapped to serotype 3, and two specimens, designated serotype 2/3, mapped to a 
unique branch of genotype 3 viruses. (Gravendyck et al., 1996; Tomaszewski et al. 
2003).   
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     These genotypes are thought to have co-evolved with several species of Neotropical 
(Central and South American) parrots (Phalen et al., 2004).  They are not believed to 
cause disease in their host species, however an acute fatal disease (Pachecos disease) 
may result when parrots are infected with a PsHV genotype to which they have not been 
evolutionarily adapted (Phalen et al., 2004; Tomaszewski et al., 2003).  Because 
extensive testing has not been performed on parrots in the wild, it is difficult to establish 
which species serve as carriers for a specific genotype.  However, testing for PsHV in 
captive birds may reflect trends in the wild.  PsHV 1 genotype 4 is found in Patagonian 
conures (Cyanoliseus patagonus), PsHV 1 genotype 3 is a common finding in hyacinth 
macaws (Andorynchus hyacinthinus), PsHV 1 genotype 1 has been identified in wild-
caught Aratinga conures, and PsHV 1 genotype 2 was found in two wild-caught redh-
shouldered macaws (Diopsittaca nobilis) (Phalen et al., 2004). 
     Data also suggests that some PsHV genotypes are more pathogenic to some species 
of parrots that others (Phalen et al., 2004; Tomaszewski et al., 2003).  For example, 
genotype 4 is usually lethal to macaws and conures but genotype 3 rarely causes death in 
these species, and genotypes 1 and 2 may not cause disease in these species.  Genotype 4 
has not been reported to cause disease in Amazon parrots in the United States, but 
genotype 3 may be lethal to this species.  Species of Pacific distribution appear to be 
susceptible to all genotypes equally (Tomaszewski et al., 2003).  
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 Pachecos disease 
     Pachecos disease (PD) was first described as an infectious disease of psittacine birds 
in 1929 (Pacheco and Bier, 1929).  PD is an acute and generally fatal disease of parrots 
caused by one or more genotypes of psittacid herpesvirus characterized by acute onset of 
illness with few premonitory signs (Tomaszewski et al., 2001). The disease is almost 
exclusively confined to psittacine birds, but has been described in a starling and is 
suspected in other passerines including a Pachecos-like herpesvirus infection in a 
toucan (Charlton et al., 1990; Phalen et al., 2004; Tomaszewski et al., 2004).  While 
many parrot species are susceptible, the disease has been predominately reported in 
Amazon parrots (Amazona spp.), African grey parrots (Psittacus erithacus), macaws 
(Ara spp.), cockatoos (Cacatua spp.), and conures (Aratinga spp. and Pyrrhura spp.) 
(Cho and McDonald, 1980; Dharma and Sudana, 1983; Randall et al., 1979; 
Tomaszewski et al., 2001; Tomaszewski et al., 2003).   Parrots manifesting clinical signs 
seldom survive but those that do may exhibit depression, anorexia, and biliverdinuria, 
which may be accompanied by elevations of serum enzymes (Godwin et al, 1982).  
Gross necropsy results have been described as variable and non-specific, but an enlarged 
liver with mottled-tan coloration is a common finding (Graham, 1980; Panigrahy and 
Grumbles, 1984; Tsai et al., 1993).   PD has been generally characterized by acute 
hepatic necrosis with minimal associated inflammation accompanied by the presence of 
viral intranuclear inclusion bodies (Panigrahy and Grumbles, 1984).  Multiple organ 
systems are involved and hepatitis is a consistent finding, but other microscopic 
characteristics may include splenic necrosis, enteritis, pancreatitis, tracheitis, and 
ingluvitis (Graham, 1980; Gravendyck et al., 1998; Panigrahy and Grumbles, 1984; 
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Tomaszewski et al., 2001).  Diagnosis of PD in the past relied on serology or viral 
isolation but has been replaced by PCR ( Gravendyck et al., 1998; Tomaszewski et al., 
2001; Tomaszewski et al., 2003). 
     PD became a disease of concern when collections of captive psittacine birds were 
assembled by aviculturists worldwide in the latter half of the 20th century (Durham et al., 
1977; Gough and Alexander, 1993; Mutlu et al., 1991; Persin and Bratrsovsky, 1986; 
Simpson et al., 1975; Simpson and Hanley, 1977; Tsai et al., 1993; Westerhof et al., 
1988).  The evolution of PD as a disease of significance was linked to the growth of the 
avicultural industry from the late 1960s to the 1990s.   The industrys growth was 
facilitated by the large-scale importation of parrots that had become practical and more 
affordable with the advent of commercial airfreight and transportation development 
within the nations of origin (Nilsson, 1981; Styles, 2002).  Prior to this time, parrots 
were expensive and difficult to obtain. They were imported directly from the nation of 
origin to the pet dealer or collector and kept by small groups of aviculturists (Styles, 
2002).  Trends in the pet industry coupled with modern transportation methods 
contributed to popularity and availability of parrots (Styles, 2002, Nilsson, 1981).   
     In the early days of the industry, little attention was given to the infectious diseases of 
exotic birds.  They could be easily replaced by another wild-caught specimen because 
few to no restrictions were placed on their importation.  However, a worldwide 
pandemic of viscerotropic velogenic Newcastle disease (VVND) in the early 1970s 
caused devastating losses in the poultry industry, and the disease was shown to have 
been introduced into this country in a shipment of parrots (Pierson and Pfow, 1975). The 
outbreak led to the destruction of millions of chickens and many parrot collections at 
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great cost in attempts to contain it.  In response to this crisis, the United States 
Department of Agriculture established in 1973 a quarantine system through which all 
birds imported into the US were channeled and tested for VVND (Pierson and Pfow, 
1975; Pilchard, 1991).  The quarantine stations were privately owned and operated, but 
were managed by USDA agents.  Station owners took measures to reduce costs:  the 
population density of birds within the station was high and hygiene was not ideal due to 
understaffing (Nilsson, 1981).  This caused birds from multiple continents to be forced 
to cohabitate in poor conditions in close proximity to each other.  These quarantine 
stations typically held the birds for 30-45 days until the VVND testing results were 
available (Pilchard, 1991).  If no VVND was detected, then the birds were released into 
the care of the importer.  While these measures prevented the entry of VVND into the 
country, they did nothing to prevent the dissemination of diseases that were infectious to 
parrots and other birds.  Birds that would not normally come into contact with each other 
were now housed closely together under stressful conditions, making the quarantine 
stations incubators of disease.   
     At about the same time, conservationists became concerned about the population 
status of the parrots in the wild (Nilsson, 1981).  This eventually led to the creation of 
national and international laws regulating their commerce.  In 1992, the Wild Bird 
Conservation Act closed import to all psittacine birds unless by special permit (Styles, 
2002; Wright et al., 2001).  The economic impact of the quarantine measures in concert 
with restricted importation served to increase the cost of the imported birds.  Therefore, 
more attention was given to the infectious diseases affecting psittacine birds and 
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Pachecos disease emerged as one of the most serious diseases challenging by the 
aviculture industry (Simpson and Hanley, 1977). 
     Classical PD was only one manifestation of the disease.  Evidence began to 
accumulate relating a constellation of pathological conditions that developed in the 
exposed birds and survivors of PD outbreaks.  The first of these conditions to be 
clinically recognized was mucosal papillomatosis.   
 
Mucosal papillomatosis 
     Mucosal papillomas are benign or pre-malignant neoplasms of mucosal epithelial 
surfaces. Mucosal papillomas have been described in many species of captive 
Neotropical parrots, with the highest incidence of these lesions occurring in Amazon 
parrots (Amazona) and macaws (Ara spp.) (Cribb, 1984; Graham, 1988; Graham, 1991; 
Johne et al., 2002; McDonald, 1988; Van der Heyden, 1988).  
     Clinically, the disease appears to be spread to in-contact birds like an infectious agent 
(McDonald, 1988).  The lesions wax and wane and may not be grossly evident but may 
be present at a microscopic level (Phalen et al., 1998; Taylor and Murray, 2002).  
Histologically they appear as papillary structures having a highly vascularized 
connective tissue core with overlying proliferative stratified cuboidal to pseudostratified 
columnar mucosal epithelium depending on the location (Schmidt et al., 2003).  
Lymphoplasmacytic infiltrate is a variable feature of mucosal papillomas, but may 
correspond to their waxing and waning behavior  (Schmidt et al., 2003). 
     Mucosal and cutaneous papillomas in mammals are known to be caused by 
papillomaviruses (Brentjens et al., 2002).  It was also known that cutaneous papillomas 
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in wild finches (Lina et al., 1973; Osterhaus et al., 1977; Moreno-Lopez et al., 1984) and 
African grey parrots (Psittacus erithacus) (Jacobson et al., 1983; OBanion et al., 1992) 
were caused by species-specific avian papillomaviruses.  Therefore, it was assumed that 
mucosal papillomas in psittacine birds had a similar etiology.  However, investigations 
could find little evidence supporting the existence of papillomaviruses in mucosal 
papillomas, and efforts to experimentally transmit the disease using homogenates from 
mucosal papillomas have failed (Sundberg et al., 1986).  Papillomavirus virions could 
not be detected in any mucosal papillomas by electron microscopy (Sundberg et al., 
1986).  Papillomavirus proteins could not be found in mucosal papillomas using 
antibodies directed against papillomavirus group-specific antigens, including the 
conserved L1 major capsid protein, except one study reporting positive 
immunoreactivity in one macaw and one Amazon parrot (Bonda et al., 1998; Sundberg 
et al., 1986).  Finally, papillomavirus DNA could not be detected in mucosal papillomas 
using a Psittacus erithacus papillomavirus (African grey parrot papillomavirus or PePV) 
virion DNA probe by Southern blotting (Sundberg et al., 1986); by in-situ hybridization, 
in-situ PCR, or nested PCR using primers derived from PePV conserved sequence 
except one African grey parrot (Latimer et al., 1997); or by direct PCR using both 
degenerate primers that amplify a wide range of different mammalian papillomavirus L1 
sequence and primers derived from PePV L1 sequence except one Amazon parrot (Johne 
et al., 2002).  Because no convincing evidence for an association between 
papillomaviruses and mucosal papillomas could be found, efforts to identify other 
potential causes were initiated. 
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     Observations were made that mucosal papillomas occurred in survivors and exposed 
birds subsequent to outbreaks of PD (Van der Heyden, 1988).  It was generally held that 
birds surviving the acute manifestations of the disease become latently infected with 
PsHV following a sub-clinical or mild infection  (Gaskin, 1989; Grund and 
Schlippenbach, 2002; Phalen et al., 2001).  Evidence began to accumulate supporting 
PsHV as a potential cause for mucosal papillomas.  One report described herpesvirus 
virions in a mucosal papilloma from an orange-fronted conure (Aratinga canicularis) 
(Goodwin and McGee, 1993).  Investigations in other species showed an association 
between herpesviruses and cutaneous papillomas in rainbow smelt (Osmerus mordax) 
(Herman et al., 1997), koi (Cyprinus carpio) (Calle et al., 1999), and marine sea turtles 
(Quackenbush et al., 1998; Quackenbush et al., 2001).   
     There were also reports describing herpesvirus-like particles in the cutaneous 
papillomas from the feet and legs of macaws (Ara spp.) (Lowenstine, 1982; Phalen, 
1997) and cockatoos (Cacatua spp.) (Lowenstine, 1982; Lowenstine et al., 1983; Phalen, 
1997).  Further support for the association between PsHV and mucosal papillomas was 
presented in a study that found that parrots with mucosal papillomas had circulating anti-
PsHV antibodies, whereas parrots without papillomas did not (Phalen et al., 1997). Two 
other investigations detected PsHV DNA in mucosal papillomas by PCR from four of 
four birds in one study (Phalen et al., 1998), and 9 of 12 birds in another (Johne et al., 
2002).  These findings were supported by the observations that the prevalence of PsHV 
infection in parrots with mucosal papillomas was higher than that seen in the general 
population of captive parrots (Grund and Schlippenbach, 2002) and parrots without 
mucosal papillomas (Tomaszewski et al., 2002).   
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     Therefore, to test the hypothesis that mucosal papillomas of Neotropical parrots are 
caused by one or more genotypes of PsHV, mucosal papillomas from 30 Neotropical 
psittacine birds were examined by PCR with PePV-specific, FPV-specific, and PsHV-
specific primers; and a subset of five mucosal papillomas were also examined by 
immunohistochemistry for L1 major capsid protein immunoreactivity.  The findings of 
this study are discussed in chapter II of this work. 
     During the investigation of the putative association between mucosal papillomas and 
PsHV, a unique PsHV sequence was discovered in the periophthalmic papilloma of a 
non-Neotropical psittacine bird, an African grey parrot (Psittacus erithacus), that 
differed significantly from the PsHVs previously described by Tomaszewski et al. 
(2003).  This finding led to further investigation of other African grey parrots to 
determine the prevalence of this unique PsHV. 
 
A novel psittacid herpesvirus in African grey parrots 
    The cause of papillomas in African grey parrots had been attributed to a species-
specific Psittacus erithacus papillomavirus (PePV) (Jacobson et al., 1983; OBanion et 
al., 1992).  However during the investigation of the putative association between PsHVs 
and mucosal papillomas, a phylogenetically unique PsHV sequence was detected in the 
biopsy of a periophthalmic papilloma from an African grey parrot.  This same sequence 
was detected in two other living African grey parrots including a bird exhibiting a 
cloacal papilloma, and a bird with a histologically normal cloaca.  The sequence was 
also found in the histologically normal cloaca of a fourth African grey parrot that died of 
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causes unrelated to PsHV.  This was the first report of a truly mucosal papilloma in an 
African grey parrot. 
     PsHV was known to kill African grey parrots (Psittacus erithacus) (Tomaszewski et 
al., 2003), but it had also been shown that PsHV existed latently in other species of 
parrots either asymptomatically or in parrots exhibiting mucosal papillomas (Grund and 
Schlippenbach, 2002; Johne et al., 2002; Phalen et al., 1998; Phalen et al., 2001).  PsHV 
associated with PD had not been reported to exist latently in African grey parrots.  
Therefore, this novel PsHV sequence demonstrated both phylogenetic as well as clinical 
variations compared to previously described PsHVs.  
     The results of this investigation are reported in Chapter III where this novel α4 
herpesvirus is phylogenetically characterized in relation to both known PsHVs and the 
broader family of alphaherpesviruses based on sequence data derived from the UL16 
(host range protein) and UL30 (DNA polymerase protein) genes. This new psittacid 
herpesvirus is related but phylogenetically distinct from previously described psittacid 
herpesviruses (Tomaszewski et al., 2003). 
 
Internal papillomatous disease and other associated tumors 
     Observations were made about seemingly related neoplastic diseases that were often 
coincidental with the presence or a history of IPD (Graham, 1991; Hillyer et al., 1991; 
Phalen et al., 1997).  These tumors associated with IPD were adenomas and carcinomas 
of the bile ducts and pancreatic ducts (Graham, 1991; Elangbam and Panciera, 1988; 
Gibbons et al., 2002; Hillyer et al., 1991; Phalen et al., 1997; Potter et al., 1983).  These 
tumors had the same Neotropical species distribution as had been described for mucosal 
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papillomas (Graham, 1991; Hillyer et al., 1991; Phalen et al., 1997).  Clinically, these 
tumors were either locally invasive or space occupying lesions, but infrequently 
metastasized (Schmidt et al., 2003).  However, these neoplasms differ from mucosal 
papillomas in that once they are established, they do not wane but appear to progress 
along a spectrum from relatively benign adenomatous change to a malignant 
carcinomatous state.  Other tumors that have been speculated to have an association with 
IPD were carcinomas of the proventriculus, ventriculus, and cloacal mucosa. 
     The cause of IPD and related diseases was unknown, but studies by Phalen et al. 
(1997 and 1998) suggested that these neoplasms might be associated with infection by 
one or more genotypes of PsHV.  Based on these preliminary findings, an investigation 
into the cause of IPD was performed building on the knowledge acquired from the work 
with mucosal papillomas.   
     Methods used to investigate theses associated neoplasms associated with IPD 
included conventional PCR of DNA extracted from the fresh and formalin-fixed 
paraffin-embedded (FFPE) tissues of birds with IPD and an associated tumor using 
probes that detected all known PsHVs.  Techniques were also performed in an attempt to 
define the exact cellular location of any PsHV found in the neoplastic tissues to establish 
a clear link between the presence of PsHV and the neoplastic tissue.  For example, in a 
liver with bile duct carcinoma, there are affected neoplastic sections and histologically 
normal sections.  The liver was determined to contain PsHV DNA by extracting DNA 
from digests of the whole tissue, including carcinoma and unaffected tissue, and 
examining it with PsHV specific probes by conventional PCR.  However, the question 
remained whether the neoplastic bile duct cells had significantly higher concentrations of 
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PsHV compared to the adjacent unaffected hepatocytes.   The first technique used in an 
attempt to localize the PsHV was laser capture microdissection (LCM).  The laser was 
used as a microsurgical instrument to collect samples within the affected and unaffected 
regions of the tissue.  The DNA was then extracted from these samples and examined by 
conventional PCR using PsHV specific probes to determine if any relative difference in 
concentration of PsHV existed between the neoplastic and unaffected tissue.  In situ 
hybridization was similarly employed to examine FFPE tissues of birds with IPD 
associated tumors using both random and specific biotinylated probes made from known 
PsHVs or amplicons of PsHV genes.  Lastly, in situ PCR was also used to examine the 
same tissues using PsHV specific primers that amplified all known PsHV genotypes 
with biotinylated nucleotides as the detection agents.  The results of this work are 
detailed in Chapter IV. 
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CHAPTER II 
PSITTACID HERPESVIRUSES ASSOCIATED WITH MUCOSAL 
PAPILLOMAS IN NEOTROPICAL PARROTS* 
 
Introduction 
     Papillomas are benign or premalignant neoplasms of cutaneous, mucocutaneous, and 
mucosal epithelial surfaces.  All papillomas in mammals appear to be caused by 
papillomaviruses (Brentjens et al., 2002).  In contrast, cutaneous papillomas in rainbow 
smelt (Osmerus mordax) (Herman et al., 1997), koi (Cyprinus carpio) (Calle et al., 
1999), and marine sea turtles (Quackenbush et al., 1998; Quackenbush et al., 2001) are 
associated with herpesvirus infections. 
     Both cutaneous and mucosal papillomas have been described in birds. Cutaneous 
papillomas have been reported in wild finches (Fringilldae) (Jennings, 1968; McDonald, 
1965; Sironi et al., 1992), African gray parrots (Psittacus erithacus) (Jacobson et al., 
1983), a Cuban Amazon parrot (Amazona leucocephala) (Johne et al., 2002), macaws 
(Ara spp.) (Phalen, 1997) and cockatoos (Cacatua spp.) (Lowenstine et al., 1983; 
Schmidt et al., 2003).   The etiologic agents responsible for cutaneous papillomas in the 
finch, African gray parrot, and Cuban Amazon parrot are papillomaviruses. Lesions 
caused by these viruses contain intra-nuclear inclusion bodies consisting of crystalline 
arrays of virus particles (Jacobson et al., 1983; Lina et al., 1973; Osterhaus et al., 1977).  
__________________ 
 *Reprinted with permission from Psittacid herpesviruses associated with mucosal papillomas in 
Neotropical parrots, by Darrel K. Styles, Elizabeth K. Tomaszewski, Laurie A. Jaeger, and David N. 
Phalen, 2004.  Virology, 325, 24-35.  Copyright 2004 by Elsevier. 
 
 46
Papillomaviruses from a finch (Fringilla coelebs papillomavirus [FPV]) and African 
gray parrot (Psittacus erithacus papillomavirus [PePV]) have been purified, cloned, and 
sequenced. The genomes of FPV and PePV are structurally similar to mammalian 
papillomaviruses but share little genetic homology to them or each other (Moreno-Lopez 
et al., 1984; OBanion et al., 1992; Tachezy et al., 2002; Terai et al., 2002). 
Nevertheless, the L1 major capsid proteins of both FPV (Dillner et al., 1991) and PePV 
(Jacobson et al.; 1983, Lim et al.; 1990, OBanion et al., 1992) are immunologically 
cross-reactive with the L1 protein of mammalian papillomaviruses.  
     In contrast to the cutaneous papillomas of finches and African gray parrots, the 
cutaneous lesions found in cockatoos and macaws appear to be caused by herpesviruses.   
These lesions of the unfeathered skin of the foot are characterized by intranuclear 
eosinophilic inclusion bodies that contain herpesviruses virions (Lowenstine et al., 1983, 
Schmidt et al., 2003). To date, the viruses associated with these lesions have not been 
characterized. 
     Mucosal papillomas have been described in many species of captive Neotropical 
psittacine birds, with the highest incidence of these lesions occurring in Amazon parrots                  
(Amazona) and macaws (Ara spp.) (Graham, 1991; Johne et al., 2002; McDonald, 1988; 
Van der Heyden, 1988). There is a single report of an oral papilloma in an African gray 
parrot (Latimer et al., 1997). However, this lesion was of squamous epithelium and not 
of the mucous membranes and therefore cutaneous in nature.   Mucosal papillomas occur 
primarily in the oral cavity and cloaca (vent). Less frequently, mucosal papillomas are 
found in the crop, esophagus, proventriculus, ventriculus, and conjunctiva (Graham, 
1991).  These lesions cause considerable discomfort to affected birds, may interfere with 
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reproduction, and in severe cases result in the birds death. Bile duct and pancreatic duct 
adenocarcinomas are also reported to occur with a relatively high prevalence in birds 
with mucosal papillomas (Graham, 1991; Hillyer et al., 1991). 
     PePV is suspected to be the etiological agent of the one oral papilloma described in 
an African gray parrot because it contained PePV DNA (Latimer et al., 1997).  However, 
the etiology of mucosal papillomas in Neotropical parrots remains unknown.  Clinical 
observations suggest that mucosal papillomas are caused by an infectious agent as they 
appear to spread from affected birds to in-contact birds (McDonald, 1988; Van der 
Heyden, 1988).  However, four parrots inoculated with a mucosal papilloma homogenate 
did not develop disease (Sundberg et al., 1986).   
     Efforts to detect papillomaviruses in mucosal papillomas have been largely 
unsuccessful.  Virus particles have not been found in these lesions.  PCR with 
degenerate primers capable of detecting most mammalian papillomavirus sequences and 
with primers derived from the PePV sequence have failed to detect papillomavirus DNA 
in the mucosal papillomas of parrots (Johne et al., 2002; Latimer et al., 1997; Sundberg 
et al., 1986). Additionally, a previous investigation failed to detect L1-like proteins in 
mucosal papillomas using anti-L1 serum made against conserved epitopes of 
mammalian papillomaviruses (Sundberg et al., 1986).    However, there is a report 
describing L1-like immunoreactivity present in epithelial cells of a cloacal papilloma 
from a hyacinth macaw (Anodorhynchus hyacinthinus) and a lilac-crowned Amazon 
parrot (Amazona finschi) (Bonda et al., 1998). 
     Psittacid herpesviruses are a heterogeneous group of viruses divided into four 
genotypes and four serotypes that are typically associated with an acute fatal infection in 
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parrots (Pachecos disease) (Tomaszewski et al., 2003).   However, some birds survive 
the acute manifestations of the disease and may become latently infected while others 
appear to become latently infected following an inapparent infection (Grund and 
Schlippenbach, 2002; Phalen et al., 2001).  Mucosal papillomas have been observed to 
develop in parrots that survived PsHV infections (Van der Heyden, 1988) and 
herpesvirus virions were observed in a mucosal papilloma from an orange-fronted 
conure (Aratinga canicularis) (Goodwin and McGee, 1993).  It is therefore likely that 
one or more of these PsHV genotypes are involved in the development of mucosal 
papillomas.   
     Epidemiologic evidence suggests that the prevalence of PsHV infection in parrots 
with mucosal papillomas is higher than that seen in the general population of captive 
parrots (Grund and Schlippenbach, 2002) and parrots without mucosal papillomas 
(Tomaszewski et al., 2002).  An initial study found that parrots with mucosal papillomas 
had circulating anti-PsHV antibodies, whereas parrots without papillomas did not 
(Phalen et al., 1997). Two studies have used PCR to detect PsHV DNA in these lesions. 
In a preliminary study, PsHV DNA was detected in mucosal papillomas from four of 
four birds (Phalen et al., 1998), and in a second study performed by other investigators, 
PsHV DNA was found in 9 of 12 (75%) mucosal papillomas (Johne et al., 2002).  
However, if PsHVs are indeed associated with the development of mucosal papillomas, 
then one would expect to find PsHV DNA in 100% of the samples and yet Johne et al. 
(2002) reported only a 75% detection rate. 
     To test the hypothesis that mucosal papillomas of Neotropical parrots are caused by 
PsHV and not a papillomavirus, mucosal papillomas from 30 Neotropical psittacine 
 49
birds were examined by PCR with PePV-specific, FPV-specific, and PsHV-specific 
primers.  Five mucosal papillomas were also examined by immunohistochemistry for L1 
major capsid protein immunoreactivity.  The genotypes of PsHVs detected in mucosal 
papillomas were determined by comparing their sequence to the sequences of previously 
reported psittacid herpesviruses (Tomaszewski et al., 2003).  
 
Results 
Immunohistochemistry of mucosal papillomas using anti-HPV6b L1 serum    
     A single investigation reports L1-like immunoreactivity in two mucosal papillomas 
from Neotropical parrots that were stained with an antibody made to a fusion protein 
containing a portion of the HPV 6b L1 protein (Bonda et al., 1998; Strike et al., 1989).   
To verify this finding, we used this same anti-L1serum to stain the papilloma from a 
hyacinth macaw (SC98-0018) that had been reported by Bonda et al. (1998) to contain 
L1 immunoreactivity, three mucosal papillomas from macaws and one mucosal 
papilloma from an Amazon parrot. Two human cervical papillomas were used as 
positive controls. A sagittal section taken through a Neotropical psittacine embryo was 
used as a negative control.  
     The human cervical papillomas showed distinct nuclear and cytoplasmic staining in 
the basalar epithelial layer and again at the non-keratinized superficial (lumenal) cell 
layer (Fig. 2.1a). Most tissues in the negative control psittacine embryo showed diffuse 
mild to moderate cytoplasmic staining and some showed a distinct nuclear staining 
pattern.  Importantly, the cloacal mucosa showed intense cytoplasmic and moderate  
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Fig. 2.1.  Immunohistochemical results of staining with the anti-L1 fusion protein 
antiserum.  (2.1a) human cervical papilloma showing distinct nuclear and cytoplasmic 
staining; (2.1b) prominent cytoplasmic and moderate nuclear staining seen in the normal 
cloacal mucosa of developing psittacine embryo SC01-0019; (2.1c) nuclear and 
cytoplasmic staining observed in a cloacal papilloma of hyacinth macaw SC98-0018; 
(2.1d) mucosal papilloma from the cloaca of a macaw DP01-0044 showing only 
background staining with the anti-L1 antiserum.  
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nuclear staining (2.1b).  This staining pattern was consistent in multiple trials and the 
intensity observed was not due to artifact.  The cloacal papilloma from the hyacinth 
macaw (SC98-0018) previously reported by Bonda et al. (1998) again stained strongly 
with the anti-L1 fusion protein antiserum (Fig. 2.1c).  Both cytoplasmic and nuclear 
staining was observed. Importantly, this pattern closely resembled that seen in some 
tissues of the developing embryo.  Three other mucosal papillomas from other macaws 
and one from an Amazon parrot showed only faint background staining. (Fig. 2.1d). 
 
Electron microscopy    
     It was assumed that if the cloacal papilloma from the hyacinth macaw (SC98-0018) 
actually contained L1 proteins, then it would also contain papillomavirus virions.  
Exhaustive examination of thin sections of the papilloma failed to demonstrate any such 
virions. 
 
PCR with PePV-  and FPV-specific primers   
     A single oral papilloma from an African gray parrot was previously shown to contain 
PePV DNA (Latimer et al., 1997).  DNA extracted from all the mucosal papillomas in 
this study were screened for papillomavirus using PePV and FPV specific primers by 
PCR.  None of the 41 papillomas contained PePV or FPV DNA. 
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Table 2.1 
 
Primer sequences for PePV, FPV, and PsHV 
 
 
1amplicon length in nucleotides 
 
 
Amplification of DNA from known PsHVs using primers from the DNA polymerase gene   
     Previously, Johne et al. reported that they were able to amplify PsHV from nine of 
twelve papillomas with PCR using primer set PsHV-Johne that was derived from the 
DNA polymerase gene (UL30) (Table 2.1).  In order to determine if the primers used by 
these investigators would consistently and efficiently amplify DNA from all known 
PsHV genotypes, an optimized PCR reaction was performed with DNA from two 
representative samples from each of the four PsHV genotypes.  These same samples 
were also amplified using the 23F-amplifying primer set (derived from the UL16/UL17 
region) that detects all known PsHV genotypes (Table 2.1).  Amplification products
Virus      Primers           Sequence (5-3)                              Amplicon1        Reference 
 
      
PePV:  ppv6621fmod (forward)      GGGCGGATATGACTTTCTGG                 204       (Johne, 2002 and 
            ppv6810r (reverse)           GCAGTGCGCACGCCTG       Tachezy, 2002) 
 
FPV:   FPV L1f (forward) AGGTGCTCAGGAGAATAATGC                       351       (Terai, 2002) 
            FPV L1r (reverse) AGAAGGTCGTCCGAAAGCCGC   
     
PsHV:   Amplifying:  PsHV-Johne 
              PsHV-s  CATGAACGGCATGCTGCCGT                           178       (Johne, 2002) 
              PsHV-as  GACTGCCACGGAGTATTG 
 
             Amplifying 23F    
             23Ff5a (forward) TGCGTGGGGTTAAACTCGGAACTAGAAG    667 (Tomaszewski, 2003) 
             23Fr3(reverse) CGACTACACGAGCCTAACATC   
     
             Sequencing  23F  
             23Ff5b (forward) GGGGTTAAACTCGGAACTAGAAG                  662 (Tomaszewski, 2003)   
             23Fr3 (reverse) CGACTACACGAGCCTAACATC  
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Fig.  2.2.  Comparison of the amplification efficiency of primer sets PsHV-Johne and 
23F-amplifying using paired DNA samples representative of each of the four PsHV 
genotypes.  Lanes 3-10 contain a 178 bp amplicon generated by primer set PsHV-Johne 
(Table 2.1).  Lanes 12-19 contain a 667 bp amplicon was generated by primer set 23F 
amplifying (Table 2.1).  DNA from genotypes 1, 2, and 3 was extracted from mucosal 
papillomas (Table 2.2). Genotype 4 DNA was extracted from tissues of birds dying with 
Pachecos disease (Table 2.2).  Specific samples amplified were:  lanes 3 and 12, SC02-
022 (genotype 1); lanes 4 and 13, SC02-038 (genotype 1); lanes 5 and 14, SC93-790 
(genotype 2); lanes 6 and 15, SC94-056 (genotype 2); lanes 7 and 16, SC94-1038 
(genotype 3); lanes 8 and 17, SC02-047 (genotype 3); lanes 9 and 18, 88-97 (genotype 
4); lanes 10 and 19, 91-864 (genotype 4).  Amplicons were electrophoresed on a 1.5% 
agarose gel.   
 
 
were detected in all of the reactions (Fig. 2.2).  Both primer sets amplified DNA from all 
four PsHV genotypes.  However, the primer set used by Johne et al had a markedly 
reduced amplification efficiency compared to the 23F primer set with PsHV genotypes 
1, 2, and 3 (Fig. 2.2). 
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PCR with PsHV specific primers   
     There are two previous studies using a limited number of tissues demonstrating PsHV 
DNA in all (Phalen et al., 1998) or many of the papillomas that they examined  (Johne et 
al., 2002).  In order to determine if PsHV DNA is in fact consistently present in mucosal 
papillomas, primer sets known to amplify all known PsHV genotypes (Table 2.1; 23F- 
amplifying) were used with PCR to screen 41 papillomas from 30 Neotropical parrots; a 
biopsy from the cloacal mucosa of a macaw without papillomas that was in contact with 
another macaw with a papilloma; and 12 histologically normal mucosa samples from 
birds that had papillomas.  PsHV DNA was detected in all of the mucosal papillomas 
examined. The estimated number of copies of the target gene per 100 pg of DNA ranged 
from approximately 1,000 to over 1,000,000 and serial 10-fold dilutions of a plasmid 
containing the UL 16/17 region showed that the sensitivity of this assay was 1,000 
copies of target DNA (Fig. 2.3). 
     PsHV DNA was not amplified from three mucosal samples that were collected from 
the mucosa adjacent to papillomas. Nine histologically normal digestive mucosal 
samples were collected from birds with papillomas.  Seven were negative, but one 
proventricular sample was weakly positive (approximately 1,000-10,000 copies of target 
DNA) and another was moderately positive (approximately 10,000-1,000,000 copies of 
target DNA). PsHV DNA was also detected in the cloacal biopsy from an in contact 
macaw (SC02-0043) not exhibiting mucosal papillomas.  There was no PsHV DNA 
amplified from DNA extracted from the tissues of a near hatch conure embryo (SC01-
0019) or the blood from an incubator-hatched African gray nestling (SC03-0005).  Also, 
PsHV DNA was not found in the brachial plexus, lumbosacral plexus, or brain of 3 birds 
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with papillomas.  Herpesvirus DNA was consistently amplified from DNA purified from 
control tissue known to contain PsHV DNA. 
 
 
 
 
 
 
Fig. 2.3.  Evaluation of the sensitivity of the 23F primer set to detect PsHV in serial 
dilutions of a PsHV clone of known concentration (clone 23F-from which the 23F 
primer sets were derived), and from 100 ng of genomic DNA extracted from mucosal 
papillomas.  Lanes 2-4 contain a 667 bp amplicons from the serial dilutions of the PsHV 
clone 23F in order of decreasing concentration (plasmids/µl): lane 2  106; lane 3  104; 
lane 4 103.  Lanes 5, 6, and 7 contain the 667 bp amplicons generated from DNA 
derived from mucosal papillomas and lane 8 contains DNA derived from the cloaca of 
an asymptomatic macaw (Table 2).  Specific samples are:  lane 5 - SC02-022 (genotype 
1); lane 6  SC00-020 (genotype 2); lane 7  SC02-047 (genotype 3); lane 8  SC02-
0043 (genotype 4). 
     
 
 56
 
Fig.  2.4.  Consensus phylogenetic tree (cladogram) of a set of 419 bp PsHV sequences 
generated by bootstrap re-sampling (numbers of repetitions=1000), distance optimality, 
and neighbor-joining search using PAUP 4.0.  Sequences preceded by SC or DP 
were derived from mucosal papillomas except for sequence SC02-0043 that was derived 
from the cloaca of an asymptomatic macaw (Table 2.2).  Sequences followed by the 
suffix GEN X were reference sequences of known genotype where X=genotype. 
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Phylogenetic analysis   
     The sequence of a 419 bp fragment of each amplicon was compared to the sequences 
of PsHVs of known genotype (Tomaszewski et al., 2000). A cladogram of all the 
sequences is shown (Fig. 2.4).  A phylogram with representatives of each genotype 
showing branch-lengths and bootstrap values was also generated (Fig. 2.5).  Of the 30 
sequences from the mucosal papillomas, four were genotype 1 (13.3%); three were 
genotype 2 (10.0%); and 23 were genotype 3 (76.7%).  The herpesvirus found in the 
cloaca of a macaw without papillomas (SC02-0043) was genotype 4. In six birds, PsHV 
amplicons were sequenced from an upper gastrointestinal papilloma and a cloacal 
papilloma from the same bird. The sequences from both lesions from each bird were 
identical. 
 
Estimation of the distribution of genotypes in the population of birds with mucosal 
papillomas   
     If PsHV sequence is amplified from a mucosal papilloma selected at random, then the 
probabilities of mapping into each PsHV genotype are:  p (genotype 1, n= 4) = 0.13 ± 
0.12; p (genotype 2, n=3) = 0.10 ± 0.11; and p (genotype 3, n=23) = 0.77 ± 0.15. 
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Fig. 2.5.  Phylogram displaying branch lengths and bootstrap values [bracketed at nodes] 
for one representative of each genotype of the 419 bp PsHV sequence.  This tree was 
generated by bootstrap re-sampling (numbers of repetitions=1000), distance optimality, 
and neighbor-joining search.   
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Significance of the observed PsHV prevalence in papillomas as compared to the 
estimated prevalence rates in the general psittacine population   
     The prevalence of PsHV infection in macaws and Amazon parrots submitted to the 
Texas Veterinary Medical Diagnostic Laboratory was 0% (0/25) (Tomaszewski et al., 
2002).  An overall seroprevalence of PsHV infection in a recent study of aviary parrots 
in Europe was 37% (200/750) (Grund et al., 2002).  The rate of detection of PsHV in the 
mucosal papilloma sample was 100% (30/30). The prevalence of the PsHV infection in 
birds with mucosal papillomas was significantly higher (p < 0.05) than the prevalence of 
infection in previously sampled USA and European populations.  
 
Discussion 
     Investigations into the etiologic agent of mucosal papillomas of Neotropical parrots 
have focused on two possible etiologies, papillomaviruses and PsHVs.  Our work, 
coupled with the work of other investigators, provides increasingly strong evidence that 
PsHVs play a direct role in the development of mucosal papillomas.  Prior to this 
investigation, it had been noted that mucosal papillomas were seen in birds that survived 
acute systemic PsHV infections (Van der Heyden, 1988).  Additionally, birds with 
mucosal papillomas had been shown to have circulating antibody to PsHVs (Phalen et 
al., 1997); PsHV DNA had been demonstrated in the epithelial layer of a mucosal 
papilloma by DNA-DNA in situ hybridization (Johne et al., 2002); and PsHV DNA had 
been found in four of four mucosal papillomas (Phalen et al., 1998) and nine of twelve 
mucosal papillomas by Johne et al. (2002).  In our current study, we found that 100% of 
the 41 mucosal papillomas collected from 30 birds were positive for PsHV DNA.  
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Importantly, PsHV DNA was not found in three histologically normal mucosal samples 
that were adjacent to papillomas, and was only found in two of seven normal mucosal 
samples taken from other parts of the digestive system.  The 100% prevalence of PsHV 
infection in the birds with papillomas was found to be significantly higher than any 
reported infection prevalence in parrots and therefore it is extremely unlikely that 
presence of PsHVs in papillomas was coincidental. 
     If PsHVs were the causative agent of mucosal papillomas in Neotropical parrots, then 
it would be expected that they would all contain PsHV. Yet, Johne et al. (2002) only 
detected PsHV DNA in 9 of 12 papillomas that they examined.  PsHV occurs in variable 
concentrations in the mucosal papillomas.  Our data shows that the 23F primer set is 
highly sensitive and capable of detecting PsHV at minimal concentrations of at 103 
copies or potentially less (Fig. 2.3). However, the primers used by Johne et al. are not as 
efficient at amplifying PsHV genotypes 1, 2, or 3 and therefore would not have detected 
PsHV at the lower concentrations found in some of the papillomas described by our 
study (Fig. 2.3).  Thus, we speculate that their negative samples may have actually been 
positive and contained concentrations of PsHV lower than the limit of detection by their 
primer set. 
     If the hypothesis that PsHV infection is necessary for the development of mucosal 
papillomas in Neotropical parrots is correct, then the phylogenetic data presented here 
provides evidence as to the epizootiology of this disease.  Only PsHV genotypes 1, 2, 
and 3 were found in the mucosal papilloma sample population, and the majority (77%) 
of the viruses were genotype 3.  The most common genotypes to cause Pachecos 
disease in the United States are genotypes 3 and 4, while genotypes 1 and 2 are less 
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commonly implicated (Tomaszewski et al., 2003).  The work by Tomaszewski et al. 
(2003) suggests that specific PsHV genotypes may be more likely to cause Pachecos 
disease in some species and less likely to cause Pachecos disease in others. Both 
genotypes 3 and 4 demonstrate some general species preference. Genotype 4 is the most 
common genotype to be found in macaws that die with Pachecos disease.  In contrast, 
genotype 3 is rarely found to cause Pachecos disease in macaws and genotypes 1 and 2 
were never found in macaws with Pachecos disease.  These data potentially explain 
why genotypes 1, 2 and 3 but not 4 are found in macaws with mucosal papillomas. 
Macaws infected with genotype 4 would be less likely to survive infection and would 
succumb before developing papillomas.  However, infections with the other genotypes 
may result in asymptomatic persistent infection and the development of papillomas. The 
unexpected discovery of a PsHV genotype 4 in from the cloacal biopsy of an 
asymptomatic macaw (SC03-0043) suggests that not all genotype 4 infections in macaws 
result in death from Pachecos disease and other factors such as individual host immune 
response may determine the ultimate outcome resulting from infection. 
     It has also been observed that infection with PsHV genotype 3 usually results in a 
fatal infection in Amazon parrots but rarely macaws.  However, our study found that 
60% of Amazon parrots with papillomas were infected with genotype 3.  This data again 
suggests that there may be factors other than genotype that determine what disease 
process may be observed.   
     These variations of individual species sensitivity to PsHV infection could result in the 
inapparent spread of genotypes 1, 2, and 3 from bird to bird, and would explain why 
mucosal papillomas can disseminate throughout a collection without an ensuing 
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outbreak of Pachecos disease.  These data also suggest that under some conditions, 
birds with mucosal papillomas may be potential sources of outbreaks of Pachecos 
disease. 
     Epizootiological evidence suggests that the PsHVs present in the papillomas go 
through periods where they produce virions.  However, it also appears these viruses are 
predominantly present in the mucosal papillomas in a latent state, or at the very least are 
slowly replicating.  Inclusion bodies and virions have only been detected in a single 
papilloma and transmission trials with a mucosal papilloma homogenate failed to induce 
mucosal papillomas or Pachecos disease (Goodwin and McGee, 1993; Sundburg et al., 
1986).  If PsHVs do maintain a latent state in the mucous membranes of parrots, this 
would be a novel strategy for an alpha herpesvirus, as they typically infect nerve cells 
and establish latency.  Whether or not PsHVs also latently infect other tissues will 
require further investigation.  Dorsal root nerve ganglia are common location for 
persistent alphaherpesvirus infection.  We were not able to detect PsHV DNA in nervous 
tissue from 3 birds, but we did not examine dorsal root ganglia or employ intensive 
amplification techniques such as nested PCR. 
     Mucosal papillomas in Amazon parrots are most often confined to the mucosa of the 
cloaca.  Macaws also typically have cloacal papillomas as well as papillomas of the 
upper digestive tract.  This difference in distribution of the lesions appears to be the 
result of host factors because the same genotypes found in macaw mucosal papillomas 
were also found in Amazon parrot papillomas.  This is further supported by the 
observations that the genotypes found in the upper digestive tract papillomas were the 
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same as the genotypes found in the cloaca papillomas in all of the birds examined with 
lesions in both locations. 
     In a previous study, a variant of the genotype 3 viruses was identified that could be 
neutralized by serum raised to either serotype 2 or serotype 3 viruses (Gravendyck et al., 
1996).  In that study, both viruses were European isolates and it was not known if  a 
similar virus was present in the USA.  A virus with an identical sequence to this variant 
was detected in one cloacal papilloma from a macaw (sample SC99-0037, Fig. 2.4) in 
this study, suggesting that this variant of the genotype 3 with its unusual serotype is also 
present in the USA.  
     The only evidence that a papillomavirus may play a role in the development of 
mucosal papillomas are the findings of PePV DNA in an oral papilloma in an African 
gray parrot (Latimer et al., 1997) and L1 immunoreactivity in papillomas from a 
hyacinth macaw and an Amazon parrot (Bonda et al., 1998).  The oral papilloma from 
the African gray parrot should not be considered as a mucosal papilloma, because the 
lesion was characterized by keratinized squamous epithelium and was not of 
mucocutaneous epithelium.  Therefore, we feel that this lesion is more representative of 
the cutaneous papillomas seen in African gray parrots that are known to be caused by 
PePV.  Previous studies failed to document PePV DNA in mucosal papillomas 
(Sundburg et al., 1986; Latimer et al., 1997).  Similarly, neither PePV nor FPV DNA 
was amplified from the mucosal papilloma population in our study.  However, we cannot 
exclude the existence of a novel avian papillomavirus that was not detected by our PePV 
or FPV primer sets in the lesions.  We chose to use these specific primers because they 
are derived from the conserved L1 major capsid protein sequence of the only known 
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avian papillomaviruses, and the nucleotide homology between PePV and FPV is too 
diverse to make degenerate primers capable of detecting both viruses and the and any 
intervening variants.     
     In order to determine whether the L1 immunoreactivity previously reported in the 
hyacinth macaw was the result of papillomavirus antigen, we repeated this experiment 
with the same antibody and papilloma from the hyacinth macaw (SC98-0018) reported 
by Bonda et al. (1998), papillomas from 3 other macaws and an Amazon parrot, a human 
cervical papilloma as a positive control, and a conure embryo as a negative control.  We 
were able to demonstrate L1 immunoreactivity in the hyacinth macaw papilloma.  
However, we also showed a similar degree and pattern of immunoreactivity in the 
psittacine embryonic control tissue. By contrast, the four other mucosal papillomas 
examined did not contain this immunoreactive protein.  Therefore, given that virions 
were not observed in this papilloma and FPV or PePV DNA was not found, we conclude 
that the immunoreactivity is either nonspecific or is due to a protein that is cross-reactive 
to the L1 anti-serum but is not in fact papillomavirus L1 major capsid protein.  
Importantly, we did amplify PsHV genotype 3 DNA from this mucosal papilloma (Fig. 
2.4). 
     In conclusion, all the evidence to date strongly suggests that PsHVs play an essential 
role in the development of mucosal papillomas in Neotropical parrots and explain their 
apparent infectious nature.  In contrast, there is no evidence to suggest that a 
papillomavirus is present in these lesions. 
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Materials and Methods 
Source of specimens   
     Tissues from thirty-one Neotropical parrots, one old world parrot, and one finch were 
used in the mucosal papilloma study (Table 2.2).   The papillomas examined in this 
study were harvested from Amazon parrots (30%), macaws (67%), and a single conure 
(3%). All birds were from aviaries in the United States of America. Tissues were 
diagnostic specimens (biopsies or whole birds) that were submitted to the Schubot 
Exotic Bird Health Center (Texas A&M University, College Station, TX).  An additional 
sample, a cloacal biopsy from an unaffected blue and gold macaw (SC02-0043) that was 
in contact with another bird with mucosal papillomas was also examined.  When tissues 
were available from more than one bird from the same source, only tissues from one of 
the birds were examined.  
     Tissues were collected using cleaned, autoclaved instruments that had been bleached 
and formalin-soaked.  A different set of instruments was used to collect each tissue to 
prevent DNA contamination.  Tissues were either processed immediately or stored at -
80°C until use.  Papillomas were taken from more than one site in 7 birds.  The total 
number of papillomas examined was 44:  choana=2, cloaca=23, crop=4, esophagus=3, 
glottis=5, oropharynx=6, proventriculus=1.   Histologically normal digestive tract  
mucosal samples were available from 6 birds with mucosal papillomas:  choana=1, 
crop=4, esophagus=1, proventriculus=3.  In two of these birds, three additional samples  
 66
 
Table 2.2   
 
Tissues and sources 
        
Isolate Genebank Species Geno2 Tissues 
Number Access #/Use1 Examined  Sequenced 
     
SC88-0097 immunohist.3 Ara macao    
SC91-0864 immunohist. Amazona aestiva   
SC92-0496 AY421976 Ara macao 3 cloacal papilloma 
SC92-0498 AY421977 Ara macao 3 cloacal papilloma 
SC92-1409 AY421978 Amazona auropalliata 3 glottal papilloma 
SC92-1584 AY421979 Ara ararauna 3 cloacal papilloma 
SC93-0192 AY421980 Ara ararauna 3 choanal papilloma 
SC93-0790 AY421981 Ara chloroptera 2 esophageal papilloma 
SC94-0056 AY421982 Ara chloroptera 2 cloacal papilloma 
SC94-0188 immunohist. Ara macao   
SC94-0390 AY421983 Aratinga spp. 3 glottal papilloma 
SC94-1038 AY421984 Ara chloroptera 3 cloacal papilloma 
SC98-0018 AY421985 Anodorhynchus hyacinthinus 3 cloacal papilloma 
SC98-0037 AY421986 Amazona aestiva 3 cloacal papilloma 
SC99-0037 AY421987 Ara macao 3 cloacal papilloma 
SC00-0020 AY421988 Amazona oratrix 2 cloacal, crop papillomas 
SC00-0077 AY421989 Amazona oratrix 3 cloacal papilloma 
DP01-0044 AY421990 Ara ararauna 3 cloacal, glottal papillomas 
SC01-0019 (-) control DNA Pyrrhura rupicola   
DP02-0034 AY421991 Ara chloroptera 3 cloacal, glottal papillomas 
SC02-0002 AY421992 Amazona autumnalis 3 cloacal papilloma 
SC02-0022 AY421993 Ara ararauna 1 cloacal papilloma 
SC02-0038 AY421994 Amazona barbadensis 1 cloacal papilloma 
SC02-0043 AY421995 Ara ararauna 4 cloaca (no papilloma) 
SC02-0044 AY421996 Ara ararauna 3 cloacal papilloma 
SC02-0045 AY421997 Amazona aestiva 3 cloacal papilloma 
SC02-0046 AY421998 Amazona aestiva 1 cloacal papilloma 
SC02-0047 AY421999 Amazona aestiva 3 cloacal papilloma 
SC02-0048 AY422000 Amazona oratrix 3 cloacal papilloma 
SC02-0049 AY422001 Ara macao 3 cloacal papilloma 
SC03-0005 (-) control DNA Psittacus erithacus   
SC03-0014 AY563422 Ara chloroptera 3 cloacal papilloma 
SC03-0027 AY563423 Ara ararauna 3 oropharyngeal papilloma 
SC03-0028 AY563424 Ara ararauna 3 oropharyngeal papilloma 
DP04-0009 (-) control DNA Lonchura striata   
SC04-0001 AY563425 Ara chloroptera 3 glottal papilloma 
SC04-0003 AY563426 Ara chloroptera 3 cloacal papilloma 
     
 
1GeneBank accession number or tissue use 
2PsHV genotype 
3immunohist.=tissues used for immunohistochemistry
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were taken from mucosa that was the immediately adjacent to papillomas but was 
histologically normal. When only a single papilloma was available, the amplicon from 
that papilloma was sequenced.  There were six birds that had papillomas in the upper 
digestive tract and cloaca.  In these birds, amplicons from both the cloacal lesion and an 
upper digestive tract lesion were sequenced.  One bird had multiple papillomas of the 
upper digestive tract; only one of the amplicons from these papillomas was sequenced.  
Neural tissue was available from 3 birds:  brachial plexus=1, lumbosacral plexus=2, and 
brain=1. 
 
Histological evaluation of the mucosal papillomas and unaffected tissue   
     Sections of the tissues were fixed in formalin, embedded in paraffin, and thin sections 
were routinely stained with hematoxylin and eosin. The tissue was considered to contain 
papillomas if the normal mucosa was replaced with papillary growths consisting of a 
narrow to broad base with the mucosal fronds containing a fine fibrovascular core 
covered by a cuboidal to tall columnar epithelium of variable thickness. 
 
Immunohistochemistry of mucosal papillomas using papillomavirus anti-L1 major 
capsid protein antibody   
     Formalin-fixed paraffin-embedded mucosal papillomas from one Amazon parrot 
(SC91-0864) and four macaws (SC88-0097, SC94-0188, SC98-0018, DP01-0044) were 
affixed to 3-aminopropyl-trimethoxysilane coated glass slides (Sigma, St. Louis, MO.).  
Tissues were incubated with rabbit polyclonal antiserum made against an HPV-6b L1 ß-
galactosidase fusion protein (Bonda et al., 1998). The antibody has been previously 
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shown to detect a highly conserved epitope within the L1 protein of mammalian 
papillomaviruses (Strike et al., 1989). Positive controls were two human cervical 
papilloma biopsies.  The negative control was a near-hatch conure embryo (SC01-0019) 
(Table 2.2). The embryo was sagittally sectioned to include cloaca and other viscera. 
    Microwave antigen retrieval was performed in 10 mM citrate buffer using methods 
similar to those described by Shi et al (Shi et al., 1991).  Tissues were permeabilized 
with 0.5% Triton X 100 in PBS, and endogenous peroxidase was quenched with 0.3% 
H2O2 in water.   Tissues were blocked with 3% BSA / 0.1% glycine /10% normal goat 
serum in 0.2% Tween 20 in PBS.    The tissues were then incubated with L1 fusion 
protein antiserum, diluted 1:500 in a solution of 10% normal goat serum / 0.2% Tween 
20 in PBS, for 12 h at 4ºC.   Immunoreactions were visualized using HRP-conjugated 
goat anti-rabbit antibody (Bethyl Labs, Montgomery, Tex.), with diaminobenzidine 
tetrahydrochloride (Sigma) and imidazole (EM Science, Gibbstown, NJ.) as 
chromogenic substrates (protocol from CHEMICON International, Inc., 
www.chemicon.com). Reactions were stopped at 15 minutes, and sections were 
examined by light microscopy (Fig. 2.1a-d). 
 
Electron microscopy   
     Formalin-fixed, paraffin-embedded papillomatous tissue from the hyacinth macaw 
(SC98-0018) that had stained positively with the anti-L1 antibody was deparafffinized 
and fixed in 3% uranyl acetate in 100% ethanol.  The tissue was then embedded in 
Spurs firm epoxy resin and 60-90 nm sections were placed on a copper grid.  The 
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sections were post stained with 3% uranyl acetate and Reynolds lead citrate. Thin 
sections were examined for papillomavirus virions at 10,000 X for two hours. 
 
DNA purification   
     DNA was extracted from the tissues using the Purgene Genomic DNA Purification 
Kit (Gentra Systems, Minneapolis, MN.) following the instructions for fresh or frozen 
solid tissue.   
 
PCR of papilloma tissues with PePV- and FPV-specific primers   
     All PCR reactions were performed on an Eppendorf Mastercycler Personal 
Thermocycler (Eppendorf, Hamburg, Germany).  Primer set were derived from the 
conserved papillomavirus L1 major capsid protein region and DNA extracted from the 
tissues was examined for the presence of PePV DNA using the PePV-specific primers 
ppv6621fmod and ppv6810r and for FPV DNA using FPV L1f and FPV L1r by PCR 
(Table 2.1). The primer set for PePV amplification was slightly modified from that 
published by Johne (Johne et al., 2002) to agree with the PePV sequence reported by 
Tachezy, et al (2002).  The negative control for the PePV PCR was DNA extracted from 
a pre-hatch conure embryo (SC01-0019).   DNA from the liver of a society finch free of 
papillomas (DP04-0009) was used as the negative control for the FPV PCR.  The 
positive controls were a clone of Psittacus erithacus papillomavirus cloned into the Sal I 
site of pBR322 and a clone of finch papillomavirus cloned into the Eco RI site of 
pBR328 (Terai et al., 2002). 
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     PCR was performed as described by Johne et al. (Johne et al., 2002). Briefly, a 25 µl 
reaction mix containing, 100 ng genomic DNA, 25 pmol of each primer, 0.1 mM of each 
of the 4 deoxynucleotide triphosphates, 2.5 mM magnesium chloride, 0.75 units Taq 
polymerase and 1X buffer A (Promega, Madison, WI.) was used in the reaction. 
     The thermocycler parameters were:  initial denaturation at 95°C for 5 minutes; 
followed by 35 cycles of denaturing at 94°C for 30 seconds, annealing at 60°C for 
30seconds, extension at 72°C for 30 seconds, and then a period of final extension at 
72°C for 10 minutes.  Amplification products were imaged on an ethidium bromide 
agarose gel. 
 
Amplification of DNA of known PsHVs using primers from the DNA polymerase gene  
     Johne et al. (2002) detected PsHV DNA in eight of twelve papillomas they examined.  
To determine if the primers (Table 2.1) used in their study would efficiently amplify 
DNA from all 4 genotypes of the PsHV, we first optimized the magnesium and dNTP 
concentrations in the PCR reaction mix for these primers using PsHV genotype 1 viral 
DNA. The optimum reaction conditions using 100 ng of DNA (avian genomic and viral) 
were determined to be: 25 pmol of each primer, 0.05 mM of each of the 4 
deoxynucleotide triphosphates, 2.5 mM magnesium chloride, 1X buffer A (Promega) 
and 0.75 units Taq polymerase per 25 ųl reaction. The thermocycler parameters were the 
same as those reported by Johne et al (1998, 2002):  initial denaturation at 95°C for 5 
minutes; followed by 35 cycles of annealing at 56°C for 30 seconds, extension at 72°C 
for 30 s, denaturing at 94°C for 30 s, and then a period of final extension at 72°C for 10 
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min.   Using the optimized reaction conditions, viral DNA was amplified from four 
viruses of each genotype.  The intensity of the amplification products was compared to 
those produced by PCR of the same viruses using primer set 23F-amplifying (Fig. 2.2).   
 
PCR of DNA from papilloma tissues with PsHV-specific primers   
     DNA was examined for the presence of PsHV DNA by PCR.  The primer set 23F-
amplifying (Table 2.1) was used to amplify PsHV DNA (Tomaszewski et al., 2000).  
The amplicon produced was 667 bps in length and spanned a section of UL16/UL17 
(host-range protein / DNA-cleaving and packaging protein) including the UL16 
initiation codon.  Negative controls were DNA extracted from the blood of an incubator-
hatched African gray parrot (SC03-0005) held in isolation and a pre-hatch conure 
embryo (SC01-0019). The positive control was DNA containing PsHV extracted from 
tissues of an Amazon parrot that died of Pachecos disease (Tomaszewski et al., 2000).   
     PCR was performed as previously described (Tomaszewski et al., 2000). Briefly, a 25 
µl reaction mix containing, 100 ng genomic DNA, 25 pmol of each primer, 0.1 mM of 
each of the 4 deoxynucleotide triphosphates, 2.5 mM magnesium chloride, 0.75 units 
Taq polymerase and 1X buffer A was used in the reaction. 
     The thermocycler parameters were:  initial denaturation at 94°C for 5 minutes; 
followed by 40 cycles of annealing at 60°C for 45 seconds, extension at 72°C for 90 
seconds, denaturing at 94°C for 30 seconds, and then a period of final extension at 72°C 
for 5 minutes.  PCR amplification products were imaged on ethidium bromide agarose 
gels.  
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     The sensitivity of the assay was determined by amplifying viral DNA from 10-fold 
dilutions of a plasmid containing the UL16/17 ORF (Fig. 2.3).  The approximate copy 
number of PsHVs in each 500 ng of genomic DNA was estimated by comparing the 
intensity of the amplification products from the papilloma samples to those of the 
amplification products from the known concentrations of plasmid DNA (Fig. 2.3). 
 
DNA sequencing of PsHV amplicons   
     PCR products were purified using QIAquick PCR Purification Kit (Qiagen Inc., 
Valencia, Cal.).  The sequencing reaction was performed using an ABI Prism  Big 
Dye  Terminators v3.0 Cycle Sequencing Kit (Applied Biosystems Inc., Foster City, 
CA) using sequencing primers 23Ff5b (forward) and 23Fr3 (reverse) (Table 2.1). 
Products were sequenced using an ABI 377 DNA sequencer or ABI 3100 DNA 
sequencer (Applied Biosystems). 
 
Phylogenetic analysis   
     A 419 bp fragment beginning at the UL16 start codon was used for the phylogenetic 
analysis (Tomaszewski et al., 2000).  All sequences were aligned using Clustal X 1.81 
(Thompson et al., 1997).  Aligned sequences were imported into PAUP for analysis 
(Swofford, 1998).  Phylogenetic trees were generated by performing a neighbor-joining 
search using bootstrap re-sampling (1,000 replications) employing distance optimality.  
A cladogram including all sequences was included in this analysis to define the specific 
branches of the phylogenetic tree (Fig. 2.4) (Tomaszewski et al., 2000).  There is also a 
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phylogram showing branch-lengths and bootstrap values employing representative 
sequences of each genotype (Fig. 2.5). 
 
Statistical analysis   
     A test of the normal approximation of the binomial was performed to estimate the 
distribution of the genotypes in the population of mucosal papillomas (Johnson, 1984).  
This test was performed using only those birds that exhibited mucosal papillomas and 
did not include the in contact macaw (SC02-0043).  A chi-square test of independence 
(Johnson, 1984) was performed to demonstrate that the prevalence of PsHV in the 
mucosal papilloma population was significantly greater than the prevalence rate in one 
population of parrots from the USA (Johne et al., 2002) and the prevalence rate of PsHV 
infection in European aviaries (Grund and Schlippenbach, 2002).  
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CHAPTER III 
A NOVEL PSITTACID HERPESVIRUS FOUND IN  
AFRICAN GREY PARROTS (PSITTACUS ERITHACUS ERITHACUS)* 
 
 Introduction 
     Herpesviruses have been identified in a broad range of birds (Sui et al., 1995; 
VanDevanter et al., 1996; Ehlers et al., 1999; Alfonso et al., 2001; Wellehan et al., 
2003).  Molecular characterization of several of these viruses shows that they all are 
alphaherpesviruses.  However, avian herpesviruses are genetically diverse and are found 
in at least three genera of the Alphaherpesvirinae (Davison, 2002).  The α4 genus 
exclusively contains the avian herpesviruses, Gallid herpesvirus 1 (GaHV-1) 
(VanDevanter et al., 1996; Davison, 2002), Passerid herpesvirus 1 (PaHV-1) (Wellehan 
et al., 2003), and Psittacid herpesvirus (PsHV) (Davison, 2002; Tomaszewski et al., 
2003). PsHV is the only herpesvirus identified to date in psittacine birds (parrots).  
PsHV consists of 4 genotypes that have distinct biological characteristics (Tomaszewski 
et al., 2003).  These genotypes appear to have co-evolved with several species of 
Neotropical (Central and South American) parrots.  In their host species, they are not 
thought to cause disease (Tomaszewski et al., 2003). However, an acute fatal disease 
(Pachecos disease) may result when parrots are infected with a PsHV genotype to which 
they are not evolutionarily adapted.   
_________________ 
*Reprinted with permission from A novel psittacid herpesvirus found in African grey parrots (Psittacus 
erithacus erithacus), by Darrel K. Styles, Elizabeth K. Tomaszewski, and David N. Phalen, 2005.  Avian 
Pathology, 34(2), 150-154.  Copyright 2005 by Taylor & Francis, http://www.tandf.co.uk. 
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     Additionally, PsHV genotypes 1, 2, and 3 are believed to cause mucosal papillomas 
in subclinically infected Neotropical parrots and survivors of Pachecos disease (Styles 
et al., 2004).  Cutaneous papillomas have been described in macaws and cockatoos and 
are thought to be caused by an uncharacterized herpesvirus (Lowenstine et al., 1983; 
Phalen, 1997). However, cutaneous papillomas in African grey parrots appear to be 
caused by Psittacus erithacus papillomavirus (PePV) (OBanion et al., 1992). 
     In this study, we report the discovery of a novel α4 herpesvirus in the tissues of four 
African grey parrots (Psittacus erithacus erithacus).  This new psittacid herpesvirus is 
related but phylogenetically distinct from previously described psittacid herpesviruses 
(Tomaszewski et al., 2003). 
 
Results  
Histological examination of tissues 
 
     Tissues were examined by light microscopy to determine if papillomatous changes 
were present.  Specimens SC00-0020, SC02-0022, SC02-0025, and SC02-0047 
manifested mucosal papillomas characterized by normal mucosa replaced with papillary 
growths consisting of a narrow to broad base with the mucosal fronds containing a fine 
fibrovascular core covered by a cuboidal to tall columnar epithelium of variable 
thicknesses (Table 3.1).  Specimen SC01-0030 had a cutaneous periophthalmic 
papilloma characterized by undulating folds of hyperkeratotic proliferating epidermis.  
Specimens DP00-0078, SC02-0043, and SC03-0001 had no histologically detectable 
lesions. 
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Table 3.1 
 
Tissues and sequences 
Specimen # Species Tissue Gene (partial) Genebank 
(PsHV/Genotype)  Sequenced Sequenced Accession # 
DP00-0078 Psittacus erithacus Cloaca UL 16 AY623129 
(PsHV-2)   UL 30 AY623121 
     
SC00-0020 Amazona oratrix Cloacal UL 16 AY421988 
(PsHV-1/2)  Papilloma UL 30 AY623125 
     
SC01-0019 Pyrrhura rupicola Embryo   
(Neg. Control)     
     
SC01-0030 Psittacus erithacus Periophthalmic UL 16 AY623131 
(PsHV-2)  Papilloma UL 30 AY623122 
     
SC02-0022 Ara ararauna Cloacal UL 16 AY421993 
(PsHV-1/1)  Papilloma UL 30 AY623126 
     
SC02-0025 Psittacus erithacus Cloacal UL 16 AY623132 
(PsHV-2)  Papilloma UL 30 AY623123 
     
SC02-0043 Ara ararauna Cloaca UL 16 AY421995 
(PsHV-1/4)   UL 30 AY623128 
     
SC02-0047 Amazona aestiva Cloacal UL 16 AY421988 
(PsHV-1/3)  Papilloma UL 30 AY623127 
     
SC03-0001 Psittacus erithacus Cloaca UL 16 AY623130 
(PsHV-2)   UL 30 AY623124 
     
SC03-0005 Psittacus erithacus Blood   
(Neg. Control)     
     
 
 
PCR with PsHV specific primers amplifying regions of UL9, UL16/17, and UL30 
     Amplicons were produced from the four African grey parrot samples using PsHV 
primer sets 23F and ILK/IYG, but not with primer sets 11R or 39F (Table 3.2 and Table 
3.3).  PsHV DNA was amplified from the positive PsHV reference controls representing  
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Table 3.2 
 
Primer sequences for PsHV and PePV 
Gene Primers Sequence (5→ 3) APa Reference 
     
PsHV:      
     
UL9 b 11Rf8  AGTTGCTGAATCGGTACTGGTTCTC 537 Tomaszewski 2001 
 11Rr4  GGATGGGAATTTGCACCTCCT   
     
UL16 c 23Ff5a  TGCGTGGGGTTAAACTCGGAACTAGAAG    667 Tomaszewski 2003 
 23Fr3    CGACTACACGAGCCTAACATC   
     
 23Ff5b  GGGGTTAAACTCGGAACTAGAAG                 662 Tomaszewski 2003 
 23Fr3    CGACTACACGAGCCTAACATC   
     
UL30 d ILK TCCTGGACAAGCAGCARNYSGCNMTNAA 266 VanDevanter 1996 
 IYG  CACAGAGTCCGTRTCNCCRTADAT   
     
 39Ff AGCCTCTACCCGAGCATAATCCAG 634 Tomaszewski e 
 39Fr  GTGAAGCTAGAGTGCGAGAAAGTGT   
     
PePV:     
     
L1 f ppv6621fmod  GGGCGGATATGACTTTCTGG                 205 Styles 2004 
 ppv6810r  GCAGTGCGCACGCCTG   
 
 
a Amplification product length in nucleotides 
b Origin of binding protein 
c Host-range protein 
d DNA polymerase protein  
e Tomaszewski unpublished work 
f  Major capsid protein 
 
 
all four genotypes using 11R, 23F, 39F, and ILK/IYG primer sets (Table 3.3).  
Amplification products were not detected in the negative control samples from the 
incubator-hatched African grey parrot chick or Pyrrhura conure embryo.  PePV DNA 
was not detected in any samples, but was amplified from the positive PePV clone 
control. 
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Table 3.3 
 
PsHV amplification results for primer sets 11R, 23F, 39F, and ILK/IYG 
Specimen # Species Tissue Primer Seta 
(PsHV/Genotype)  Examined 11R 23F 39F ILK/IYG 
       
DP00-0078 Psittacus erithacus Cloaca - + - + 
(PsHV-2)       
       
SC00-0020 Amazona oratrix Cloacal + + + + 
(PsHV-1/2)  Papilloma     
       
SC01-0019 Pyrrhura rupicola Embryo - - - - 
(Neg. control)       
       
SC01-0030 Psittacus erithacus Periopthalmic - + - + 
(PsHV-2)  Papilloma     
       
SC02-0022 Ara ararauna Cloacal + + + + 
(PsHV-1/1)  Papilloma     
       
SC02-0025 Psittacus erithacus Cloacal - + - + 
(PsHV-2)  Papilloma     
       
SC02-0043 Ara ararauna Cloaca + + + + 
(PsHV-1/4)       
       
SC02-0047 Amazona aestiva Cloacal + + + + 
(PsHV-1/3)  Papilloma     
       
SC03-0001 Psittacus erithacus Cloaca - + - + 
(PsHV-2)       
       
SC03-0005 
(Neg. control) 
Psittacus erithacus Blood - - - - 
       
 
a The results of primer sets were designated as + if an amplicon resulted and a - if no amplification. 
 
 
 
Sequencing of PsHV amplicons from UL16/17 and UL30 
     Sequence data was generated for all samples from the UL16/17 amplicon using 
primer set 23Ff5b/23Fr3.  UL30 sequence data for the PsHV reference samples was 
produced using primer set 39F.  UL30 sequence data for the African grey parrot samples 
was generated using primer set ILK/IYG. 
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Phylogenetic analysis 
     An 88 amino acid sequence was translated from a 266 bp fragment amplified from 
UL30 of all samples and was compared to homologous sequence from four 
representative mammalian and five non-psittacine avian alphaherpesviruses (Figure 3.1).  
Only 57 amino acids (177 bp) of PaHV-1 UL 30 sequence were available, so the 
phylogram distance and location is approximate for this virus. A 139 amino acid 
sequence translated from a 419 bp fragment amplified from the UL16 gene was used to 
compare PsHV genotypes to the herpesvirus sequences obtained from the African grey 
parrots (Figure 3.2).  Comparison of the UL16 ORF of other non-psittacid avian α-
herpesviruses was not possible because GaHV-1 does not contain an UL16 ORF and this 
sequence has not been determined for PaHV-1.  
     Phylogenetic trees were generated using both nucleotides and amino acid sequences 
by performing a neighbor-joining search using bootstrap re-sampling (1,000 
replications) employing distance optimality as previously described (Styles et al., 2004).  
Both nucleotide and amino acid sequences yielded similar phylograms, but only the 
amino acid sequence data is illustrated. 
    
Discussion 
     This is the first report of a mucosal papilloma in an African grey parrot, bird SC02-
0025.  Papillomas from African grey parrots in previous reports have been cutaneous in 
character (Jacobson et al.; 1983; Latimer et al., 1997).  The significance of this finding is 
that mucosal papillomas are found in psittacine species other than Neotropical parrots. 
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Fig. 3.1.  Unrooted consensus phylogram of an 88 amino acid fragment (except PaHV-1 where only 57 
amino acids were available) from the DNA polymerase gene (UL30) generated by bootstrap re-sampling 
(repetitions=1000), distance optimality, and neighbor-joining search using PAUP 4.0. Distance values are 
displayed on the branches and bootstrap values are in parentheses.  All sequences beginning with SC or 
DP are psittacine birds.  PsHV-1 samples are followed by a slash and the corresponding genotype.  The 
African grey parrots are designated by PsHV-2.  The remaining herpesvirus sequences are BoHV 1 = 
bovine; CoHV 1 = columbiform (pigeon); EqHV 1 = equine; GaHV 1 = gallid (chicken) 1 or infectious 
laryngotracheitis; GaHV 2 = gallid 1 or Mareks disease; HSV 1 = human herpes simplex 1; MeHV 1 = 
meleagrid (turkey); PaHV 1 = passerid (finch); and SuHV 1 = suid. 
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Fig. 3.2.  Unrooted consensus phylogram of a 139 amino acid fragment (except SC02-0043 PsHV-1/4 
which is 137 amino acids due to a two residue deletion) from the host range protein gene (UL16) of 
African grey parrots and four PsHV-1 reference sequences from Neotropical parrots generated by 
bootstrap re-sampling (repetitions=1000), distance optimality, and neighbor-joining search using PAUP 
4.0. Distance values are displayed on the branches and bootstrap values are in parentheses. PsHV-1 
samples are followed by a slash and the corresponding genotype.  The African grey parrots are designated 
by PsHV-2.   
 
 82
     Amplicons were produced from the African grey parrot samples using primer sets 
23F and ILK/IYG, but not with primer sets 11R and 39F.  Experiments by Tomaszewski 
et al. (2001) described an atypical amplification product using primer set 11R found in 
the DNA extracted from tissues of African grey parrots that died of Pachecos disease.  
However, no such product was amplified from the African grey parrot samples in this 
study.   
     The UL16 products for the African grey parrot samples and the PsHV positive 
reference controls were sequenced with primer set 23Ff5b/23Fr3.  However, obtaining 
the UL30 products for sequencing was more complicated.  Primer set 39Ff/39Fr 
amplified the PsHV reference controls but not the African grey samples.  Primer set 
ILK/IYG amplified both the PsHV positive reference controls and the African grey 
samples.  However, while primer set ILK/IYG was successfully employed in sequencing 
the African grey parrot samples, it failed to produce suitable products for sequencing the 
PsHV reference samples despite the fact that appropriately sized products were 
visualized on the agarose gel.  This failure may have been due to the fact that primer set 
ILK/IYG is degenerate and did not work equally well as a sequencing primer set with all 
PsHV reference genotypes, but was sufficient for amplification.  Fortunately, the 266 bp 
(base pair) ILK/IYG sequence was nested within the 634bp product created by primer 
set 39F that did permit amplification and sequencing of the PsHV reference samples. 
     The phylogram generated using UL30 sequences showed that the herpesviruses from 
the four African grey parrots were virtually identical α4 herpesviruses and were most 
closely related to PsHV (Figure 3.1).  This relationship was supported by analysis of the 
UL16 gene data (Figure 3.2).  While only limited sequence data was available from 
 83
UL16 and UL30 genes, the phylogenetic analysis of both genes shows identical 
placement of the previously described PsHVs and the African grey sequences.  This 
independent analysis supports the hypothesis that these two viruses are related but 
distinct. The sequences of the African grey viruses showed nucleotide diversity from the 
closest PsHV genotype (genotype 2) of 20% in UL30 to 23% in UL16.  Therefore, in 
accordance with the guidelines of the International Committee on the Taxonomy of 
Viruses, it is proposed that these alphaherpesviruses found in the African grey parrots be 
designated as PsHV-2 and the PsHVs found primarily in Neotropical parrots as PsHV-1.  
It is understood that further study of the biological properties of PsHV-2 will be 
necessary in order to adequately characterize it as a unique psittacid herpesvirus.  
However, the phylogenetic analysis of the sequence data from the four African grey 
parrots in this study is sufficient to suggest the existence of this novel psittacid 
herpesvirus and its placement within the herpesvirus family tree. 
     The discovery of PsHV-2 in wild caught African grey parrots from three unique 
origins suggests that PsHV-2 may be adapted to this species and predictably could be the 
first indigenous herpesvirus described in psittacines from the African continent.  
However, all of the African grey parrots examined in this study were exposed to other 
psittacine species from multiple geographic locations around the world during the 
quarantine process and afterwards in the aviary.  It is possible that they could have 
become infected with PsHV-2 some time after importation rather than being infected in 
the wild, but the birds came from different sources and were presumably imported at 
different times.  Therefore, it is likely that the birds were infected in the wild rather than 
in captivity.  Given the diversity of PsHV-1, it is possible that multiple genotypes of 
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PsHV-2 exist in other African parrot species, but verification will require screening of 
parrots in Africa. 
     It appears that PsHV-2 is a relatively nonpathogenic virus since it has not been 
detected in birds with Pachecos disease.  However, we detected PsHV-2 DNA in a 
mucosal and a cutaneous papilloma, suggesting that like PsHV-1 genotypes 1, 2, and 3; 
PsHV-2 may have the potential to induce papillomas.  This is also the first report of a 
purely mucosal papilloma in an African grey parrot.  Cutaneous papillomas in this 
species are rare and reported to be caused by PePV (OBanion et al., 1992); but no PePV 
DNA was detected in this lesion.  Therefore, if PsHV-2 has oncogenic potential, then 
infections are either uncommon or the virus is minimally oncogenic. 
     Infection by PsHV-2 may complicate the identification of PsHV-1 infected birds.   
This is because primer set 23F, which is used in PCR diagnostic testing, detects all 
known PsHV-1 genotypes and PsHV-2.  Because PsHV-1 can cause Pachecos disease 
in many species of psittacine birds including African grey parrots, infected parrots 
should be segregated from susceptible birds.  However, infection with PsHV-2 may have 
less clinical significance, and differentiating these infections by the use of virus-specific 
PCR primers is indicated. 
     Psittaciforms probably evolved on the Gondwanaland super-continent and radiated 
outward with continental drift (Hedges et al., 1996; Cracraft, 2001).  If indeed PsHV-2 is 
found in wild African parrots, then the close relationship between PsHV-1 and PsHV-2 
could suggest that the ancestral predecessor of the PsHVs probably originated in 
Gondwanaland before the radiation of the parrots occurred rather than PsHV-2 arising de 
novo or migrating into African parrots from another avian species.  Therefore, it is 
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possible that additional undiscovered herpesviruses exist in other psittacine species 
originating in Gondwanaland and Australian parrots are the likely candidates for 
screening.  
 
Materials and Methods 
Sample history and collection 
     Tissues from four African grey parrots (Psittacus erithacus erithacus) kept as pets or 
aviary specimens in the USA were examined in this study (DP00-0078, SC01-0030, 
SC02-0025, SC03-0001) (Table 3.1).  Three of these birds were wild-caught (DP00-
0078, SC02-0025, SC03-0001); the origin of the fourth bird was unknown (SC01-0030). 
Tissues examined included a biopsy from a parrot with a cloacal papilloma (SC02-
0025); the histologically normal cloacal mucosa of this birds cage-mate that died of 
peritonitis unrelated to PsHV (SC03-0001); a biopsy of a periophthalmic cutaneous 
papilloma (SC01-0030); and the histologically normal cloacal mucosa of a parrot that 
died of atherosclerosis (DP00-0078) (Table 3.1). Tissues were collected using cleaned, 
autoclaved instruments that had been bleached and formalin-soaked.  A different set of 
instruments was used to collect each tissue to prevent DNA contamination.  Tissues 
were either processed immediately or stored at -80°C until use.   
     Negative control DNA was extracted from the blood of an incubator-hatched African 
grey parrot chick (SC03-0005) and a near hatch psittacine embryo (SC01-0019).  Four 
DNA samples representing all known PsHV genotypes were used as positive reference 
controls (SC02-0022 PsHV-1 genotype 1; SC00-0020 PsHV-1 genotype 2; SC02-0047 
PsHV-1 genotype 3; SC02-0043 PsHV-1 genotype 4) (Tomaszewski et al., 2003) (Table 
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3.1). The positive control for PePV was a clone of Psittacus erithacus papillomavirus 
inserted into the Sal I site of pBR322 (Terai et al., 2002; Styles et al., 2004).   
 
Histological evaluation of the tissue  
     Sections of the tissues were fixed in formalin, embedded in paraffin, and thin sections 
were routinely stained with hematoxylin and eosin.  These sections were then 
microscopically examined for the presence of any lesions. 
 
DNA extraction and polymerase chain reaction 
     DNA was extracted from the tissues using the Purgene Genomic DNA Purification 
Kit (Gentra Systems, Minneapolis, MN.) following the instructions for fresh or frozen 
solid tissue.  Samples were either processed immediately or stored at -80°C until use.   
     All PCR reactions were performed on an Eppendorf Mastercycler Personal 
Thermocycler (Eppendorf, Hamburg, Germany).  PCR screening for PsHV DNA was 
performed as previously described (Tomaszewski et al., 2001). Briefly, a 25 µl reaction 
mix containing, 100 ng genomic DNA, 25 pmol of each primer, 0.1 mM of each of the 4 
deoxynucleotide triphosphates, 2.5 mM magnesium chloride, 0.75 units Taq polymerase 
and 1X buffer A was used in the reaction.  The thermocycler parameters were:  initial 
denaturation at 94°C for 5 minutes; followed by 40 cycles of annealing at 60°C for 45 
seconds, extension at 72°C for 90 seconds, denaturing at 94°C for 30 seconds, and then a 
period of final extension at 72°C for 5 minutes.  PCR amplification products were 
imaged on ethidium bromide agarose gels. The samples were examined for PsHV DNA 
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using primer sets 11R (11Rf8/11Rr4); 23F (23Ff5a, 23Ff5b/23Fr3); 39F (39Ff/39Fr) 
(Tomaszewski et al., 2001; Tomaszewski et al., 2003), and degenerate primer set 
ILK/IYG (VanDevanter et al., 1996) (Table 3.2).   
     PCR screening for PePV DNA was performed as previously described (Styles et al., 
2004).  Briefly, a 25 µl reaction mix containing, 100 ng genomic DNA, 25 pmol of each 
primer, 0.1 mM of each of the 4 deoxynucleotide triphosphates, 2.5 mM magnesium 
chloride, 0.75 units Taq polymerase and 1X buffer A (Promega, Madison, WI.) was used 
in the reaction.  The thermocycler parameters were:  initial denaturation at 95°C for 5 
minutes; followed by 35 cycles of denaturing at 94°C for 30 seconds, annealing at 60°C 
for 30 seconds, extension at 72°C for 30 seconds, and then a period of final extension at 
72°C for 10 minutes.  Amplification products were imaged on an ethidium bromide 
agarose gel.  Samples were examined for PePV DNA using primer set 
ppv6621fmod/ppv6810R (Terai et al., 2002; Styles et al., 2004) (Table 3.2).    
 
PCR product purification and sequencing 
     Amplicons generated by the 23F and 39F primer sets were column purified using a 
QIAquick PCR Purification Kit (Qiagen Inc., Valencia, Cal.).  ILK/IYG products were 
extracted from a 1% agarose gel using a QIAquick Gel Extaction Kit (Qiagen Inc., 
Valencia, CA.).   
     All sequencing reactions were performed using an ABI Prism Big Dye  
Terminators v3.0 Cycle Sequencing Kit (Applied Biosystems Inc., Foster City, CA) 
employing sequencing primers 23Ff5b/23Fr3 for the UL16 product of all bird samples; 
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39Ff/39Fr (UL30) for the four PsHV reference control samples; and ILK/IYG (UL30) 
for the four African grey parrot samples (Table 3.2).  Products were sequenced using an 
ABI 3100 DNA sequencer (Applied Biosystems). 
 
Phylogenetic analysis 
 
     Both nucleotide and amino acid sequences were aligned using Clustal X 1.81 
(Thompson et al., 1997).  Aligned sequences were imported into PAUP for analysis 
(Swofford, 1998).  Phylogenetic trees were generated by performing a neighbor-joining 
search using bootstrap re-sampling (1,000 replications) employing distance optimality.  
Phylograms showing branch-lengths and bootstrap values for UL30 and UL16 are 
illustrated in Figures 3.1 and 3.2 respectively. 
 89
 
CHAPTER IV 
 
INTERNAL PAPILLOMATOUS DISEASE AND OTHER TUMORS 
ASSOCIATED WITH PSITTACID HERPESVIRUS INFECTIONS IN PARROTS 
 
Introduction  
 
     Internal papillomatous disease (IPD) affects predominately captive Neotropical 
parrots.   The greatest prevalence has been reported in macaws (Ara spp.), Amazon 
parrots (Amazona spp.), conures (Aratinga spp.), and hawk-headed parrots (Deroptyus 
accipitrinus) (Graham, 1991; Gibbons et al., 2002; Hillyer et al., 1991; Phalen et al., 
1997; Van der Heyden, 1988).  IPD is characterized by the presence of mucosal 
papillomas primarily affecting the epithelium of the oral cavity and cloaca, but also 
observed in the esophagus, crop, proventriculus, ventriculus, conjunctiva, nasolacrimal 
duct, and bursa (Graham, 1991).  Grossly, mucosal papillomas are pink to grey-tan 
verrucous lesions (Graham, 1991; Phalen et al., 1997).  Histologically, they appear as 
papillary structures having a highly vascularized connective tissue core with overlying 
proliferative stratified cuboidal to pseudostratified columnar mucosal epithelium 
depending on the location, with lymphoplasmacytic infiltrate as a variable feature of the 
lesions (Phalen et al., 1997; Schmidt et al., 2003).  These papillomas will wax and wane 
(Phalen et al., 1997) and the presence of the lymphoplasmacytic infiltrates may be 
related to this behavior.   
     The clinical manifestations of IPD depend on the species of parrot, stage of the 
disease and the lesions.  Mucosal papillomas (MP) are found most frequently in the 
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cloaca of Amazon parrots and the oral cavity, upper digestive tract, and cloaca of 
macaws and conures (Phalen et al., 1997; Phalen et al., 1998).  The lesions in macaws 
and conures are more likely to be progressive and less likely to display the waxing and 
waning behavior (Phalen et al., 1997).   While mucosal papillomas are benign, they can 
result in clinical complications where they ulcerate and hemorrhage, obstruct the 
respiratory tract (choana and glottis), upper digestive tract (esophagus and crop), or 
lower digestive tract (proventriculus, ventriculus, and cloaca) (Graham, 1991; 
McDonald, 1988; Phalen et al., 1997).  Birds with chronic mucosal papillomatosis were 
observed to develop other tumors including adenomas and carcinomas of the bile and 
pancreatic ducts (Graham, 1991; Elangbam and Panciera, 1988; Gibbons et al., 2002; 
Hillyer et al., 1991; Phalen et al., 1997; Potter et al., 1983).   Clinically, these bile and 
pancreatic neoplasms result in parenchymal destruction or space occupying lesions, but 
metastasize infrequently (Schmidt et al., 2003).   
     IPD and associated tumors can be found in a wide age-range of parrots.  They are 
normally found in adult birds but one macaw was observed to develop a cloacal 
papilloma within 6 months of its hatch-date, and within 1.5 years this bird had developed 
bile duct carcinoma and died at the age of two from the disease (Styles, 2004).   
     The prominent feature of IPD is the development of mucosal papillomas.  Because 
papillomas in other animals were known to be caused by papillomaviruses, it seemed 
likely that a papillomavirus might be associated with the development of IPD.  
Cutaneous and mucosal papillomas in mammals (Brentjens et al., 2002) and cutaneous 
papillomas in finches (Moreno-Lopez et al., 1984) and African grey parrots (OBanion 
et al., 1992) were shown to be caused by species-specific papillomaviruses.  However, 
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there was little evidence supporting papillomaviruses as the cause of IPD in parrots.  
Efforts to detect papillomavirus group-specific antigens were largely unsuccessful 
(Sundberg et al., 1986) and papillomavirus DNA could not be found in mucosal 
papillomas (Johne et al., 2002; Latimer et al., 1997; Sundberg et al., 1986).  However, 
there is one report of papillomavirus L1 protein-like immunoreactivity in the epithelial 
cells of the cloacal papillomas from two parrots, but further investigation provided 
evidence that the observed staining was non-specific (Bonda et al., 1998; Styles et al., 
2004).  While no papillomaviruses could be found in the IPD lesions, mucosal 
papillomas and associated tumors appeared to have an infectious etiology because 
unaffected birds developed mucosal papillomas after being exposed to birds with IPD 
(Graham, 1991; McDonald, 1988; Phalen et al., 1997; Van der Heyden, 1988).  
Therefore, in an effort to differentiate those papillomas known to be caused by 
papillomaviruses from the mucosal papillomas and associated tumors of Neotropical 
parrots, Graham (1991) introduced the term internal papillomatous disease to make this 
distinction.  Due to the paucity of evidence associating papillomaviruses with IPD, 
investigations were conducted to identify other potential causes.   
     Studies suggested that these IPD might be associated with infection by one or more 
genotypes of the alphaherpesvirus, psittacid herpesvirus 1 (PsHV 1).  In one 
investigation, 18/18 (100%) parrots with IPD were seropositive for anti-PsHV antibody 
while 11 clinically normal parrots were seronegative (Phalen et al., 1997).  Two studies 
reported finding PsHV DNA in the mucosal papillomas from a small group of parrots 
(Phalen et al., 1998; Phalen et al., 1999), and from the papillomas of 9/12 (75%) parrots 
in another study (Johne et al., 2002). 
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     Herpesviruses are known to cause neoplasia in some animal species including the 
development of papillomas.  Unclassified herpesviruses have been associated with the 
development of cutaneous fibropapillomas in rainbow smelt (Osmerus mordax) (Herman 
et al., 1997), koi (Cyprinus carpio) (Calle et al., 1999), marine sea turtles (Quackenbush 
et al., 1998; Quackenbush et al., 2001), macaws (Ara spp.) (Lowenstine, 1982; Phalen, 
1997), and cockatoos (Cacatua spp.) (Lowenstine, 1982; Lowenstine et al., 1983; 
Phalen, 1997).  Herpesviruses have also been associated with the development of other 
types of tumors.   Adenocarcinomas of frogs (Rana spp.) were found to be caused by an 
unclassified herpesvirus (Epstein, 2001).   B-cell lymphomas (Burkitts lymphoma), 
nasopharyngeal carcinomas, and gastric carcinomas affecting humans were associated 
with the gammaherpesvirus Epstein-Barr virus (EBV or human herpesvirus 4) (Epstein, 
2001; Takada, 2000).   Vascular endotheliosarcomas (Kaposis sarcoma) were caused by 
the gammaherpesvirus Kaposis sarcoma-associated herpesvirus (KSHV or human 
herpesvirus-8) (Boshoff et al., 1995; Damania, 2004).  However, only one herpesvirus 
was known to cause tumors in avian species which is Mareks disease, that causes T-cell 
lymphomas to develop gallinaceous birds caused by the alphaherpesvirus Mareks 
disease herpesvirus (MDHV or gallid herpesvirus-2 (GaHV 2)) (Venugopal, 2000; 
Lupiani et al., 2004).   
     A recent investigation into the cause of mucosal papillomas detected PsHV 1 DNA in 
the mucosal papillomas of 30/30 (100%) Neotropical parrots, but was not detected in the 
histologically normal tissue from the same bird (Styles et al., 2004).  Given this evidence 
and the previous work of Phalen et al. (1997, 1998, 1999), it seemed likely that the bile 
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and pancreatic duct carcinomas associated with IPD were similarly associated with 
PsHV 1.   
     Other tumors involving the mucosal epithelium of Neotropical parrots have also been 
described including proventricular and ventricular carcinomas, and cloacal carcinomas 
(Schmidt et al., 2003).  During the investigation of mucosal papillomas, PsHV DNA was 
detected in a cloacal carcinoma from a bird that no other lesions (Styles, 2004).  Given 
the association of PsHV with mucosal papillomas, it was also possible that these 
mucosal tumors could be similarly associated with the virus.  Therefore, the hypothesis 
tested in this study was that the bile and pancreatic tumors associated with IPD, and the 
endoventricular and cloacal carcinomas found in Neotropical parrots are caused by one 
or more genotypes of PsHV 1. 
     Several methods were employed to test this hypothesis.   Conventional PCR using 
PsHV 1 specific primers was used to show that PsHV DNA was found in the tumors 
from affected birds using both fresh and formalin-fixed paraffin-embedded (FFPE) 
tissue.  To determine if any PsHV DNA detected in the tissue was localized to the 
tumors, experiments were performed to show that PsHV DNA was in significantly 
higher concentration in the tumors compared to the adjacent histologically normal tissue.  
These efforts included examining the DNA from tumors and adjacent histologically 
normal tissue collected by laser capture microdissection (LCM) with conventional PCR 
and PsHV 1 specific probes, and using in situ hybridization with PsHV 1 biotinylated 
probes or direct in situ PCR using PsHV 1 specific primers.    
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Fig. 4.1.  Gross and microscopic views of the spectrum of change in two parrots with 
bile duct carcinoma.  (a) 10x magnification of the liver showing adenomatous ducts 
blending into the carcinomatous tissue accompanied by a nodule of liver regeneration 
(SC96-0604), (b) 40 x magnification of the adenomatous ducts (SC96-0604), (c) 40 x 
magnification of the carcinomatous tissue showing highly undifferentiated cells with 
some attempts to form a glandular architecture (SC96-0604), and (d) gross view of a 
carcinomatous liver from bird (SC04-0012).
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Fig. 4.2.  Microscopic views of an endoventricular and cloacal carcinoma.  (a) 
Endoventriculuar carcinoma from sample SC96-0604 showing highly undifferentiated 
cells with some attempts to form a ductular architecture.  Goblet cells producing mucin 
can also be seen.  (b) Cloacal carcinoma from sample SC04-0010 showing aberrant 
ducts, fibroplasia, and mucin lakes. 
 
 
     In this investigation, a single PsHV 1 genotype was found in all the affected tissue 
examined except one bird.    Efforts to localize the virus to the affected tissue were 
inconclusive.  
 
Results  
Histological evaluation of tissues 
     Adenomatous and/or carcinomatous neoplasms were observed in the liver (Fig 4.1 a-
d) and pancreas.  Fourteen of the birds had bile duct neoplasms and three of these birds 
also had pancreatic tumors (Tables 4.1 and 4.2).  All birds with bile or pancreatic duct 
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Table 4.1 
 
Fresh IPD tissues, samples and sequence results 
Isolate 
Number 
GenBank 
Accession# 
Species 
Examined 
Tissues PCR1 
Result 
SC92-0496 AY421976 Ara macao cloacal papilloma 
bile duct carcinoma 
+ 
+ 
     
SC92-0498 AY421977 Ara macao cloacal papilloma 
crop (normal) 
bile duct carcinoma 
+ 
- 
+ 
     
SC92-1409 AY421978 Amazona auropalliata glottal papilloma 
bile duct carcinoma 
+ 
+ 
     
SC93-0192 AY421980 Ara ararauna choanal papilloma 
bile duct carcinoma 
+ 
+ 
     
SC94-0390 AY421983 Aratinga spp. glottal papilloma 
bile duct carcinoma 
+ 
+ 
     
SC00-0020 AY421988 
(+) Control 
Amazona oratrix Genotype 2 + 
     
SC00-0077 AY421989 Amazona oratrix cloacal papilloma 
crop (normal) 
bile duct adenoma 
+ 
- 
+ 
     
SC01-0019 (-) Control Pyrrhura rupicola embryo - 
     
DP02-0034 AY421991 Ara chloroptera cloacal papilloma 
crop (normal) 
bile duct carcinoma 
+ 
- 
+ 
     
SC02-0022 AY421993 
(+) Control 
Ara ararauna Genotype 1 + 
     
SC02-0024 Sample Ara ararauna cloacal carcinoma + 
     
SC02-0043 AY421995 
(+) Control 
Ara ararauna Genotype 4 + 
     
SC02-0047 AY421999 
(+) Control 
Amazona aestiva Genotype 3 + 
     
SC03-0005 (-) Control Psittacus erithacus blood - 
     
DP04-0006 Sample Eclectus roratus cloacal papilloma 
crop (normal) 
bile duct adenoma 
proventriculus (normal) 
+ 
- 
+ 
- 
     
SC04-0010 Sample Cyanoliseus patagonus glottal papilloma 
cloacal carcinoma 
proventriculus (normal) 
+ 
+ 
- 
     
SC04-0012 Sample Ara severa bile duct carcinoma 
choanal papilloma 
cloacal papilloma 
crop (normal) 
pancreatic adenoma 
proventriculus (normal) 
+ 
+ 
+ 
- 
+ 
- 
 
1 PCR  Result:  amplicon produced = (+),  no amplicon produced = (-).  Samples accompanied by a 
GenBank submission number were also used in Chapter II (Styles et. al., 2004). 
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Table 4.2 
 
PCR results of formalin-fixed paraffin-embedded tissues 
 
Sample GenBank PsHV Species Tissue PCR4 
Number1 Access#/Use2 Geno3 Examined Examined +/- 
      
SC91-1299 Sample 3 Cacatua moluccanus 
 
bile duct adenoma 
brain 
cloacal papilloma 
pancreatic adenoma 
+ 
+/- 
+ 
- 
SC92-0058 (-) Control  Cacatua alba liver - 
SC92-0573 (+) Control 
Pachecos  DZ 
Unk  liver  + 
SC93-0780 (+) Control 
Pachecos DZ 
Unk Psittaucs erithacus liver + 
 SC95-0028 Sample 3 Amazona oratrix bile duct adenoma 
brain 
crop papilloma 
lung 
pancreatic adenoma 
+ 
+/- 
+ 
+/- 
+ 
SC96-0604 Sample 3 Amazona ochrocephla 
(history of papillomas) 
bile duct adenoma 
brain 
lung 
proventricular carcinoma 
skeletal muscle metastasis 
+ 
+ 
+ 
+ 
+ 
SC96-0622 Sample 3 Amazona ochrocephla bile duct adenoma 
lung 
ventricular carcinoma 
+ 
- 
+ 
SC97-0365 Sample 3 Amazona oratrix bile duct adenoma 
brain 
cloacal papilloma 
endoventric. carcinoma 
lung 
+ 
- 
+ 
+ 
- 
SC00-0020 AY421988 2 Amazona oratrix cloacal papilloma + 
SC01-0019 (-) Control  Pyrrhura rupicola embryo - 
SC02-0022 AY421993 1 Ara ararauna cloacal papilloma + 
SC02-0043 AY421995 4 Ara ararauna cloaca + 
SC02-0047 AY421999 3 Amazona aestiva cloacal papilloma + 
 
1 Samples were fixed in formalin for less than 72 hours and then paraffin-embedded except samples SC01-
0030, SC00-0020, SC02-0022, SC02-0043 and SC02-0047 that were collected as fresh tissues and used 
as representatives of each PsHV genotype to develop the internal primer sets for the UL16/17 region.  
2 Tissues with a GeneBank Accession # were sequenced as fresh tissues using primer set 23Ff5b/23Fr3 
and FFPE tissues with primer set 23Ff5a/23Fr+114D.  Unk are unknown PsHV genotypes.  
3 All samples were PsHV 1 geontypes.  Unk designates an unknown PsHV 1 genotype (not sequenced). 
4 PCR result given as (+) for successful amplification and (-) if no amplification 
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neoplasia had mucosal papillomas present with the exception of one sample that had a 
history of papillomas.  Two birds had cloacal carcinomas and three birds had carcinomas 
of the proventriculus or ventriculus (Fig 4.2 a-b; Table 4.2).  Of the two birds with 
cloacal tumors, one bird was accompanied by a mucosal papilloma and the other had not 
papillomas.   Of the three bird with proventricular or ventricular carcinomas, all three 
birds were accompanied by bile duct tumors, one bird exhibited a papilloma, one had a 
history of papillomas, and one had no overt or history of papillomas (Table 4.2). 
 
PCR of fresh IPD tissues with PsHV-specific primers 
     The purpose of this experiment was to determine if PsHV 1 DNA could be detected 
in the tumors and not in histologically normal mucosal tissue by conventional PCR using 
PsHV 1 specific probes.   Fresh tissues were available from 11 parrots with mucosal 
tumors and DNA was extracted from neoplastic and histologically normal tissue (Table 
4.1).  Primer sets used to amplify any PsHV 1 DNA found in the tissues produced a 667 
bp amplicon from the UL16/UL17 region of the genome (Table 4.3). 
     PsHV 1 DNA was consistently amplified from DNA purified from the positive 
reference controls that were infected with PsHV of known genotype. There was no 
PsHV DNA amplified from the negative control tissues of a near hatch conure embryo 
or the blood from an incubator-hatched African grey parrot (Table 4.1).    
     PsHV 1 DNA was amplified from all tumors.  PsHV 1 DNA was not detected in any 
of the adjacent unaffected tissue or histologically normal mucosal tissue available in six 
of the birds. 
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Table 4.3  
 
Primer sequences for PsHV and cytochrome oxidase I 
 
Gene Primers Sequence (5→ 3) AP1 Reference 
 
Psittacine ctyochrome oxidase I protein 
 
COI H7523 ACTGTGAATATGTGGTGGGC 207 Eberhard 2004 
 COIf CCTGCAGGAGGAGGAGAYCC   
     
UL9:  Origin of binding protein 
 
 11Rf8 AGTTGCTGAATCGGTACTGGTTCTC 537 Tomaszewski 2001 
 11Rr4 GGATGGGAATTTGCACCTCCT   
 
PsHV 1 UL16/17:  Host range protein/DNA cleaving-packaging protein  
 
 23Ff5a  TGCGTGGGGTTAAACTCGGAACTAGAAG    667 Tomaszewski 2003 
 23Fr3    CGACTACACGAGCCTAACATC   
     
 23Ff5b GGGGTTAAACTCGGAACTAGAAG 662 Tomaszewski 2003 
 23Fr3 CGACTACACGAGCCTAACATC   
     
 23Ff-131D GAGACCCTYGACGAAGTGTGG 194 Styles 2 
 23Fr+63 GTTGACGTCGTTGAGAAGTCG   
     
 23Ff5a  TGCGTGGGGTTAAACTCGGAACTAGAAG    320 Tomaszewski 2003 
 23 Fr+114D CTTGGCBGTMAGGATGGTC  Styles 2 
     
 23Ff+43 GACTTCTCAACGACGTCAACG 223 Styles 2 
 23Fr+266D GCMGTTATGTGAACGTTGC   
 
PsHV 1 UL30:  DNA polymerase protein 
 
   39Ff AGCCTCTACCCGAGCATAATCCAG 634 Tomaszewski 2 
 39Fr  GTGAAGCTAGAGTGCGAGAAAGTGT   
     
 39FfRad ATGAACGGCATGCTGC 197 Tomaszewski 2 
 39Fr2 GAGTCGGTGTCCCCGTAGAT   
  
 
 
1 Amplification product length in nucleotides 
2 Unpublished work  
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Fig. 4.3.  Consensus phylogenetic tree of a set of 419 bp PsHV sequences generated by bootstrap re-
sampling (1000 repetitions), distance optimality, and neighbor-joining search using PAUP 4.0.  Branch 
lengths are provided and bootstrap values are displayed in parentheses.  Sequences preceded by SC or 
DP denote samples exhibiting lesions of IPD (Table 1).  Sequences followed by the suffix GEN X 
were reference sequences of known genotype where X=genotype. 
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Phylogenetic analysis of PsHV DNA sequences from the fresh IPD tissues 
     A 419 bp fragment was parsed from the 667 bp PsHV amplicon produced by the 23F 
primers as described by Tomaszewski et al. (2003) for phylogenetic comparison.   This 
fragment began at the start codon of the PsHV 1 UL16 (host range protein) gene and was 
compared to analogous sequences from PsHVs of known genotype.  A phylogram with 
representatives of each genotype showing branch-lengths and bootstrap values was 
generated as described by Tomaszewski et al. (2003) (Fig. 4.3).  All tumor sample 
sequences were determined to be PsHV 1 genotype 3 except one sample that was PsHV 
1 genotype 4 (SC04-0010).  
 
PCR of formalin-fixed paraffin-embedded IPD tissues with PsHV specific primers 
     Because fresh samples of birds with IPD and associated tumors are difficult to obtain 
in a timely fashion, an attempt was made to expand the data set using archived FFPE 
histopathology samples of five IPD cases from the Schubot Exotic Bird Health Center 
(Texas A&M University, College Station, TX).  DNA was extracted from the tissues of 
five parrots with bile duct tumors and examined by conventional PCR using primers 
derived from a 662 bp sequence spanning a section of the PsHV 1 UL16/UL17 genes 
that produced amplicons ranging from 194-320 bp in length (Table 4.3).  Primers were 
designed to produce smaller amplicons to overcome any DNA degradation due to the 
fixation process.  The UL16/UL17 region was chosen so that sequence comparison could 
be made to homologous PsHV 1 sequences of known genotype as described by 
Tomaszewski et al. (2003).   
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     Three sets of primers were tested to determine which sets consistently amplified the 
greatest number of formalin-fixed samples.   These primer sets were tested to determine 
which was superior at detecting PsHV in the tissue (Table 4.3).   Some of the individual 
FFPE tissues had no amplification results with all of the three primer sets presumably 
because of damage to the DNA.  Most notably the pancreatic tumors from the FFPE 
tissues gave no amplification results with two of the primer set but did with primer set 
23Ff5a/23Fr+114D.  DNA damage in the pancreas may be compounded due to release 
of autolytic enzymes at the time of death followed by damage due to fixation.  While 
some samples were amplified by all primer sets, most produced detectable products from 
primer set 23Ff5a/23Fr+114D.  Therefore, primer set 23Ff5a/23Fr+114D was used to 
probe the samples and primer set 23Ff5b/23Fr+114D was used to sequence any 
amplicons (Fig. 4.4).   
     PsHV 1 DNA was detected in the positive control tissues, but not from the negative 
controls.  PsHV 1 DNA was amplified from all tumors with the exception of one 
pancreatic adenoma (SC91-1299) (Table 4.2).  This negative result was most likely 
attributed to pancreatic enzymes degrading the DNA post-mortem. The intensity of the 
PCR signal acquired from each sample was used as an indirect measure of whether the 
sample was positive or possibly contaminated.  Strong signals were interpreted as true 
positives (i.e. the signal was gave similar intensity to the known positive control).  
Results from samples giving weak signals were less clear and possible interpretations of 
this result are described below. 
      One concern with using archived specimens is that they are usually not collected 
using precautions to prevent DNA contamination from tissues containing high
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Fig 4.4.  A 1% agarose gel showing PCR results using  
primer set 23Ff5a/23Fr+114D with tissues of three 
different samples (Table 4.2 and Table 4.3).  The product  
is 320bp in size. 
 
 
 
concentrations of virus to other tissues.  For example, mucosal papillomas were shown 
to have detectable quantities of PsHV DNA while adjacent histologically normal mucosa 
from the same organ was not (Styles et al., 2004).  Contamination could be a problem 
when using conventional PCR to detect PsHV DNA with FFPE tissues, but if 
contamination is present it may only be superficial and possibly below the limit of 
detection of the primer set used in this experiment which was determined to be about 103 
copies of virus/µl (Styles et al., 2004).  In an attempt to determine if DNA contamination 
had occurred with the FFPE tissues, the brain and lung were used as negative internal 
controls because they might be expected to contain a concentration of PsHV DNA below 
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the level of detection of the primer sets (Styles, 2004).  PsHV DNA was not detected in 
the brain or lung of sample SC97-0365 or the lung of SC96-0622, but was consistently 
detected in the brain and lung of sample SC96-0604 (Table 4.2).  The brain of sample 
SC91-1299 and the brain and lung of sample SC95-0028 varied between positive and 
negative PCR results depending on the specific DNA extraction (multiple extractions 
were performed in an attempt to eliminate the possibility of experimental contamination) 
and the individual primer sets used to amplify the DNA.  This result suggests several 
possibilities:  that contamination may have been a factor in some samples, variable 
concentrations of PsHV DNA found in these samples were at or below the limit of 
detection of the primers and the result depended on the concentration of virus in a 
particular extraction, or these tissues may have been positive.  However, analogous 
tissues from fresh samples of birds with IPD were consistently negative (Styles, 2004; 
Styles, unpublished data).   
 
Phylogenetic analysis of PsHV DNA sequences from the FFPE-IPD tissues 
     The sequence of a 238 bp fragment spanning the PsHV 1 genes UL16/UL17 was 
derived from the amplicon produced by primer set 23Ff5a/23Fr+114D and subjected to 
phylogenetic analysis using analogous PsHV 1 sequences of known genotype (data not 
shown) (Styles et al., 2004).  All samples were determined to be PsHV 1 genotype 3. 
 
PCR of tissue collected by laser capture microdissection 
     One important aspect of this investigation was to show that the PsHV viral 
concentrations found in the neoplastic tissue were significantly higher than that found in 
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histologically normal adjacent or distant mucosal tissue.  The FFPE tissues from four 
parrots were affixed to glass slides, visualized microscopically, and the samples of 
neoplastic and adjacent histologically normal tissue were collected using LCM (Table 
4.4).  LCM is a microsurgical technique using a precision cutting laser that can excise 
minute sections of tissue and collect it on a plastic cap.  
     DNA was extracted from the three samples and controls collected by LCM using the 
Pico Pure  DNA Extraction Kit and then either used directly as recommended by the 
kit or further purified in an attempt to improve the quality of the sample with a Purgene 
Genomic DNA Purification Kit.  The signal integrity of the psittacine cytochrome 
oxidase I housekeeping gene was diminished by further purification with the Purgene 
kit so only the Pico Pure  kit was used.  The DNA was then examined by PCR using 
the same three primer sets described above in the section of PCR with FFPE tissues 
(Table 4.2 and Table 4.3). 
     The primer sets failed to produce amplicons from positive control (SC93-0780) or 
tumor samples, even though these tissues had been shown to contain PsHV DNA by 
PCR of their FFPE sections (Table 4.4).  However, amplicons were produced with the 
Neotropical psittacine cytochrome oxidase I internal control primers (Eberhard and 
Bermingham, 2004) from the unaffected pancreas, pancreatic duct adenoma, and choanal 
papilloma of parrot SC04-0012, but not from the unaffected liver, bile duct carcinoma, 
or cloacal papilloma.  This result suggests that multiple factors such as length of fixation 
prior to embedding, formalin permeability differences in tissues, and the thicknesses to 
which tissues are cut may affect the DNA integrity and ability to detect DNA in FFPE 
tissues.   
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Table 4.4 
 
Tissues examined using LCM 
Sample Genebank PsHV Species Tissue 
Number1 Accession# or Use Geno2 Examined Examined 
     
SC93-0780 (+) Control  
 
Unk Psittacus erithacus  liver 
(Pachecos disease) 
SC96-0622 Sample 
 
3 Amazona ochrcephala bile duct adenoma 
liver (unaffected) 
ventricular carcinoma 
SC00-0077 AY421989/Sample  3 Amazona oratrix bile duct adenoma 
SC01-0019 (-) Control N/A Pyrrhura rupicola  embryo 
DP04-0006 Sample 3 Eclectus roratus bile duct adenoma  
liver (unaffected) 
SC04-0012 Sample  3 Ara severa bile duct carcinoma 
choanal papilloma 
cloacal papilloma 
liver (unaffected) 
pancreas (unaffected) 
pancreatic adenoma 
 
 
1 Samples were collected as fresh tissues and then formalin fixed for less than 72 hours and then paraffin 
embedded except SC93-0780 and SC96-0622 that were submitted as FFPE tissues.  Samples SC93-0780 
and SC96-0622 were positive for PsHV DNA by PCR from digestion of tissue taken from the paraffin 
block.   All other samples were positive on PCR using DNA extracts of fresh tissue. 
2 All samples were PsHV 1 types.  Samples SC98-0019, SC00-0077, DP04-0006, and SC04-0012 were 
sequenced and genotyped using primer set 23Ff5b/23Fr3; sample SC96-0622 was sequenced and 
genotyped using primer set 23Ff5a/23Fr+114D.  Unk designates an unknown PsHV 1 genotype (not 
sequenced) 
N/A = not appilicable 
 
 
     Tissues from bird SC04-0012 were also fixed with paraformaldehyde. 
Paraformaldehyde has been reported to demonstrate a higher detection rate of DNA from 
fixed samples in some applications, but not necessarily for PCR (Schmid et al., 1991; 
Greer et al., 1991).  However, paraformaldehyde-fixed tissues were deemed unsuitable 
for LCM or any subsequent use of microscopically sectioned tissue due to poor fixation 
and loss of tissue architecture.  Therefore, due to the inability to amplify PsHV DNA 
from FFPE tissues, LCM was determined not to be an effective method for showing 
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differences in concentration of PsHV DNA in neoplastic and histologically normal FFPE 
tissues. 
 
In situ hybridization 
     In situ hybridization (ISH) was also used to determine relative differences in PsHV 
concentration in neoplastic and normal tissue.  Biotinylated DNA probes were generated 
with either random primers or specific primers.  Biotinylated DNA probes 50-300 bp in 
length were generated using random primers with whole PsHV 1 genotype 1 and 4 virus, 
and using both random primers and specific primers with sections of four different PsHV 
1 genotype 3 genes, UL9, UL16/17, and UL30 gene (Tomaszewski et al., 2001; 
Tomaszewski et al., 2003).  The PsHV positive control sample SC92-0142 was the crop 
of a bird that died of Pachecos disease exhibiting PsHV intranuclear inclusion bodies in 
the crop mucosal epithelium (Table 4.5).   This positive control sample was used to 
screen the efficiency of the different biotinylated probes to detect the PsHV.  A signal 
amplification system was used to enhance the sensitivity of the probes and crimson stain 
was produced.   
     PsHV 1 DNA was detected in the inclusion bodies of the positive control tissue and 
the strongest signal was observed using those random biotinylated DNA probes 
generated from the whole PsHV 1 genotype 1 and genotype 4 viruses (Fig. 4.5a).    
     The negative control samples exhibited non-specific staining of the cytoplasm of the 
hepatocytes in the liver of samples SC92-0111 and the glandular mucosa of samples 
SC01-0019 (Fig. 4.5b).   However, non-specific staining was not observed in the crop or 
cloacal mucosa of negative control SC01-0019 suggesting that ISH may still have utility  
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Table 4.5 
 
Tissues examined by in situ hybridization and in situ PCR 
 
Sample Genbank PsHV Species Tissue 
Number Accession# or Use1 Gen2 Examined Examined 
     
SC92-0111 (-) Control  Eclectus roratus liver 
SC92-0142  (+) Control 
(Pachecos disease) 
Unk  Amazona farinosa guatemalae crop, pancreas  
SC97-0365 Sample 3 Amazona oratrix endoventric. carcinoma 
SC98-0018 AY421985/Sample 3 Anodorhynchus hyacinthinus cloacal papilloma 
SC00-0077 AY421989/Sample 3 Amazona oratrix bile duct adenoma 
SC01-0019  (-) Control  Pyrrhura rupicola embryo 
SC02-0002 AY421992/Sample 3 Amazona autumnalis cloacal papilloma 
SC04-0012 Sample  3 Ara severa bile duct carcinoma 
spleen 
 
 
1 All samples were formalin-fixed and paraffin-embedded for less than 72 hours.  Samples SC98-0018, 
SC00-0077, SC02-0002, and SC04-0012 were collected as fresh tissues and then fixed while the 
remainder of the tissues were submitted as routine diagnostic histopathology submissions. 
2 Freshly collected tissues were sequenced and genotyped using primer set 23Ff5b/23Fr3.  Histopathology 
submissions were sequenced and genotyped using primer set 23Ff5a/23Fr+114D.  Unk are unknown 
PsHV genotypes.  
 
 
 
in a some mucosal tissues (Fig. 4.5c).  It was assumed that this non-specific staining was 
due to an endogenous protein, probably biotin that reacted with the streptavidin, but was 
in such abundance that it could not be blocked.         
     Staining was not observed in any of the neoplastic tissues, but non-specific 
cytoplasmic staining was observed in the cytoplasm of the hepatocytes (Fig. 4.5d).  
Therefore, ISH with biotinylated DNA probes was not a suitable method for 
demonstrating PsHV 1 DNA in ISD tissues.  The problems arising from the non-specific 
staining of histologically normal tissue coupled with the non-staining of neoplastic 
tissues eliminated this method.  The concentration of intact PsHV 1 DNA may have been 
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Fig. 4.5.  In situ hybridization results of three control tissues and a liver with bile 
duct carcinoma.  (a) Using random probes generated from a PsHV genotype 4 whole 
virus staining PsHV intranuclear inclusion bodies in the crop of sample SC92-0142;  
(b) Non-specific staining observed in the cytoplasm of hepatocytes and 
proventricular glands of negative control sample SC01-0019 using probes random 
probes generated from the UL16/17 amplicon; (c) Lack of non-specific staining in 
the crop of negative control sample SC01-0019 using the same probes as in (b); (d) 
Unaffected liver exhibiting non-specific staining of hepatocyte cytoplasm with 
adjacent bile duct carcinoma showing no staining of sample SC04-0012 using the 
same probes as in (b).   
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below the limit of detection of this technique because its presence had been established 
by PCR with DNA extracted from the whole tissue in earlier experiments. 
 
Direct in situ PCR 
     The negative results in the experiments using ISH suggested that the concentration of 
PsHV 1 might be below the level of detection for that method.  Most ISH methods have 
sensitivities in the 104 range while conventional PCR techniques are in the range of 103  
(Morel and Raccurt, 2003).  Therefore, in a final attempt to show a difference in 
concentration of PsHV 1 DNA in neoplastic versus histologically normal tissue, in situ 
PCR (ISPCR) was employed.  Perhaps the level of detection could be improved by this 
method since the process would amplify the target DNA.  The same sample tissues and 
controls used in the ISH experiments were examined by ISPCR using the three primer 
sets used to amplify PsHV 1 DNA from the FFPE tissues (Table 4.2 and Table 4.3).   
The primers were used individually and in combination in case the genome had 
sustained more damage from fixation at one locus compared to another.  Biotinylated 
dCTP was added to the amplification mix so that the label could be incorporated into the 
amplicons and the sample signal amplification/detection system was used.   
PsHV 1 DNA was amplified from the inclusion bodies of the positive control tissue most 
reliably using primer sets 23Ff-131D/23Fr+63 and 39RADFf/39Fr3 (Fig. 4.6 a-f).  These 
two primer sets produced the greatest signal intensity in the control tissues and infected 
cells could be easily discerned.  However, there was staining due to non-specific 
amplification of host DNA that contributed to the background.  Attempts to reduce this 
background are described below.  Also, the negative control tissue showed the same
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Panel 1         Panel 2 
 
 
 
 
 
Fig. 4.6.  In situ PCR results from two sections of crop.  Panel 1 (first section) is (a, c, e) and Panel 2 
(second section) is (b, d, f) from sample SC92-0142 using primer sets 23Ff-131D/23Fr+63 and 
39RADf/39Fr2.  (a) No S1 or ddTTP treatment;  (b) No S1 or ddTTP treatment; (c) S1 treatment; (d) S1 
treatment; (e) ddTTP treatment; (f) ddTTP treatment. 
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Fig. 4.7.  In situ PCR results using a combination of PsHV primers 23Ff-131D/23Fr+63 
(UL16/17 genes) and 39RADf/39Fr2 (UL30 gene) with S1 nuclease treatment.   (a) a 
bile duct adenoma from sample SC00-0077 showing non-specific staining of the 
hepatocytes and no staining of the neoplastic cells; (b) a cloacal papilloma from sample 
SC98-0018 showing no positive staining. 
     
 
intense non-specific staining in the cytoplasm of the hepatocytes and the mucosal 
epithelium of the proventriculus, but not the mucosal surfaces of the crop or cloaca that 
was observed in the ISH experiments.  Again this was due to presumably and 
endogenous protein that could not be blocked in the samples.   
     Non-specific amplification of fragmented host DNA resulted because the taq 
polymerase initiated a nascent DNA chain at points of DNA fragmentation that were 
created by the fixation process (Morel and Raccurt, 2003; Nuovo, 1997). Two methods 
were tested to try and reduce this non- specific amplification artifact.  Tissues were 
treated with S1 nuclease that cleaved any overhanging nucleotides from fragmented host 
DNA creating a blunt end, and ddTTP that acted as a chain terminator.  While both 
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methods were effective at reducing non-specific amplification, they did not completely 
eliminate it.  One method did not appear to be superior to the other and both treatments 
appeared to diminish the intensity of the signal (Fig. 4.6a-f).  For most applications, the 
S1 nuclease was employed due to the cost difference between the enzyme and ddTTP.      
     The results of the ISPCR procedure were that neoplastic tissues did not show any 
amplification (Fig. 4.7a and 4.7 b) but non-specific staining was again observed in the 
cytoplasm of the hepatocytes (Fig. 4.7a).   
     The results of this experiment suggest that as with the ISH results, the concentration 
of intact PsHV 1 in the IPD tissues was below the level of detection for this method.   
Therefore, it does not appear that in situ PCR can be used to detect PsHV 1 DNA in IPD 
tissues.  
 
Discussion 
     Work done by our laboratory demonstrated the association between PsHV 1 
genotypes 1, 2, or 3 and the development of mucosal papillomas in Neotropical parrots 
(Styles et al., 2004).  Tissues of 17 parrots with IPD related tumors and carcinomas of 
the digestive tract were probed using PCR for PsHV 1 DNA.   With the exception of one 
sample (SC04-0010), PsHV 1 genotype 3 DNA was amplified from all bile tumors, two 
out of three pancreatic duct tumors, all proventricular/ventricular carcinomas, all cloacal 
carcinomas, and all mucosal papillomas, but not in histologically normal tissue.  These 
findings suggest that PsHV 1 genotype 3 is associated with IPD-related and other 
mucosal tumors and is not a systemic infection.   
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     Phylogenetic analysis was performed on a 219 bp fragment of UL16 amplified from 
the fresh tissues (Fig. 4.1) and a 238 bp fragment spanning a segment of UL16/UL17 of 
the FFPE tissues (data not shown).   PsHV 1 genotype 3 was identified in all birds 
except a Patagonian conure (SC04-0010), where a PsHV 1 genotype 4 was amplified. 
     It had been previously shown that PsHV 1 DNA could not be amplified with 
conventional PCR from the histologically normal tissue adjacent to mucosal papillomas 
(Styles et al., 2004).  To show that PsHV in the neoplastic tissue was in significantly 
higher concentration than adjacent histologically normal tissue, LCM was used to 
selectively collect neoplastic and histologically normal FFPE tissue from birds with 
tumors associated with IPD and other mucosal tumors.  However, PsHV 1 DNA was not 
amplified from any of the neoplastic tissue (Table 4.4), although these tissues were 
known to contain PsHV DNA by PCR.   
     The psittacine cytochrome oxidase I gene housekeeping gene was not consistently 
amplified from all samples suggesting that the integrity of the DNA was varied with the 
sample and tissue.  Given these results, it is possible that an insufficient number of cells 
containing PsHV DNA were collected, or that the concentration of intact DNA was 
inadequate to permit amplification.   
     Optimal PCR amplification of viral DNA from FFPE tissues depends on several 
factors, the particular virus, whether the virus exists as an episome or in an integrated 
state, the particular tissue, the type and length of fixation, and length of storage of the 
fixed tissues (Biedermann et al., 2004; Chen et al., 1991; Cohen et al., 2002; Greer et al., 
1991; Evans et al., 2003; Yazdi et al., 2004).  Amplification from LCM collected tissues 
has greater success with tissues that are either frozen or formalin-fixed for less than 24 
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hours.  The archived FFPE tissues used in this experiment were fixed for an average of 
about 48-72 hours.  Also, the target DNA such as a host gene or viral DNA integrated 
into the host genome demonstrates greater amplification efficiency compared to 
episomal viral DNA because the integrated virus is protected from fixation degradation 
along with the host DNA (Evans et al., 2003).  PsHV DNA exists in a latent state 
probably as an episome in these mucosal cells, and therefore would be exposed to a 
greater degree of damage from the fixation process (Evans et al., 2003).   
     Viral concentration plays an important role in the success of these types of detection 
methods.  The viral copy number for latent herpes simplex viruses has been estimated to 
be greater than 20 copies per neuron (Simmons et al., 1992), but a recent report by Cai et 
al. (2002) places the estimate between 2-20 copies per neuron.  At best, there would 
have been 200-2000 copies of PsHV DNA/µl in the LCM samples.  The limit of 
detection of the primers used in this experiment was about 103 virus/µl and the 
concentration of the PsHV DNA was at that limit (Styles et al., 2004).   However, the 
integrity of this episomal DNA was poor as evidenced by the intermittent amplification 
of the cytochrome oxidase I gene, further reducing the amount of useful DNA for 
detection.  Low viral copy numbers coupled with insufficient numbers cells containing 
intact PsHV DNA was likely to be responsible for the failure to amplify DNA from the 
LCM samples.  
      Further attempts to localize PsHV in these tumors included in situ hybridization and 
in situ PCR using biotin-labeled probes or nucleotides for detection.  The sensitivity of 
both of these techniques is similar to that for conventional PCR with the limit of 
detection for in situ hybridization for cell preparations and 104 copies per cell for fixed 
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tissues with no signal amplification techniques (Mabruk, 2004; Kim, 2004; Speel et al., 
1999).  The range is similar with in situ PCR at about 103 copies per cell being only 
slightly more sensitive without signal amplification techniques.  However in this 
experiment, a chromagen-tyramide signal amplification system was used that was 
reported to detect 1-2 copies of integrated HPV DNA in FFPE tissues (Evans et al., 
2003).  The results for both the in situ techniques were that no PsHV DNA could be 
detected in the tumors, but PsHV DNA was detected in the positive control tissue from a 
bird that died from Pachecos disease where presumably high copy numbers existed in 
the tissues.  The failure of PsHV DNA to be detected by in situ hybridization or in situ 
PCR could be explained for some of the same reasons discussed with the LCM results 
including the likelihood that the concentration of virus was below the limit of detection 
for the method used.   One other important factor regarding the inability to amplify 
PsHV DNA using these in situ techniques is that PsHV is assumed to exist as an 
episome, and as previously discussed, would be at higher risk for degradation due to the 
fixation process. 
     The problems with non-specific staining with the streptavidin/biotin system could not 
be overcome.  It is likely that an endogenous protein existed in the tissues (probably 
biotin) in concentrations sufficient to overcome blocking that caused this artifact.  It was 
observed that tissues of the embryonic control stained more intensely than did the 
analogous adult tissues.  Biotin is found in high concentrations in avian embryos and an 
overabundance of this protein was most likely responsible for the artifact (Vanio and 
Imhof, 1996).  This may be a shortcoming of using the chromagen-tyramide 
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amplification system in avian tissues, except that the non-specific staining in mucosal 
epithelium could be greatly reduced by manipulating experimental factors. 
     While attempts to localize PsHV 1 DNA in the tumors failed, it is important to note 
that only PsHV 1 genotype 3 DNA was amplified from the lesions with the exception of 
one bird that will be discussed below.  Previous work also found that 76% of the 
mucosal papillomas contained PsHV 1 genotype 3 DNA (Styles et al., 2004).  These 
results suggest that genotype 3 viruses may possess a higher oncogenic potential than 
other genotypes, or that other genotypes are equally oncogenic but genotype 3 may exert 
a tropism for mucosal cells of the bile and pancreatic ducts, and glandular mucosa of the 
proventriculus and cloaca.  Further studies will need to be done to determine what 
factors are involved with the oncogenic potential of genotype 3 viruses, but it must first 
be definitively shown that PsHV is localized to the neoplastic tissue.  
     There were two non-Neotropical species reported in this study that had IPD and 
associated tumors.  These were an eclectus parrot (DP04-0006) and a Moluccan 
cockatoo (SC91-1299).  This is the first report of IPD in these species.  PsHV-1 
genotype 3 DNA was amplified from the lesions of both birds.  The history of the 
Moluccan cockatoo is largely unknown except that it was a wild-caught bird living in an 
aviary until it died from tumors associated with IPD.  However, the eclectus parrot 
originated from a collection that had suffered a Pachecos disease outbreak.  This bird 
showed clinical signs consistent with the disease and was treated with the anti-
herpesviral drug acyclovir.  This bird survived and subsequently developed IPD and bile 
duct adenoma.  All PsHV 1 genotypes appear to be equally lethal to parrots of Pacific 
distribution (Tomaszewski et al., 2003).  It is likely that this bird would have also 
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succumbed to the disease had it not been rescued with treatment, so this example may 
not be representative of natural disease.   
     The finding of PsHV 1 genotype 4 in Patagonian conure (SC04-0010) is the first 
instance of amplifying a genotype other than genotype 3 from a bird with a mucosal 
papillloma.  This bird had a glottal papilloma and a cloacal carcinoma.  Several 
possibilities may help to explain this finding.  It is possible that genotype 4 could have 
been associated with the lesions or that the bird was co-infected with a genotype 3 virus, 
but further investigation will need to be done although precedence for such co-infection 
does exist (Tomaszewski, personal communication).  A more likely explanation is that 
the mechanisms giving rise to the mucosal papilloma and cloacal carcinoma were 
different.  This idea will be elucidated below.   
     Bile and pancreatic duct neoplasms and perhaps proventricular/ventricular 
carcinomas are associated with IPD but cloacal carcinomas are not.  The sample size for 
proventricular/ventricular carcinomas is small (n=3), but each is coincidental with bile 
duct tumors.  The data set only has two examples of cloacal carcinomas, one from a 
macaw that had no evidence of IPD, and one from the conure with genotype 4 that had a 
glottal papilloma and more tumors need to be examined.  Bile duct, pancreatic duct, and 
endoventricular carcinomas do not readily metastasize in contrast to cloacal carcinomas 
that do metastasize.  Also, these former tumors can develop in a broad age-range of 
birds, but cloacal carcinomas tend to develop only in older parrots.  The difference in 
age predilection and metastatic behavior separates cloacal carcinomas from the other 
tumors associated with IPD.   While cloacal carcinomas may be coincidental with IPD, 
they may not be a manifestation of IPD. 
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     The results of this investigation suggest that bile and pancreatic duct tumors are 
manifestations of IPD, and that proventricular/ventricular tumors may also be related but 
the numbers are too small to draw clear conclusions.  Cloacal carcinomas appear to 
develop by a different pathway that may be unrelated to IPD.  The development of all of 
these tumors is associated with the presence of PsHV 1 genotype 3.  Further studies will 
need to be performed to elucidate the oncogenic mechanisms of this genotype.   
 
Materials and Methods 
Samples:   sources, history, and processing 
     Tissues used in this study were acquired as diagnostic submissions to the Schubot 
Exotic Bird Health Center (Texas A&M University, College Station, TX) and originated 
from aviaries within the United States.  Tissues were processed as either routine 
histopathology submissions and available as FFPE specimens or for study as cases of 
IPD available as fresh tissues (Tables 4.1, 4.3, 4.4, and 4.5).  Fresh specimens submitted 
for study as cases of IPD were collected using cleaned, autoclaved instruments that had 
been bleached and then soaked in formalin.  A different set of instruments was used to 
collect each tissue to prevent DNA contamination.  However, no precautions guarding 
against PsHV DNA contamination were taken with specimens processed for routine 
diagnostic submissions for histopathology.  
     The tissue was considered to contain papillomas if the normal mucosa was replaced 
with papillary growths consisting of a narrow to broad base with the mucosal fronds 
containing a fine fibrovascular core covered by a cuboidal to tall columnar epithelium of 
variable thickness.  Adenomatous and/or carcinomatous neoplasms were observed in the 
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liver and pancreas (Fig. 4.1a).  Lesions were classified as bile or pancreatic duct 
adenomas if they displayed moderately well differentiated ductal architecture 
accompanied by a variable amount of stroma (Fig. 4.1b) (Schmidt et al., 2003).  Bile 
duct carcinomas were less well differentiated and tended to form nests and cords of 
poorly formed ducts or individual cells accompanied by a moderate amount of stroma 
(Fig. 4.1c).   Proventricular/ventricular carcinomas were observed in three birds and 
were more malignant in nature.  They consisted of poorly differentiated cells that 
appeared to be derived from the glandular mucosa of the proventriculus arranged as 
infiltrative nests and cords displaying extensive stromal proliferation and extended 
through the muscularis through to the serosa (Fig. 4.2a).  Goblet cells were also observed 
but the mitotic index was very low.  Cloacal carcinomas were seen as infiltrative lesions 
characterized by moderately to poorly differentiated epithelial cells that formed cords 
and nests supported by a scirrhous stroma (4.2b). 
     The fresh tissues from 11 parrots and the FFPE tissues of 5 other birds were 
examined (Tables 4.1 and 4.2).  Six of the birds were macaws (38%), 6 were Amazon 
parrots (38%), 2 were conures (12%), one was an eclectus parrot (6%), and one bird was 
a cockatoo (6%).  Fifteen of these birds (94%) either exhibited mucosal papillomas and a 
related tumor or had a history of mucosal papillomas, however one macaw (6%) with a 
cloacal carcinoma had no gross evidence or history of mucosal papillomas.  Eight birds 
had bile duct carcinoma accompanied by at least one mucosal papilloma, one of which 
also had pancreatic duct adenoma; six birds had bile duct adenomas (two of which also 
had pancreatic duct adenomas) and five which were accompanied by at least one 
mucosal papilloma and one that had no evidence or history of papillomas; there were 
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two birds with proventricular carcinomas one of which had mucosal papillomas, and 
there were two birds with cloacal carcinomas one of which had mucosal papillomas.  
Histologically normal digestive tract mucosal samples were available from 6 birds:  
crop=5, proventriculus=3 (Table 4.1).   
     Fresh tissues were either processed immediately or stored at -80°C until use.  
Formalin-fixed paraffin-embedded (FFPE) tissues that had been fixed in formalin for 72 
hours or less were selected for the study (Table 4.2).   
     Tissues used for the LCM experiment (Table 4.4) were FFPE sections that had been 
shown to be positive by PCR examination of the DNA extracted from either fresh (Table 
4.1) or FFPE (Table 4.2) tissues.   All tissues were fixed in formalin for 72 hours or less. 
Tissues included an Amazon parrot with bile duct adenoma, another Amazon parrot with 
bile duct adenoma and ventricular carcinoma, a macaw with bile duct carcinoma and 
pancreatic adenoma, and an eclectus parrot with bile duct adenoma (Table 4.4).  Both the 
formalin-fixed and paraformaldehyde-fixed tissues of sample SC04-0012 were 
examined.   
     IPD tissues examined by in situ hybridization and direct in situ PCR (Table 4.5) were 
processed as those described above for LCM.  The tissues used in these experiments 
were FFPE tissues fixed for 72 hours or less and had been shown to contain PsHV DNA 
by conventional PCR except the spleen of sample SC04-0012 where the concentration of  
PsHV 1 DNA was below the limit of detection for PCR.  Tissues examined were an 
endoventricular carcinoma from an Amazon parrot, a bile duct adenoma from another 
Amazon parrot, a bile duct carcinoma and histologically normal spleen from a macaw, 
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and a cloacal papilloma from a second macaw (Table 4.5).  The spleen from SC04-0012 
was used as a negative internal control tissue for this bird. 
 
Histological evaluation of the tissues  
     Sections of the tissues were fixed in formalin, embedded in paraffin, and thin sections 
were routinely stained with hematoxylin and eosin.  These sections were then 
microscopically examined for the presence of lesions. 
 
Extraction of DNA from fresh IPD tissues 
     DNA was extracted from the tissues using the Purgene Genomic DNA Purification 
Kit (Gentra Systems, Minneapolis, MN.) following the instructions for fresh or frozen 
solid tissue.  The extracted DNA was then re-hydrated in nuclease-free water (Promega, 
cat# P1193, Madison, WI). 
 
Extraction of DNA from formalin-fixed paraffin-embedded tissues 
     Many of the paraffin blocks contained multiple tissues.  Tissues of interest were 
isolated from those not examined by melting the paraffin block and re-embedding the 
tissue of interest in another paraffin block separately, so that there was only one tissue 
present in each block.   Blocks were then cut into 5 µm sections using a Leitz 1512 
rotary microtome.  A new microtome blade was used to cut each tissue and the 
microtome was cleaned with DNA AWAY (Molecular BioProducts, cat# 7010, San 
Diego, CA), absolute ethanol, and distilled de-ionized water before and between each 
tissue to prevent contamination.  Fifteen to twenty 5 µm paraffin sections containing the 
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tissue of interest were collected and placed into sterile microcentrifuge tubes.  Tissues 
were deparaffinized using the following protocol of Shi et al. (2002).  Briefly, 1 ml of 
xylene was added to the sections and incubated at room temperature with intermittent 
mixing for 30 minutes, followed by centrifugation at 14,000 rpm using a Beckman-
Coulter Mircofuge 18 centrifuge, and then decanting.   Then the tissues were similarly 
treated in 100% and 75% ethanol.  Final re-hydration was performed by washing in PBS 
(pH=7.0) for 15 minutes twice.   
     DNA was extracted from the tissues using the Purgene Genomic DNA Purification 
Kit (Gentra Systems, Minneapolis, MN.) following the instructions for fresh or frozen 
solid tissue except the amount of proteinase K was doubled for the initial digestion for a 
minimum of 12 hours at 55°C.  Following the initial digestion, fresh proteinase K was 
added to the tissue and digestion was continued for an additional hour or until the tissue 
had completely dissolved.  The extracted DNA was then re-hydrated in nuclease-free 
water (Promega, cat# P1193, Madison, WI). 
 
PCR of IPD tissues with PsHV 1-specific primers 
     All PCR reactions were performed on an Eppendorf Mastercycler Personal 
Thermocycler (Eppendorf, Hamburg, Germany).  PCR was performed as previously 
described (Tomaszewski et al., 2000). Briefly, a 25 µl reaction mix containing, 100 ng 
genomic DNA, 25 pmol of each primer, 0.1 mM of each of the 4 deoxynucleotide 
triphosphates, 2.5 mM magnesium chloride, 0.75 units Taq polymerase and 1X buffer A 
was used in the reaction (Promega, cat# M1861, Madison, WI).   
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     Primer set 23Ff5a/23Fr3 was used to amplify a 667 bp product that spanned PsHV 1 
genes UL16/UL17 from fresh or frozen tissues (Table 4.3).  Three other primer sets were 
used for FFPE tissue including the LCM experiment:  23Ff-131D/23Fr+63, 
23Ff5a/23Fr+114D, and 23Ff+43/23F4+266D (Table 4.3).  These primer sets amplified 
different consecutive segments of the UL16/UL17 genes to ensure consistent 
amplification at different loci in case damage had resulted from the fixation process at 
any one locus.  All primer sets used amplified the four PsHV 1 genotypes. 
     The positive control for fresh tissues was DNA containing PsHV extracted from the 
tissues of an Amazon parrot that died of Pachecos disease.  Positive controls for FFPE 
tissue were DNA extracted from the FFPE liver of two parrots that died of Pachecos 
disease (Table 4.2).  The negative controls for the fresh tissues were the DNA extracted 
from a near hatch psittacine embryo and the blood of an incubator hatched African grey 
parrot held in isolation (Table 4.1).  Negative controls for FFPE tissue were DNA 
extracted from the FFPE liver of a bird that died of causes unrelated to PsHV and from 
the whole body of a near hatch psittacine embryo (Table 4.4).  For the LCM experiment, 
primer set H7523/COIf amplified a section of Neotropical psittacine cytochrome oxidase 
I and served an internal control (Eberhard and Bermingham, 2003) (Table 4.3).  
Reference samples representing each PsHV 1 genotype were used to verify the 
functionality of the primers used to probe both fresh and FFPE tissues (Styles et al., 
2004; Tomaszewski et al., 2003). 
     The thermocycler parameters were:  initial denaturation at 94°C for 5 minutes; 
followed by 40 cycles of annealing at 60°C for 45 seconds, extension at 72°C for 90 
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seconds, denaturing at 94°C for 30 seconds, and a final extension at 72°C for 5 minutes.  
PCR amplification products were imaged on ethidium bromide agarose gels. 
 
DNA sequencing of PsHV amplicons from IPD tissues 
      PCR products were purified using QIAquick PCR Purification Kit (Qiagen Inc., 
Valencia, CA).  The sequencing reaction was performed using an ABI Prism  Big 
Dye  Terminators v3.0 Cycle Sequencing Kit (Applied Biosystems Inc., Foster City, 
CA).  Amplicons from fresh tissues were sequenced with primer set 23Ff5b/23Fr3 and 
PCR products from the FFPE tissues were sequenced with primer set 23Ff5b/23Fr+114D 
(Table 4.3).  Products were sequenced using an ABI 377 DNA sequencer or ABI 3100 
DNA sequencer (Applied Biosystems). 
 
Phylogenetic analysis of sequences from IPD tissues 
     Phylogenetic analysis was performed as described by Tomaszewski et al., (2003).  A 
419 bp product amplified fresh tissues and a 238 bp product amplified from FFPE tissue 
were subjected to phylogenetic analysis.  The 419 bp amplicon began at the UL16 start 
codon and the 238 bp product started in the UL17 gene, 169 bp in front of the UL16 start 
codon, and continued for 66 bp beyond the UL16 start codon.   All sequences were 
aligned using Clustal X 1.81 (Thompson et al., 1997).  Aligned sequences were imported 
into PAUP for analysis (Swofford, 1998).   Phylogenetic trees were generated by 
performing a neighbor-joining search using bootstrap re-sampling (1,000 replications) 
employing distance optimality.  A phylogram was generated from the sequence data 
showing branch-lengths and bootstrap values employing representative sequences of 
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each genotype for sequences generated from the fresh tissues (Fig. 4.1) and for the FFPE 
tissues (data not shown).   
 
Preparation and sectioning of tissues for LCM 
     FFPE tissues were sectioned at 5 µm thickness on a Leitz 1512 rotary microtome and 
then floated onto 3-aminopropyl-trimethoxysilane coated glass slides (HistoBond +, 
StatLabs Medical Products Inc., Lewisville, TX).  Each individual tissue section was cut 
with a new microtome blade to prevent contamination.  Sections were then permitted to 
air dry at room temperature after which the sections were fixed to the slides by heating 
in an oven at 60° C for one hour.  The tissues were routinely stained with hematoxylin 
and eosin (and deparaffinized in the process).  Stained tissue sections were placed in a 
slide box that contained silicone-desiccating packets to maintain low humidity and keep 
the tissue as dry as possible until use.   
  
Laser capture microdissection (LCM) 
     Slides containing tissues to be examined were placed onto the sampling stage of an 
Acrturus PixCell II Laser Capture Microdissection instrument (Arcturus, Mountain 
View, CA).  A microscope objective of 10X was selected and the area of interest was 
identified, that area was centered in the middle of the slide stage, and the slide secured in 
place with the vacuum slide-holding system.  A CapSure Macro LCM Cap (Arcturus, 
cat# 10284-04, Mountain View, CA) was loaded onto the sampling arm of the 
instrument.  The LCM cap was lowered onto the sample surface ensuring that the cap 
was level, centered, and there was effective contact with the sample.  The instrument 
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settings varied between 7.5-15 microns of cutting diameter; 75-100 mW laser power; 
and cutting time of 1-3 milliseconds depending on the type and topography of the tissue 
being sampled.  The laser was then activated and tuned for maximum cutting efficiency.  
As the LCM cap surface became filled with cut sections, the cap was lifted from the 
surface and manually rotated to expose areas of the cap surface that were empty so that 
collection could continue.  This activity was repeated until between 2000-5000 sections 
had been acquired.   
     When sufficient tissue had been collected, then the LCM cap was removed and 
inserted into a 500 µl microcentrifuge tube.  The tissue was held at room temperature in 
the tube until processed.  DNA was extracted from the collected tissue using a Pico Pure 
 DNA Extraction Kit (Arcturus, cat# KIT0103, Mountain View, CA).  Once the 
digestion was completed, the digest was processed in two ways, either used directly for 
PCR as recommended by the kit or further purified using a Purgene Genomic DNA 
Purification Kit (Gentra Systems, Minneapolis, MN). 
 
Tissue processing for in situ hybridization and in situ PCR 
     Sections to be used for in situ hybridization and in situ PCR were processed routinely 
as described in the section on preparation of tissues for LCM except tissues were not 
stained and were deparaffinized and re-hydrated by the following protocol:  immersion 
in xylene for 5 minutes; repeat with fresh xylene; immersion in absolute ethanol for 3 
minutes; repeat with fresh absolute ethanol; immersion in a 95% ethanol for 3 minutes; 
repeat with fresh 95% ethanol; immersion in a 70% ethanol for 3 minutes; followed by 
three washes in distilled de-ionized water for 2 minutes. 
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     DNA retrieval was then performed to enhance the signal integrity.  The re-hydrated 
tissue sections were placed in a glass slide tray and immersed into 1 liter of 10 mM 
citrate buffer (pH=6.0).  Sections were then heated in this solution in a microwave set at 
maximum power for 5 minutes; the heated solution was then allowed to rest for 5 
minutes after initial heating; this was followed by another period of heating at maximum 
power for an additional 5 minutes, however, the solution was not permitted to boil.  
After the second heating, the sections were allowed to remain in the hot solution for 30 
minutes (Shi et al., 1991).  Sections were then rinsed in three changes of water for 5 
minutes each and then allowed to air dry.  
     Tissue sections were then subjected to pepsin protease digestion to free the DNA 
from the cross-linked proteins (Evans et al., 2003).   A 6000 U/ml stock solution of 
pepsin (Sigma P-7012, Sigma, St Louis, MO) was prepared with 0.2 M HCl, then 
aliquoted into 1 ml increments and stored at 20 ° C until needed.  The working pepsin 
solution of 300 U/ml in 0.2 M HCl was applied to the tissues in a humid chamber at 
room temperature and sections were allowed to digest for 30 minutes at room 
temperature.  The sections were then rinsed with water for 5 minutes; followed by 3 
changes of a solution of PBS/0.05% Tween 20 (pH 7.0) for five minutes each; and rinsed 
again in water for 5 minutes. 
     Following protease unmasking, any endogenous peroxidase was quenched by 
immersing the tissue sections into a solution of methanol and 0.6% hydrogen peroxide 
for 30 minutes at room temperature.  This step was followed by three water rinses for 5 
minutes each.  Sections were then permitted to air dry. 
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      Endogenous cross-reactive streptavidin/biotin proteins were blocked prior to ISH or 
ISPCR.   Blocking was accomplished by using a Streptavidin/Biotin Blocking Kit 
(Vector Labs. Inc., SP-2002, Burlingame, CA).   
 
In situ hybridization:  synthesis of biotinylated probes  
     Both random primer and specific primer directed probes were synthesized using the 
BD Biosciences Clontech SpotLight Random Primer Labeling Kit (BD Biosciences 
Clontech, cat# K1027-1, Palo Alto, CA).  The kit produced probes between 50-300 base 
pairs in length.  Random probes were generated using the random primers provided in 
the kit and the following DNA templates:  PsHV 1 genotype 4 (whole virus); PsHV 1 
genotype 1 (whole virus); a 537 bp amplicon encompassing a section of the PsHV 1 
gene UL9 produced from a genotype 3 sample by primer set 11Rf8/11Rr4 (Table 4.2); a 
667 bp amplicon spanning a section of PsHV 1 genes UL16/UL17 produced from a 
genotype 3 sample by primer set 23Ff5a/23Fr3 (Table 4.3); and a 634 bp amplicon 
encompassing a section of PsHV 1 gene UL30 also produced from a genotype 3 sample 
by primer set 39Ff/39Fr (Table 4.3).  Specific primer-directed probes were generated 
using primers 23Ff5a/23Fr3 and 39Ff/39Fr using their respective amplicons as templates 
(Table 4.3).  
     The sensitivity and relative concentration of both random and specific primer-
directed probes was assessed using a BD Biosciences Clontech SpotLight 
Chemiluminescent Hybridization & Detection Kit (BD Biosciences Clontech, cat# 
K1032-1, Palo Alto, CA) (Fig. 4.8).
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Fig. 4.8.  Chemiluminescent film of relative intensities of signal of random probes to 
concentrations of known standards.  1β-actin and PsHV concentrations are given as 
relative dilutions, and biotinylated dT100 is given in absolute concentration units. 
2Exposure time to radiographic film is given in seconds.  A biotinylated 100mer of poly-
T was used as a known standard.  β-actin was used as an internal experimental positive 
control.  Viral templates were PsHV 1 genotypes 1 and 4 whole purified virus. 
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In situ hybridization 
     Tissue sections were covered with sealable reaction chambers (HybriWell, HBW22 
or HBW1932, Grace Bio-Labs, Bend, OR).  The chambers were then filled with a 
hybridization mixture that consisted of 40% 2X SSC buffer (Sigma, S-6639, St Louis, 
MO), 10% dextran sodium sulfate (ICN Biomedical Inc., cat# 160110, Aurora, OH), 
50% N, N-dimethylforamide (Aldrich; cat # 22, 705-6; Milwaukee, WI) (Evans, M. et 
al., 2003).  Sonicated salmon sperm DNA (Sigma, D-7656, St Louis, MO) that had been 
denatured by boiling for 5 minutes was added to the hybridization mix of some samples 
at concentration of 400 ng/µl to determine its utility as a blocking agent for non-specific 
binding of the PsHV probes to genomic DNA.  Probes were added to the hybridization 
mix at a concentration of 1 µl of probe per 10 µl of hybridization mix.  The reaction 
chamber port seals were placed over the ports and rubber cement was applied over the 
ports and around the edges of the chamber to secure it to the slide and prevent loss of 
liquid during heating. 
     The sections in the sealed chambers were then placed into a PTC-100 thermocycler  
(MJ Research Inc, Watertown, MA) equipped with a block that accommodated 
microscope slides.  The thermocycler program was initial denaturation at 94° C for 5 
minutes followed by a minimum of 12 hours hybridization at 37° C. 
     Following hybridization, the hybridization chambers were removed under a solution 
of 2X SSC with 0.05% Tween 20 (pH=7.0) at room temperature.  The tissues were then 
washed in a high stringency bath of a solution of 0.2 SSC with 0.05% Tween 20 at 55° C 
for 15 minutes (Evans, M. et al., 2003). 
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In situ hybridization and direct in situ PCR:  detection of biotin and chromagenic 
staining  
          IPD tissues used in this experiment were the FFPE tissues that had been shown by 
PCR to contain PsHV DNA (Table 4.4).  The positive control tissue was an Amazon 
parrot that died of Pachecos disease and exhibited PsHV intranuclear inclusion bodies 
in the crop and pancreas.  The negative control was a near-hatch psittacine embryo 
(Table 4.4).   
     Tissues were washed in three changes of a solution of PBS with 0.05% Tween 20 
(pH=7.0) for five minutes.  The excess liquid was removed and biotinylated probes were 
detected in the tissue using a DakoCytomation GenPoint Tyramide signal amplification 
system (DakoCytomation Inc., product # K0620, Carpinteria, CA).  The protocol for 
biotin detection was performed in accordance with the GenPoint directions except the 
primary streptavidin-HRP was used at a dilution of 1:5000 in PBS with 0.05% Tween 20 
(pH=7.0) and left in contact with the tissue for 1 hour.  The remainder of the procedure 
was completed as directed except that the wash buffer employed was PBS with 0.05% 
Tween 20 (pH=7.0) and 3-amino-9-ethyl-carbazole (AEC) was used as a chromagenic 
stain rather than diaminobenzidine (Evans, M. et al., 2003).  All staining reactions were 
conducted within a sealed humid chamber at room temperature. 
     An aminotethylcarbazole (Sigma, cat# A-5474, St Louis, MO) solution was prepared 
in accordance with a protocol from Harlow (Harlow et al., 1988).  Once the AEC was 
activated, the tissues were permitted to develop in contact with the reagent for about 15 
minutes.  The reaction was quenched by immersing in water for 5 minutes.  The tissues 
were then counterstained with aqueous hematoxylin (Biomeda, cat# M10, Foster City, 
 133
CA), rinsed in water, air-dried, and sealed with an impervious resin (Crystal Mount, 
Biomeda, cat# M03, Foster City, CA).   
 
Direct in situ PCR:  blocking of non-specific amplification using S1 nuclease or 2, 3 
dideoxythymidine 5-triphophate (ddTTP) 
     Two methods were tested on the tissues in an attempt to inhibit non-specific 
amplification due to breaks in non-target (host genomic) DNA.  S1 nuclease (Promega, 
cat# M5761, Madison, WI) was used to create blunt end DNA chains to inhibit binding 
of the DNA polymerase and ddTTP (Amersham, cat# 27-2081, Piscataway, NJ) was 
used as a DNA chain-terminator to prevent extension by DNA polymerase. 
      Treatment with S1 nuclease was accomplished by covering the tissues with sealable 
reaction chambers (HybriWell) and filling the reaction chamber with 0.1 U/µl of S1 
nuclease enzyme. The slides were incubated at 37° C for 30 minutes in a PTC-100 
thermocycler  (MJ Research Inc, Watertown, MA) (Ausbel et al., 1998).  The reaction 
was stopped by the addition of 1µl of 0.5 M EDTA.  Tissues were then rinsed in two 
changes of water for 5 minutes and allowed to air dry. 
     The chain terminator ddTTP was also tested as an inhibitor of non-specific 
amplification.  Tissues were covered with sealable reaction chambers (HybriWell).   
The protocol was performed in accordance with Nuovo, 1997.  The reaction mixture 
contained [1X buffer A, 4.5 mM MgCl2 , 0.167 U/µl Taq polymerase (Promega, cat# 
M1861, Madison, WI)]; 200 µM dNTPs (Promega, cat# U1330, Madison, WI) , 1000 
µM ddTTP, 0.067% bovine serum albumin (Sigma, cat# A3059, St Louis, MO) mixed in 
Nuclease-free water (Promega, cat# P1193, Madison, WI).  The reaction chamber ports 
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were sealed and the slides were incubated at 55° C for 30 minutes in a PTC-100 
thermocycler.  The reaction chamber was removed from the slide and the tissues were 
then rinsed in two changes of water for 5 minutes and allowed to air dry.  
 
Direct in situ PCR 
     IPD tissues used in this experiment were the FFPE tissues that had been shown by 
PCR to contain PsHV DNA (Table 4.5).  The positive control tissue was an Amazon 
parrot that died of Pachecos disease and exhibited PsHV intranuclear inclusion bodies 
in the crop and pancreas.  The negative controls were the liver of an eclectus parrot that 
died of causes unrelated to PsHV and a near-hatch psittacine embryo (Table 4.4).   
     Direct in situ PCR was performed as described by Morel et al., 2003.  Briefly, the 
tissues were covered with sealable reaction chambers (HybriWell) and the reaction 
mixture was [1X buffer A, 1.5 mM MgCl2, 0.1 U/µl Taq polymerase (Promega, cat# 
M1861, Madison, WI)];  [0.2 mM dATP, dGTP, dTTP;  0.1 mM dCTP (Promega, cat# 
U1330, Madison, WI)]; 0.1 mM biotin-14-dCTP (Invitrogen, cat # 19518-018, Carlsbad, 
CA); 0.3 µM sense primer; 0.3 µM anti-sense primer; 5% DMSO (HybriMax®, Sigma, 
St Louis, MO); made quantity sufficient for volume with nuclease-free water (Promega, 
cat# P1193, Madison, WI).  Primers used to probe for PsHV 1 DNA were 23Ff-
131D/23Fr+63 and 39RADFf/39Fr2 (Table 4.3).   The reaction chamber port seals were 
placed over the ports and rubber cement was applied over the ports and around the edges 
of the chamber to secure it to the slide and prevent loss of liquid during heating. 
     The reaction was conducted on a PTC-100 thermocycler and the parameters were:  
95° C for 5 minutes initial denaturation followed by 20-30 cycles of:  95° C for 1 
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minute, 60° C for 1.5 minutes annealing, and 72° C for 1.5 minutes extension.  The 
reaction was completed with a final extension of 72° C for 5 minutes. 
    The reaction chambers were removed from the slides and the tissues were washed in 
PBS with 0.05% Tween 20 (pH=7.0) twice for five minutes.  The slides were then air-
dried and the amplicons fixed in absolute ethanol at a temperature of -20° C for five 
minutes.  The tissues were then re-hydrated at room temperature in 95% ethanol for 3 
minutes, then 70 % ethanol for 3 minutes.  
     Tissues were then processed to develop chromagenic stain as described in the section 
on detection of biotin and chromagenic staining above. 
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CHAPTER V 
 
DISCUSSION AND CONCLUSIONS 
 
Discussion 
     Internal papillomatous disease is characterized by mucosal papillomas primarily 
affecting the epithelium of the oral cavity and cloaca of predominantly Neotropical 
parrots, but is also observed in the esophagus, crop, proventriculus, ventriculus, 
conjunctiva, nasolacrimal duct, and bursa  (Graham, 1991).  While these papillomas 
grossly and histologically resemble those caused by papillomaviruses, there is little 
evidence supporting the existence of papillomaviruses in these lesions (Johne et al., 
2002; Latimer et al., 1997; Sundberg et al., 1986).  However, strong evidence was 
presented suggesting that mucosal papillomatosis in Neotropical parrots is associated 
with PsHV 1 genotypes 1, 2, and 3, with the most prevalent genotype being 3 in the 
mucosal papilloma sample population of 30 parrots (Styles et al., 2004).  Other tumors 
have also been associated with IPD including neoplasms of the bile and pancreatic ducts 
(Graham, 1991; Hillyer, 1991; Phalen et al., 1997).  Data presented in Chapter 4 showed 
that only PsHV 1 genotype 3 DNA was detected in the bile and pancreatic duct tumors, 
and endoventricular carcinomas associated with IPD.  This finding along with the results 
of the mucosal papilloma study showing that genotype 3 was the predominant PsHV 
genotype in the mucosal papilloma population suggests that genotype 3 may possess 
oncogenic properties that differ from other genotypes.  It is possible that PsHV 1 
genotype 3 may exert an oncogenic activity greater than other genotypes.   Another 
possibility is that other PsHV genotypes have equivalent oncogenic activity to genotype 
3, but genotype 3 displays a particular tropism for cells not observed with other 
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genotypes such as bile and pancreatic duct cells.   For example, genotype 3 may be able 
to infect cells such as bile and pancreatic epithelium more efficiently than other 
genotypes which would provide the opportunity for oncogenesis in these tissues.  
     Development of tumors in birds infected with PsHV is thought to be associated with 
latent infection by the virus.  PsHV latently infects parrots that are survivors of 
Pachecos disease, and is shed intermittently or continuously at very low levels (Phalen 
et al., 1999).  Latency has been established for the closely related alphaherpesvirus 
infectious laryngotracheitis, where the trigeminal ganglion was determined to be the site 
of latent infection (Hughes et al., 1987, Williams et al., 1992).  It is unknown whether 
PsHV exists latently in nerve tissue.  PsHV DNA could not be detected in peripheral 
nerve and ganglia by conventional PCR from birds with IPD, but it may be present in 
concentrations below the limit of detection of this method.  In herpes simplex viruses, 
LAT (latency associated transcript) is believed to play a vital role in the maintenance of 
latency in the neuron (Howley and Lowy, 2001).  Whether PsHV contains an LAT-like 
sequence is unknown, but alignment of the HSV 1 LAT sequence with the PsHV 1 
genome resulted in no significant similarity.   
     The results of our investigations suggest that PsHV exists latently in the neoplastic 
epithelial cells.   PsHV DNA could be consistently amplified from affected neoplastic 
mucosa, but not from adjacent or distant histologically normal mucosa from birds with 
IPD (Styles et al., 2004; Chapter IV).  It is likely that through a currently unknown 
mechanism, PsHV induces the development of tumors and the type and severity of 
tumor depends on the genotype of PsHV and origin of the tissue. 
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     Based on evidence from other oncogenic viruses, there are likely PsHV oncogenic 
proteins that interfere with the cell cycle, signal transduction, or other pathways that 
result in the development of mucosal papillomas.  For example, the E5 protein found in 
bovine papillomavirus is responsible for the development of papillomas (Howley and 
Lowy, 2001).  Each subunit of the E5 homodimer binds to a PDGF β receptor resulting 
in dimerization and activation of the receptors.  The activated receptors then initiate a 
signal transduction pathway that leads to mitogenic stimulation.  In cows infected with 
the group of bovine papillomaviruses that includes BPV 4, gastrointestinal tumors can be 
induced by a co-carcinogen (quercetin) found in a diet that includes bracken fern 
(Campo, 2002).  It is possible that a similar initiating factor could be found in psittacine 
diets.   However, when the E5 nucleotide and protein sequences of BPV 1 and 4 and two 
high-risk HPV viruses (16 and 18) were aligned against the PsHV, no similarities were 
observed.  The oncogenic proteins of other herpesviruses such as the alphaherpesvirus 
Mareks disease target cell cycle activity within leukocytes and may be less suitable for 
comparison when trying to elucidate a mechanism for genotype 3.  The Meq protein 
targets the cell cycle controls in B-lymphocytes, whether a Meq like protein in PsHV 
would have a similar effect is unknown.  However, alignment of the Meq sequence with 
the PsHV genome resulted in no significant similarity.   What advantage PsHV may gain 
by generating tumors is unclear.  The papillomas that are caused by species-specific 
papillomaviruses are vehicles that permit continued replication of the virus.  However, 
the replication rate in birds latently infected with PsHV appears to be low or not 
measurable using conventional methods (Phalen et al., 1999).  It is possible that birds 
with IPD or tumors associated with PsHV are infected with a genotype to which they 
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may not be adapted.  However, it is not clear what parrot species serve as hosts for PsHV 
and the host may vary with genotype.  There is some evidence suggesting that hyacinth 
macaws (Anodorhynchus hyacinthinus) may a candidate species as hosts for genotype 3 
since only one bird has been found to have a mucosal papilloma, but several hyacinth 
macaws were found to be asymptomatically infected (Phalen et al., 2004).  Further 
studies need to be undertaken to quantify rates of viral shedding from birds with overt 
IPD and those that have no obvious lesions.  This may give some indication that the 
development of tumors enhances viral survival.  For example, if birds with overt 
papillomas, including papillomas that can only be visualized microscopically or with an 
endoscope, shed higher concentrations of PsHV as compared to those infected with the 
virus but appear grossly normal.   
     PsHV 1 genotype 3 DNA was found in the IPD lesions of two non-Neotropical 
species, an eclectus parrot and a Moluccan cockatoo.  While the history of the Moluccan 
cockatoo is largely unknown, the eclectus parrot was a survivor of a Pachecos disease 
outbreak that had been rescued with acyclovir treatment.  The fact that only two non-
Neotropical parrots exhibiting IPD were found in the data set including the entire tissue 
archive of the Schubot Exotic Bird Health Center collection, suggests that these two 
birds are exceptional and that IPD is predominantly a disease of Neotropical parrots.       
     PsHV 1 genotype 3 was amplified from all IPD tissues except the glottal papilloma 
and cloacal carcinoma of a Patagonian conure where a PsHV genotype 4 was detected.  
Patagonian conures have been speculated to be carriers of this genotype so it is possible 
that PsHV 1 genotype 4 may have been coincidental with these lesions (Phalen et al., 
2004).  While it is possible that genotype 4 was responsible for these lesions, the 
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dynamics of papillomas and cloacal carcinomas may be different and it must not be 
assumed they arise from a common set of mechanisms.  IPD can develop in a wide age 
range of birds where they develop benign mucosal papillomas, and the tumors associated 
with IPD rarely metastasize.  In contrast, cloacal carcinomas are malignant and may 
metastasize, and have thus far only been observed in older birds (Phalen, personal 
communication).  However, the data set in this study was small (n=2) and while the 
tumors were malignant, there was no evidence of metastasis in these birds.  However 
like IPD, cloacal carcinomas do appear to be associated with the presence of PsHV.  It is 
also possible that this conure was co-infected with another PsHV genotype that caused 
the lesions (Tomaszewski, personal communication).  
     The discovery of PsHV 2 in African grey parrots suggests that there may be a 
diversity of PsHVs that are yet to be described in other psittacine species (Styles et al., 
2005).  Whether PsHV 2 causes IPD is unknown, but two African grey parrots were 
reported to have mucosal papillomas (Styles et al., 2005).  It is unknown whether these 
lesions were caused by PsHV 2 or were coincidental with the infection.  This is because 
PsHV 2 DNA was also amplified from the tissues of two other African grey parrots in 
the study that lacked any lesions or history of lesions (Styles et al., 2005).  Infection by 
PsHV 2 may complicate the identification of PsHV 1 infected birds given that primers 
used in PCR diagnostic testing may detect both species of PsHV.  Because PsHV-1 can 
cause Pachecos disease in many species of psittacine birds including African grey 
parrots, infected parrots should be segregated from susceptible birds.  However, 
infection with PsHV-2 may have less clinical significance, and differentiating these 
infections by the use of virus-specific PCR primers is indicated.  The existence of PsHV 
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2 also opens the possibility that there may be other unrecognized PsHVs in other species.  
PsHV 1 has been associated with parrots from the neotropics, and now PsHV 2 with 
African grey parrots.  Since the proto-continent that included Australia is believed to be 
the origin of psittaciforms (Cracraft, 2001), then species from that continent may be 
good candidates for future investigation for other PsHVs. 
 
Future studies 
     Infectivity studies may be required to answer conclusively the question of whether 
PsHV 1 can cause IPD or other tumors.  Efforts to transmit mucosal papillomas to 
clinically normal birds with homogenates failed (Sundberg et al., 1986).   However in 
this transmission attempt, the birds were necropsied after 10 weeks and there may not 
have been sufficient time for lesions to develop, or there were insufficient numbers of 
infectious virions in the innoculum.  Such an infectivity study would probably require a 
minimum of two years to identify and test the appropriate model species.  In addition, 
these studies could be quite expensive due to the cost of test subjects, their maintenance, 
and the labor involved in maintaining them.   
     The pool of likely choices as test subjects would include Amazon parrots (Amazona), 
conures (Aratinga), and macaws (Ara).  Each of these species has merit as a model, but 
Ara macaws, such as blue and gold macaws, may be best suited for test subject given the 
lower cost of these animals, their representation in the IPD population, and that these 
birds are susceptible to infection but rarely die of Pachecos disease (PD) with genotype 
3 (Phalen et al., 2004; Tomaszewski et al., 2003).  These birds can be acquired as 
 142
incubator-hatched chicks at four weeks of age and could be hand-reared to completion to 
ensure a specific pathogen-free population.    
     Infecting the birds would require inoculating infectious PsHV 1 genotype 3 virions 
probably by an oral route.  These macaws should become infected but are not likely to 
develop PD.  If species more sensitive to genotype 3 are used in the study or if the 
macaws develop clinical signs, it may be possible to induce a latent infection by rescuing 
the birds with the anti-herpesviral drug acyclovir that might permit infection without 
resulting in PD.   
     The results of our investigations demonstrated that PsHV was present in the tumors 
associated with IPD, but not unaffected tissue.  Efforts to localize PsHV in the neoplastic 
tissues failed due to the limit of detection of the methods used coupled with low 
concentrations and the poor integrity of the PsHV DNA.  It may be possible to improve 
the detection rate of these methods by using frozen sections fixed briefly with 
paraformaldehyde rather than FFPE tissues (Chen et al., 2002).  The use of frozen 
sections with LCM or in situ techniques would avoid the problems related to harsh 
fixation and is associated with a higher degree of success.  If sensitivity can be 
improved, then it may be possible to employ another detection system such as 
digoxigenin, and avoid the non-specific staining associated with the chromagen-
tyramide amplification system in those tissues that were problematic.  Another approach 
would be to sample the frozen sections using LCM in conjunction and examined by 
nested PCR or possibly employ real-time PCR to quantify the concentration of PsHV in 
affected versus unaffected tissues.  The negative controls for such an experiment would 
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include analogous tissues from birds known not to be infected with PsHV, and similarly 
positive controls from birds that died of Pachecos disease.  
     The cutaneous papillomas found on the feet and legs of cockatoos and macaws 
contain herpesvirus virions (Lowenstine et al., 1983; Schmidt et al., 2003).  Yet, these 
herpesviruses have yet to be characterized and do not amplify with known PsHV primers 
(Phalen et al., 1998).  Four cockatoos with plantar papillomas were reported by 
Lowenstine et al. (1983).   Three of these birds were most likely imported, and the fourth 
bird was documented as newly imported.  Whether the herpesviruses found in these 
lesions are endemic to cockatoos or originate in an unknown host species is unclear 
because birds undergoing the quarantine process would have been exposed to parrots 
from other continents.  Further studies elucidating these viruses will need to be 
conducted, probably starting with the use of degenerate primers for conserved 
herpesvirus sequences similar to those used in the discovery of PsHV 2.  Another 
approach may be to use in situ hybridization using randomly generated probes to one or 
more genotypes of PsHV whole virus.  Random probes would target more of the PsHV 
genome and perhaps enhance detection potential. 
     The discovery of PsHV 2 in African grey parrots has potential implications for the 
existence of a broader PsHV family.  The sample size in our investigation was small (4 
birds), and the prevalence of PsHV 2 is unknown.  A PCR survey for the presence of 
PsHV 2 DNA in captive African grey parrots and other psittacines of African origin 
would provide some insight into the species range affected by this virus.  Degenerate 
herpesvirus primers such as those used to amplify the UL30 gene (VanDevanter et al., 
1996) of PsHV 2 could be used to survey Australian parrots.  Ideally, the testing of wild 
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parrots in Africa may help to determine whether PsHV 2 originated in parrots on the 
African continent or came from other species.  Investigating whether PsHV 2 is 
pathogenic is more challenging.  Whether it is associated with papillomas could not be 
concluded from the results of our investigation.   
       The results of these investigations provide strong evidence linking PsHV to the 
development of IPD and other tumors in parrots.  The findings show that mucosal 
papillomas are strongly associated with the presence of PsHV and suggest that bile and 
pancreatic duct tumors are manifestations of IPD and that proventricular/ventricular 
tumors may be related.  Cloacal carcinomas appear to develop by a different pathway.  
With the exception of some mucosal papillomas, the development of all of these tumors 
is associated with the presence of PsHV 1 genotype 3.  Further studies will need to be 
performed to elucidate the oncogenic mechanisms of this genotype. 
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